This pipeline computes the correlation between significant copy number variation (cnv focal) genes and selected clinical features.
Testing the association between copy number variation 100 focal events and 7 clinical features across 528 patients, 443 significant findings detected with Q value < 0.25.
-
amp_1p35.2 cnv correlated to 'YEARS_TO_BIRTH', 'HISTOLOGICAL_TYPE', and 'RACE'.
-
amp_1p34.2 cnv correlated to 'Time to Death', 'YEARS_TO_BIRTH', 'HISTOLOGICAL_TYPE', 'COMPLETENESS_OF_RESECTION', and 'RACE'.
-
amp_1p22.3 cnv correlated to 'YEARS_TO_BIRTH', 'HISTOLOGICAL_TYPE', and 'ETHNICITY'.
-
amp_1q21.3 cnv correlated to 'Time to Death', 'YEARS_TO_BIRTH', 'HISTOLOGICAL_TYPE', and 'RACE'.
-
amp_1q22 cnv correlated to 'Time to Death', 'YEARS_TO_BIRTH', 'HISTOLOGICAL_TYPE', and 'RACE'.
-
amp_1q44 cnv correlated to 'Time to Death' and 'YEARS_TO_BIRTH'.
-
amp_2p24.3 cnv correlated to 'Time to Death', 'YEARS_TO_BIRTH', 'HISTOLOGICAL_TYPE', and 'RADIATIONS_RADIATION_REGIMENINDICATION'.
-
amp_2q13 cnv correlated to 'Time to Death', 'YEARS_TO_BIRTH', and 'HISTOLOGICAL_TYPE'.
-
amp_3p25.1 cnv correlated to 'Time to Death', 'YEARS_TO_BIRTH', 'HISTOLOGICAL_TYPE', 'RADIATIONS_RADIATION_REGIMENINDICATION', and 'RACE'.
-
amp_3p14.1 cnv correlated to 'Time to Death', 'YEARS_TO_BIRTH', 'HISTOLOGICAL_TYPE', 'RADIATIONS_RADIATION_REGIMENINDICATION', 'RACE', and 'ETHNICITY'.
-
amp_3q26.2 cnv correlated to 'Time to Death', 'YEARS_TO_BIRTH', 'HISTOLOGICAL_TYPE', 'RADIATIONS_RADIATION_REGIMENINDICATION', and 'RACE'.
-
amp_3q26.2 cnv correlated to 'Time to Death', 'YEARS_TO_BIRTH', 'HISTOLOGICAL_TYPE', 'RADIATIONS_RADIATION_REGIMENINDICATION', and 'RACE'.
-
amp_4p16.3 cnv correlated to 'YEARS_TO_BIRTH' and 'HISTOLOGICAL_TYPE'.
-
amp_5p15.33 cnv correlated to 'Time to Death', 'YEARS_TO_BIRTH', 'HISTOLOGICAL_TYPE', 'RADIATIONS_RADIATION_REGIMENINDICATION', 'COMPLETENESS_OF_RESECTION', and 'RACE'.
-
amp_5q35.3 cnv correlated to 'Time to Death', 'YEARS_TO_BIRTH', 'HISTOLOGICAL_TYPE', and 'RACE'.
-
amp_6p24.2 cnv correlated to 'Time to Death', 'YEARS_TO_BIRTH', 'HISTOLOGICAL_TYPE', and 'RADIATIONS_RADIATION_REGIMENINDICATION'.
-
amp_6p22.3 cnv correlated to 'YEARS_TO_BIRTH', 'HISTOLOGICAL_TYPE', 'RADIATIONS_RADIATION_REGIMENINDICATION', and 'RACE'.
-
amp_6q25.1 cnv correlated to 'Time to Death', 'YEARS_TO_BIRTH', 'HISTOLOGICAL_TYPE', and 'RACE'.
-
amp_7q31.2 cnv correlated to 'Time to Death', 'YEARS_TO_BIRTH', 'HISTOLOGICAL_TYPE', and 'RADIATIONS_RADIATION_REGIMENINDICATION'.
-
amp_8p11.22 cnv correlated to 'Time to Death'.
-
amp_8p11.21 cnv correlated to 'Time to Death', 'HISTOLOGICAL_TYPE', 'RADIATIONS_RADIATION_REGIMENINDICATION', and 'COMPLETENESS_OF_RESECTION'.
-
amp_8q24.21 cnv correlated to 'Time to Death', 'YEARS_TO_BIRTH', 'HISTOLOGICAL_TYPE', and 'RADIATIONS_RADIATION_REGIMENINDICATION'.
-
amp_8q24.21 cnv correlated to 'Time to Death', 'YEARS_TO_BIRTH', 'HISTOLOGICAL_TYPE', 'RADIATIONS_RADIATION_REGIMENINDICATION', and 'COMPLETENESS_OF_RESECTION'.
-
amp_9p24.2 cnv correlated to 'Time to Death', 'YEARS_TO_BIRTH', 'HISTOLOGICAL_TYPE', 'COMPLETENESS_OF_RESECTION', and 'ETHNICITY'.
-
amp_9q34.3 cnv correlated to 'Time to Death', 'YEARS_TO_BIRTH', 'HISTOLOGICAL_TYPE', and 'RACE'.
-
amp_10q22.2 cnv correlated to 'Time to Death' and 'HISTOLOGICAL_TYPE'.
-
amp_11p11.2 cnv correlated to 'Time to Death', 'YEARS_TO_BIRTH', and 'HISTOLOGICAL_TYPE'.
-
amp_11q13.2 cnv correlated to 'Time to Death', 'YEARS_TO_BIRTH', and 'HISTOLOGICAL_TYPE'.
-
amp_11q14.1 cnv correlated to 'Time to Death', 'YEARS_TO_BIRTH', 'HISTOLOGICAL_TYPE', 'RADIATIONS_RADIATION_REGIMENINDICATION', and 'RACE'.
-
amp_12p12.1 cnv correlated to 'YEARS_TO_BIRTH', 'HISTOLOGICAL_TYPE', 'RACE', and 'ETHNICITY'.
-
amp_12q13.11 cnv correlated to 'HISTOLOGICAL_TYPE', 'RADIATIONS_RADIATION_REGIMENINDICATION', and 'RACE'.
-
amp_12q13.2 cnv correlated to 'YEARS_TO_BIRTH', 'HISTOLOGICAL_TYPE', 'RADIATIONS_RADIATION_REGIMENINDICATION', 'COMPLETENESS_OF_RESECTION', and 'RACE'.
-
amp_13q34 cnv correlated to 'YEARS_TO_BIRTH', 'HISTOLOGICAL_TYPE', 'COMPLETENESS_OF_RESECTION', and 'RACE'.
-
amp_14q24.3 cnv correlated to 'Time to Death', 'YEARS_TO_BIRTH', and 'HISTOLOGICAL_TYPE'.
-
amp_14q32.33 cnv correlated to 'Time to Death', 'YEARS_TO_BIRTH', 'HISTOLOGICAL_TYPE', 'RADIATIONS_RADIATION_REGIMENINDICATION', and 'RACE'.
-
amp_15q26.3 cnv correlated to 'Time to Death', 'YEARS_TO_BIRTH', 'HISTOLOGICAL_TYPE', 'RADIATIONS_RADIATION_REGIMENINDICATION', and 'COMPLETENESS_OF_RESECTION'.
-
amp_16p11.2 cnv correlated to 'Time to Death', 'YEARS_TO_BIRTH', 'HISTOLOGICAL_TYPE', 'COMPLETENESS_OF_RESECTION', and 'RACE'.
-
amp_17q11.2 cnv correlated to 'Time to Death', 'YEARS_TO_BIRTH', 'HISTOLOGICAL_TYPE', 'COMPLETENESS_OF_RESECTION', and 'RACE'.
-
amp_17q12 cnv correlated to 'Time to Death', 'YEARS_TO_BIRTH', 'HISTOLOGICAL_TYPE', and 'RACE'.
-
amp_17q25.1 cnv correlated to 'Time to Death', 'YEARS_TO_BIRTH', 'HISTOLOGICAL_TYPE', and 'RACE'.
-
amp_18p11.31 cnv correlated to 'Time to Death', 'YEARS_TO_BIRTH', 'HISTOLOGICAL_TYPE', 'RADIATIONS_RADIATION_REGIMENINDICATION', 'COMPLETENESS_OF_RESECTION', and 'RACE'.
-
amp_18q11.2 cnv correlated to 'Time to Death', 'YEARS_TO_BIRTH', 'HISTOLOGICAL_TYPE', 'COMPLETENESS_OF_RESECTION', and 'RACE'.
-
amp_19p13.2 cnv correlated to 'Time to Death', 'YEARS_TO_BIRTH', 'HISTOLOGICAL_TYPE', 'RADIATIONS_RADIATION_REGIMENINDICATION', and 'RACE'.
-
amp_19q12 cnv correlated to 'Time to Death', 'YEARS_TO_BIRTH', 'HISTOLOGICAL_TYPE', and 'RACE'.
-
amp_20p13 cnv correlated to 'YEARS_TO_BIRTH', 'HISTOLOGICAL_TYPE', 'RADIATIONS_RADIATION_REGIMENINDICATION', and 'RACE'.
-
amp_20q11.21 cnv correlated to 'Time to Death', 'YEARS_TO_BIRTH', 'HISTOLOGICAL_TYPE', 'RADIATIONS_RADIATION_REGIMENINDICATION', 'COMPLETENESS_OF_RESECTION', and 'RACE'.
-
amp_20q13.12 cnv correlated to 'Time to Death', 'YEARS_TO_BIRTH', 'HISTOLOGICAL_TYPE', 'RADIATIONS_RADIATION_REGIMENINDICATION', 'COMPLETENESS_OF_RESECTION', and 'RACE'.
-
amp_20q13.33 cnv correlated to 'Time to Death', 'YEARS_TO_BIRTH', 'HISTOLOGICAL_TYPE', 'RADIATIONS_RADIATION_REGIMENINDICATION', 'COMPLETENESS_OF_RESECTION', and 'RACE'.
-
amp_22q12.2 cnv correlated to 'Time to Death', 'YEARS_TO_BIRTH', 'HISTOLOGICAL_TYPE', 'RADIATIONS_RADIATION_REGIMENINDICATION', 'COMPLETENESS_OF_RESECTION', and 'RACE'.
-
amp_xp11.23 cnv correlated to 'Time to Death', 'YEARS_TO_BIRTH', 'HISTOLOGICAL_TYPE', and 'RADIATIONS_RADIATION_REGIMENINDICATION'.
-
amp_xq28 cnv correlated to 'Time to Death', 'YEARS_TO_BIRTH', and 'HISTOLOGICAL_TYPE'.
-
del_1p36.21 cnv correlated to 'YEARS_TO_BIRTH' and 'HISTOLOGICAL_TYPE'.
-
del_1p36.11 cnv correlated to 'Time to Death', 'YEARS_TO_BIRTH', 'HISTOLOGICAL_TYPE', and 'COMPLETENESS_OF_RESECTION'.
-
del_2p25.3 cnv correlated to 'Time to Death', 'YEARS_TO_BIRTH', 'HISTOLOGICAL_TYPE', and 'RADIATIONS_RADIATION_REGIMENINDICATION'.
-
del_2q22.1 cnv correlated to 'Time to Death', 'YEARS_TO_BIRTH', 'HISTOLOGICAL_TYPE', 'RADIATIONS_RADIATION_REGIMENINDICATION', 'COMPLETENESS_OF_RESECTION', and 'RACE'.
-
del_2q37.3 cnv correlated to 'Time to Death', 'YEARS_TO_BIRTH', 'HISTOLOGICAL_TYPE', 'RADIATIONS_RADIATION_REGIMENINDICATION', 'COMPLETENESS_OF_RESECTION', and 'RACE'.
-
del_3p14.2 cnv correlated to 'YEARS_TO_BIRTH', 'HISTOLOGICAL_TYPE', 'RACE', and 'ETHNICITY'.
-
del_3q13.31 cnv correlated to 'YEARS_TO_BIRTH' and 'HISTOLOGICAL_TYPE'.
-
del_4p16.3 cnv correlated to 'Time to Death', 'YEARS_TO_BIRTH', and 'HISTOLOGICAL_TYPE'.
-
del_4p15.2 cnv correlated to 'Time to Death', 'YEARS_TO_BIRTH', 'HISTOLOGICAL_TYPE', and 'RADIATIONS_RADIATION_REGIMENINDICATION'.
-
del_4q22.1 cnv correlated to 'Time to Death', 'YEARS_TO_BIRTH', 'HISTOLOGICAL_TYPE', 'RADIATIONS_RADIATION_REGIMENINDICATION', and 'COMPLETENESS_OF_RESECTION'.
-
del_4q34.3 cnv correlated to 'Time to Death', 'YEARS_TO_BIRTH', 'HISTOLOGICAL_TYPE', 'RADIATIONS_RADIATION_REGIMENINDICATION', 'COMPLETENESS_OF_RESECTION', and 'RACE'.
-
del_5q12.1 cnv correlated to 'Time to Death', 'YEARS_TO_BIRTH', 'HISTOLOGICAL_TYPE', and 'RACE'.
-
del_6q26 cnv correlated to 'YEARS_TO_BIRTH' and 'HISTOLOGICAL_TYPE'.
-
del_7p22.3 cnv correlated to 'Time to Death', 'YEARS_TO_BIRTH', 'HISTOLOGICAL_TYPE', and 'RACE'.
-
del_7q11.22 cnv correlated to 'YEARS_TO_BIRTH' and 'HISTOLOGICAL_TYPE'.
-
del_7q31.1 cnv correlated to 'Time to Death', 'YEARS_TO_BIRTH', 'HISTOLOGICAL_TYPE', and 'RACE'.
-
del_7q36.1 cnv correlated to 'Time to Death', 'YEARS_TO_BIRTH', and 'HISTOLOGICAL_TYPE'.
-
del_8p23.2 cnv correlated to 'Time to Death', 'YEARS_TO_BIRTH', 'HISTOLOGICAL_TYPE', 'RADIATIONS_RADIATION_REGIMENINDICATION', 'COMPLETENESS_OF_RESECTION', and 'RACE'.
-
del_8p21.2 cnv correlated to 'Time to Death', 'YEARS_TO_BIRTH', 'HISTOLOGICAL_TYPE', 'RADIATIONS_RADIATION_REGIMENINDICATION', 'COMPLETENESS_OF_RESECTION', and 'RACE'.
-
del_9p23 cnv correlated to 'Time to Death', 'YEARS_TO_BIRTH', 'HISTOLOGICAL_TYPE', 'RADIATIONS_RADIATION_REGIMENINDICATION', and 'RACE'.
-
del_9q21.2 cnv correlated to 'Time to Death', 'YEARS_TO_BIRTH', 'HISTOLOGICAL_TYPE', 'RADIATIONS_RADIATION_REGIMENINDICATION', and 'RACE'.
-
del_9q34.2 cnv correlated to 'Time to Death', 'YEARS_TO_BIRTH', 'HISTOLOGICAL_TYPE', and 'RADIATIONS_RADIATION_REGIMENINDICATION'.
-
del_10q23.31 cnv correlated to 'Time to Death', 'YEARS_TO_BIRTH', 'HISTOLOGICAL_TYPE', and 'RADIATIONS_RADIATION_REGIMENINDICATION'.
-
del_11p15.5 cnv correlated to 'Time to Death', 'YEARS_TO_BIRTH', 'HISTOLOGICAL_TYPE', 'RADIATIONS_RADIATION_REGIMENINDICATION', 'COMPLETENESS_OF_RESECTION', and 'RACE'.
-
del_11q14.1 cnv correlated to 'Time to Death', 'YEARS_TO_BIRTH', 'HISTOLOGICAL_TYPE', 'RADIATIONS_RADIATION_REGIMENINDICATION', 'RACE', and 'ETHNICITY'.
-
del_11q25 cnv correlated to 'Time to Death', 'YEARS_TO_BIRTH', 'HISTOLOGICAL_TYPE', 'RADIATIONS_RADIATION_REGIMENINDICATION', and 'RACE'.
-
del_12q23.1 cnv correlated to 'Time to Death', 'YEARS_TO_BIRTH', 'HISTOLOGICAL_TYPE', 'RADIATIONS_RADIATION_REGIMENINDICATION', 'COMPLETENESS_OF_RESECTION', and 'RACE'.
-
del_12q24.33 cnv correlated to 'Time to Death', 'YEARS_TO_BIRTH', 'HISTOLOGICAL_TYPE', 'RADIATIONS_RADIATION_REGIMENINDICATION', and 'COMPLETENESS_OF_RESECTION'.
-
del_13q11 cnv correlated to 'Time to Death', 'YEARS_TO_BIRTH', 'HISTOLOGICAL_TYPE', and 'RADIATIONS_RADIATION_REGIMENINDICATION'.
-
del_13q14.2 cnv correlated to 'Time to Death', 'YEARS_TO_BIRTH', 'HISTOLOGICAL_TYPE', 'RADIATIONS_RADIATION_REGIMENINDICATION', and 'RACE'.
-
del_14q13.1 cnv correlated to 'Time to Death', 'YEARS_TO_BIRTH', 'HISTOLOGICAL_TYPE', and 'RACE'.
-
del_15q15.1 cnv correlated to 'Time to Death', 'YEARS_TO_BIRTH', 'HISTOLOGICAL_TYPE', 'RADIATIONS_RADIATION_REGIMENINDICATION', 'COMPLETENESS_OF_RESECTION', and 'RACE'.
-
del_15q23 cnv correlated to 'Time to Death', 'YEARS_TO_BIRTH', 'HISTOLOGICAL_TYPE', 'RADIATIONS_RADIATION_REGIMENINDICATION', and 'RACE'.
-
del_16p13.3 cnv correlated to 'Time to Death', 'YEARS_TO_BIRTH', 'HISTOLOGICAL_TYPE', 'RADIATIONS_RADIATION_REGIMENINDICATION', 'COMPLETENESS_OF_RESECTION', and 'RACE'.
-
del_16q21 cnv correlated to 'Time to Death', 'YEARS_TO_BIRTH', 'HISTOLOGICAL_TYPE', 'RADIATIONS_RADIATION_REGIMENINDICATION', and 'RACE'.
-
del_16q22.3 cnv correlated to 'Time to Death', 'YEARS_TO_BIRTH', 'HISTOLOGICAL_TYPE', and 'RACE'.
-
del_16q23.1 cnv correlated to 'Time to Death', 'YEARS_TO_BIRTH', 'HISTOLOGICAL_TYPE', 'COMPLETENESS_OF_RESECTION', and 'RACE'.
-
del_17p13.3 cnv correlated to 'Time to Death', 'YEARS_TO_BIRTH', 'HISTOLOGICAL_TYPE', 'RADIATIONS_RADIATION_REGIMENINDICATION', 'COMPLETENESS_OF_RESECTION', and 'RACE'.
-
del_17p11.2 cnv correlated to 'Time to Death', 'YEARS_TO_BIRTH', 'HISTOLOGICAL_TYPE', 'RADIATIONS_RADIATION_REGIMENINDICATION', and 'RACE'.
-
del_17q11.2 cnv correlated to 'Time to Death', 'YEARS_TO_BIRTH', and 'HISTOLOGICAL_TYPE'.
-
del_17q21.31 cnv correlated to 'Time to Death', 'YEARS_TO_BIRTH', 'HISTOLOGICAL_TYPE', 'RADIATIONS_RADIATION_REGIMENINDICATION', 'COMPLETENESS_OF_RESECTION', and 'ETHNICITY'.
-
del_18q21.2 cnv correlated to 'YEARS_TO_BIRTH', 'HISTOLOGICAL_TYPE', 'RADIATIONS_RADIATION_REGIMENINDICATION', 'COMPLETENESS_OF_RESECTION', and 'RACE'.
-
del_18q23 cnv correlated to 'Time to Death', 'YEARS_TO_BIRTH', 'HISTOLOGICAL_TYPE', 'RADIATIONS_RADIATION_REGIMENINDICATION', 'COMPLETENESS_OF_RESECTION', 'RACE', and 'ETHNICITY'.
-
del_19p13.3 cnv correlated to 'Time to Death', 'YEARS_TO_BIRTH', 'HISTOLOGICAL_TYPE', 'RADIATIONS_RADIATION_REGIMENINDICATION', 'COMPLETENESS_OF_RESECTION', and 'RACE'.
-
del_19p12 cnv correlated to 'Time to Death', 'YEARS_TO_BIRTH', 'HISTOLOGICAL_TYPE', 'RADIATIONS_RADIATION_REGIMENINDICATION', and 'RACE'.
-
del_19q13.43 cnv correlated to 'Time to Death', 'YEARS_TO_BIRTH', 'HISTOLOGICAL_TYPE', and 'COMPLETENESS_OF_RESECTION'.
-
del_20p12.1 cnv correlated to 'Time to Death', 'YEARS_TO_BIRTH', 'HISTOLOGICAL_TYPE', and 'COMPLETENESS_OF_RESECTION'.
-
del_22q13.32 cnv correlated to 'Time to Death', 'YEARS_TO_BIRTH', 'HISTOLOGICAL_TYPE', 'RADIATIONS_RADIATION_REGIMENINDICATION', and 'RACE'.
-
del_xp21.1 cnv correlated to 'Time to Death', 'YEARS_TO_BIRTH', 'HISTOLOGICAL_TYPE', 'COMPLETENESS_OF_RESECTION', and 'RACE'.
Clinical Features |
Time to Death |
YEARS TO BIRTH |
HISTOLOGICAL TYPE |
RADIATIONS RADIATION REGIMENINDICATION |
COMPLETENESS OF RESECTION |
RACE | ETHNICITY | ||
nCNV (%) | nWild-Type | logrank test | Wilcoxon-test | Fisher's exact test | Fisher's exact test | Fisher's exact test | Fisher's exact test | Fisher's exact test | |
del 18q23 | 95 (18%) | 433 |
0.0051 (0.0141) |
0.000443 (0.00168) |
1e-05 (5.88e-05) |
0.000482 (0.00181) |
0.0122 (0.0291) |
0.0608 (0.114) |
0.149 (0.236) |
amp 3p14 1 | 63 (12%) | 465 |
0.00125 (0.00421) |
0.00377 (0.011) |
8e-05 (0.000397) |
0.0476 (0.0932) |
0.263 (0.368) |
0.0109 (0.0264) |
0.0802 (0.145) |
amp 5p15 33 | 88 (17%) | 440 |
0.000241 (0.001) |
0.000107 (0.000504) |
1e-05 (5.88e-05) |
0.113 (0.191) |
0.133 (0.22) |
0.00247 (0.00758) |
0.277 (0.384) |
amp 18p11 31 | 94 (18%) | 434 |
0.00693 (0.0177) |
8.63e-05 (0.000422) |
1e-05 (5.88e-05) |
0.0204 (0.0451) |
0.0266 (0.0567) |
0.00112 (0.00385) |
1 (1.00) |
amp 20q11 21 | 149 (28%) | 379 |
0.000289 (0.00116) |
1.88e-08 (1.2e-06) |
1e-05 (5.88e-05) |
0.00612 (0.0161) |
0.106 (0.182) |
0.00654 (0.017) |
0.542 (0.637) |
amp 20q13 12 | 149 (28%) | 379 |
0.00947 (0.0234) |
1.34e-08 (1e-06) |
1e-05 (5.88e-05) |
0.00104 (0.00369) |
0.0596 (0.112) |
0.00522 (0.0143) |
0.554 (0.648) |
amp 20q13 33 | 150 (28%) | 378 |
0.014 (0.0326) |
3.51e-08 (1.75e-06) |
1e-05 (5.88e-05) |
0.00101 (0.00362) |
0.0133 (0.0313) |
0.0395 (0.0806) |
1 (1.00) |
amp 22q12 2 | 62 (12%) | 466 |
0.000495 (0.00185) |
0.000572 (0.00212) |
1e-05 (5.88e-05) |
0.0474 (0.0932) |
0.00228 (0.00709) |
0.0256 (0.0548) |
0.675 (0.762) |
del 2q22 1 | 46 (9%) | 482 |
1.26e-07 (5.19e-06) |
0.0048 (0.0134) |
1e-05 (5.88e-05) |
0.0027 (0.00814) |
0.00162 (0.00525) |
0.0849 (0.152) |
1 (1.00) |
del 2q37 3 | 52 (10%) | 476 |
0.0185 (0.0413) |
0.00257 (0.00787) |
0.0001 (0.000473) |
0.137 (0.223) |
0.0439 (0.0871) |
0.142 (0.228) |
1 (1.00) |
del 4q34 3 | 127 (24%) | 401 |
0.00667 (0.0172) |
6.72e-07 (2.35e-05) |
1e-05 (5.88e-05) |
0.134 (0.221) |
0.137 (0.224) |
0.0115 (0.0277) |
1 (1.00) |
del 8p23 2 | 115 (22%) | 413 |
0.000772 (0.00282) |
2.17e-05 (0.00012) |
1e-05 (5.88e-05) |
0.122 (0.205) |
0.0585 (0.111) |
0.00564 (0.0151) |
0.319 (0.422) |
del 8p21 2 | 113 (21%) | 415 |
0.00679 (0.0174) |
2.6e-06 (5.88e-05) |
1e-05 (5.88e-05) |
0.151 (0.24) |
0.146 (0.233) |
0.00731 (0.0186) |
0.743 (0.808) |
del 11p15 5 | 102 (19%) | 426 |
0.0163 (0.037) |
1.22e-05 (6.98e-05) |
1e-05 (5.88e-05) |
0.00584 (0.0155) |
0.0897 (0.159) |
0.0548 (0.105) |
0.498 (0.593) |
del 11q14 1 | 70 (13%) | 458 |
0.0903 (0.16) |
0.000288 (0.00116) |
1e-05 (5.88e-05) |
0.0591 (0.112) |
0.65 (0.738) |
0.0717 (0.132) |
0.0431 (0.0857) |
del 12q23 1 | 53 (10%) | 475 |
0.000179 (0.000803) |
0.00236 (0.00727) |
1e-05 (5.88e-05) |
0.0491 (0.0956) |
0.041 (0.083) |
0.0413 (0.0831) |
1 (1.00) |
del 15q15 1 | 136 (26%) | 392 |
7.04e-05 (0.000357) |
2.37e-08 (1.38e-06) |
1e-05 (5.88e-05) |
0.0131 (0.0308) |
0.0396 (0.0806) |
0.0549 (0.105) |
1 (1.00) |
del 16p13 3 | 90 (17%) | 438 |
0.00536 (0.0145) |
2.2e-06 (5.88e-05) |
1e-05 (5.88e-05) |
0.0682 (0.127) |
0.105 (0.181) |
0.0297 (0.0618) |
1 (1.00) |
del 17p13 3 | 119 (23%) | 409 |
0.000112 (0.000522) |
0.000232 (0.000974) |
1e-05 (5.88e-05) |
0.0451 (0.0889) |
0.146 (0.233) |
0.00155 (0.00507) |
1 (1.00) |
del 17q21 31 | 109 (21%) | 419 |
0.000198 (0.000864) |
1.18e-05 (6.85e-05) |
1e-05 (5.88e-05) |
0.0522 (0.101) |
0.0707 (0.131) |
0.174 (0.267) |
0.0481 (0.094) |
del 19p13 3 | 151 (29%) | 377 |
7.09e-06 (5.88e-05) |
1.35e-10 (4.73e-08) |
1e-05 (5.88e-05) |
0.0815 (0.147) |
0.00614 (0.0161) |
0.00027 (0.00111) |
0.241 (0.343) |
amp 1p34 2 | 72 (14%) | 456 |
0.00499 (0.0138) |
9.18e-05 (0.00044) |
1e-05 (5.88e-05) |
0.254 (0.358) |
0.0924 (0.163) |
0.0283 (0.0597) |
0.698 (0.781) |
amp 3p25 1 | 80 (15%) | 448 |
0.031 (0.0639) |
0.000276 (0.00113) |
1e-05 (5.88e-05) |
0.0992 (0.173) |
0.695 (0.78) |
0.00328 (0.00969) |
0.47 (0.572) |
amp 3q26 2 | 171 (32%) | 357 |
0.000911 (0.00327) |
2.54e-11 (1.78e-08) |
1e-05 (5.88e-05) |
0.0273 (0.0577) |
0.306 (0.412) |
2e-05 (0.000111) |
0.563 (0.655) |
amp 3q26 2 | 159 (30%) | 369 |
0.00286 (0.00857) |
3.3e-09 (4.62e-07) |
1e-05 (5.88e-05) |
0.0533 (0.103) |
0.201 (0.298) |
0.00015 (0.000686) |
0.243 (0.345) |
amp 8q24 21 | 212 (40%) | 316 |
0.000397 (0.00152) |
0.0149 (0.0343) |
1e-05 (5.88e-05) |
0.00359 (0.0105) |
0.0114 (0.0276) |
0.566 (0.658) |
0.786 (0.84) |
amp 9p24 2 | 64 (12%) | 464 |
0.0302 (0.0625) |
0.00194 (0.00614) |
1e-05 (5.88e-05) |
0.291 (0.396) |
0.135 (0.222) |
0.166 (0.26) |
0.0214 (0.0472) |
amp 11q14 1 | 56 (11%) | 472 |
5.34e-07 (1.97e-05) |
0.0108 (0.0263) |
1e-05 (5.88e-05) |
0.15 (0.237) |
0.335 (0.44) |
0.101 (0.176) |
1 (1.00) |
amp 12q13 2 | 97 (18%) | 431 |
0.697 (0.78) |
0.113 (0.192) |
1e-05 (5.88e-05) |
0.0561 (0.106) |
0.124 (0.207) |
0.124 (0.207) |
0.745 (0.809) |
amp 14q32 33 | 76 (14%) | 452 |
0.00433 (0.0123) |
0.00112 (0.00385) |
1e-05 (5.88e-05) |
0.00784 (0.0197) |
0.401 (0.508) |
0.0198 (0.0439) |
0.703 (0.783) |
amp 15q26 3 | 37 (7%) | 491 |
0.00146 (0.00479) |
0.00329 (0.00969) |
9e-05 (0.000434) |
0.081 (0.146) |
0.0122 (0.0291) |
0.787 (0.84) |
0.346 (0.453) |
amp 16p11 2 | 64 (12%) | 464 |
0.0156 (0.0359) |
0.000343 (0.00134) |
1e-05 (5.88e-05) |
0.451 (0.553) |
0.0732 (0.135) |
0.0954 (0.167) |
0.692 (0.778) |
amp 17q11 2 | 71 (13%) | 457 |
0.00184 (0.00588) |
0.00579 (0.0154) |
1e-05 (5.88e-05) |
0.313 (0.418) |
0.00113 (0.00386) |
0.00234 (0.00725) |
0.404 (0.509) |
amp 18q11 2 | 68 (13%) | 460 |
0.00841 (0.021) |
0.00197 (0.00623) |
1e-05 (5.88e-05) |
0.383 (0.49) |
0.0755 (0.138) |
0.00519 (0.0142) |
1 (1.00) |
amp 19p13 2 | 97 (18%) | 431 |
0.0128 (0.0303) |
4.56e-10 (9.41e-08) |
1e-05 (5.88e-05) |
0.0561 (0.106) |
0.301 (0.408) |
0.00133 (0.00443) |
1 (1.00) |
del 4q22 1 | 102 (19%) | 426 |
0.00539 (0.0145) |
8e-06 (5.88e-05) |
1e-05 (5.88e-05) |
0.135 (0.222) |
0.0787 (0.144) |
0.238 (0.34) |
0.737 (0.806) |
del 9p23 | 76 (14%) | 452 |
0.0163 (0.037) |
0.00143 (0.00473) |
1e-05 (5.88e-05) |
0.0491 (0.0956) |
0.331 (0.436) |
0.13 (0.215) |
0.703 (0.783) |
del 9q21 2 | 126 (24%) | 402 |
1.41e-05 (8.05e-05) |
5.38e-10 (9.41e-08) |
1e-05 (5.88e-05) |
0.135 (0.221) |
0.173 (0.267) |
0.0288 (0.0605) |
0.751 (0.812) |
del 11q25 | 92 (17%) | 436 |
0.00906 (0.0224) |
0.000253 (0.00105) |
1e-05 (5.88e-05) |
0.00266 (0.0081) |
0.39 (0.497) |
0.0842 (0.151) |
0.725 (0.799) |
del 12q24 33 | 63 (12%) | 465 |
0.00562 (0.0151) |
2.22e-05 (0.000121) |
1e-05 (5.88e-05) |
0.0219 (0.0481) |
0.0267 (0.0567) |
0.29 (0.396) |
1 (1.00) |
del 13q14 2 | 103 (20%) | 425 |
0.00126 (0.00423) |
0.00137 (0.00454) |
1e-05 (5.88e-05) |
0.009 (0.0223) |
0.403 (0.509) |
0.154 (0.243) |
0.192 (0.291) |
del 15q23 | 113 (21%) | 415 |
0.0119 (0.0286) |
8.57e-06 (5.88e-05) |
1e-05 (5.88e-05) |
0.0551 (0.105) |
0.431 (0.534) |
0.0338 (0.0691) |
0.318 (0.422) |
del 16q21 | 150 (28%) | 378 |
0.00957 (0.0235) |
1.31e-08 (1e-06) |
1e-05 (5.88e-05) |
0.082 (0.148) |
0.23 (0.331) |
0.0232 (0.0507) |
0.765 (0.825) |
del 16q23 1 | 162 (31%) | 366 |
0.00282 (0.00847) |
8.79e-09 (8.79e-07) |
1e-05 (5.88e-05) |
0.201 (0.298) |
0.0173 (0.039) |
0.00318 (0.00943) |
1 (1.00) |
del 17p11 2 | 124 (23%) | 404 |
0.000381 (0.00148) |
4.49e-06 (5.88e-05) |
1e-05 (5.88e-05) |
0.105 (0.182) |
0.514 (0.611) |
0.0125 (0.0296) |
1 (1.00) |
del 18q21 2 | 89 (17%) | 439 |
0.427 (0.532) |
0.0003 (0.0012) |
1e-05 (5.88e-05) |
0.00383 (0.0111) |
0.129 (0.214) |
0.0696 (0.13) |
0.288 (0.395) |
del 19p12 | 57 (11%) | 471 |
0.0869 (0.155) |
0.0143 (0.0332) |
1e-05 (5.88e-05) |
0.0256 (0.0548) |
0.166 (0.26) |
0.126 (0.21) |
0.659 (0.746) |
del 22q13 32 | 136 (26%) | 392 |
0.000218 (0.000919) |
1.05e-07 (4.59e-06) |
1e-05 (5.88e-05) |
0.0242 (0.0525) |
0.288 (0.395) |
0.0157 (0.0359) |
0.224 (0.324) |
del xp21 1 | 84 (16%) | 444 |
1.97e-05 (0.000111) |
0.000139 (0.00064) |
1e-05 (5.88e-05) |
0.178 (0.272) |
0.125 (0.208) |
0.00411 (0.0117) |
0.254 (0.358) |
amp 1q21 3 | 236 (45%) | 292 |
0.0153 (0.0353) |
5.3e-06 (5.88e-05) |
2e-05 (0.000111) |
0.237 (0.34) |
0.647 (0.738) |
0.00663 (0.0171) |
0.276 (0.383) |
amp 1q22 | 249 (47%) | 279 |
0.000798 (0.00289) |
4.65e-08 (2.17e-06) |
1e-05 (5.88e-05) |
0.431 (0.534) |
0.284 (0.392) |
0.0165 (0.0374) |
0.42 (0.525) |
amp 2p24 3 | 118 (22%) | 410 |
6.26e-05 (0.000324) |
0.0135 (0.0316) |
1e-05 (5.88e-05) |
0.0251 (0.0542) |
0.723 (0.799) |
0.433 (0.537) |
0.203 (0.3) |
amp 5q35 3 | 53 (10%) | 475 |
0.00614 (0.0161) |
0.000282 (0.00115) |
1e-05 (5.88e-05) |
0.194 (0.292) |
0.522 (0.619) |
0.0197 (0.0438) |
0.388 (0.495) |
amp 6p24 2 | 114 (22%) | 414 |
0.0559 (0.106) |
2.5e-06 (5.88e-05) |
1e-05 (5.88e-05) |
0.0937 (0.164) |
0.733 (0.804) |
0.162 (0.255) |
0.744 (0.808) |
amp 6p22 3 | 104 (20%) | 424 |
0.352 (0.459) |
0.000195 (0.000856) |
1e-05 (5.88e-05) |
0.108 (0.185) |
0.553 (0.648) |
0.00738 (0.0187) |
0.484 (0.582) |
amp 6q25 1 | 84 (16%) | 444 |
0.0921 (0.163) |
0.00172 (0.00555) |
1e-05 (5.88e-05) |
0.42 (0.525) |
0.17 (0.264) |
0.00526 (0.0143) |
0.704 (0.783) |
amp 7q31 2 | 90 (17%) | 438 |
8.52e-07 (2.73e-05) |
0.0795 (0.144) |
7e-05 (0.000357) |
0.0184 (0.0413) |
0.45 (0.553) |
0.764 (0.825) |
0.482 (0.581) |
amp 8p11 21 | 161 (30%) | 367 |
1.13e-05 (6.56e-05) |
0.918 (0.966) |
1e-05 (5.88e-05) |
0.019 (0.0423) |
0.00642 (0.0168) |
0.184 (0.28) |
0.562 (0.655) |
amp 8q24 21 | 206 (39%) | 322 |
0.000217 (0.000919) |
0.0412 (0.083) |
1e-05 (5.88e-05) |
0.00478 (0.0134) |
0.199 (0.296) |
0.159 (0.25) |
0.418 (0.523) |
amp 9q34 3 | 38 (7%) | 490 |
0.0429 (0.0855) |
0.00159 (0.00516) |
1e-05 (5.88e-05) |
0.708 (0.785) |
0.557 (0.651) |
0.00983 (0.0241) |
0.612 (0.705) |
amp 12p12 1 | 92 (17%) | 436 |
0.95 (0.996) |
0.145 (0.232) |
1e-05 (5.88e-05) |
0.299 (0.406) |
0.634 (0.726) |
0.117 (0.198) |
0.145 (0.232) |
amp 13q34 | 57 (11%) | 471 |
0.526 (0.622) |
8.49e-05 (0.000418) |
1e-05 (5.88e-05) |
0.874 (0.927) |
0.0141 (0.0327) |
0.0622 (0.116) |
1 (1.00) |
amp 17q12 | 74 (14%) | 454 |
0.000384 (0.00148) |
0.0027 (0.00814) |
1e-05 (5.88e-05) |
1 (1.00) |
0.261 (0.367) |
0.0053 (0.0144) |
1 (1.00) |
amp 17q25 1 | 102 (19%) | 426 |
0.000212 (0.000903) |
0.00112 (0.00385) |
1e-05 (5.88e-05) |
0.457 (0.558) |
0.175 (0.268) |
8e-05 (0.000397) |
0.318 (0.422) |
amp 19q12 | 116 (22%) | 412 |
4.99e-05 (0.000265) |
1.44e-08 (1e-06) |
1e-05 (5.88e-05) |
0.285 (0.393) |
0.217 (0.316) |
3e-05 (0.000162) |
1 (1.00) |
amp 20p13 | 116 (22%) | 412 |
0.307 (0.412) |
2.37e-06 (5.88e-05) |
1e-05 (5.88e-05) |
0.033 (0.0678) |
0.518 (0.615) |
0.0445 (0.088) |
0.317 (0.422) |
amp xp11 23 | 89 (17%) | 439 |
0.0887 (0.158) |
0.029 (0.0605) |
0.00034 (0.00134) |
0.025 (0.0541) |
0.486 (0.584) |
0.942 (0.988) |
0.48 (0.58) |
del 1p36 11 | 79 (15%) | 449 |
0.00773 (0.0195) |
9.85e-05 (0.000469) |
1e-05 (5.88e-05) |
0.49 (0.587) |
0.0421 (0.0845) |
0.344 (0.451) |
0.247 (0.349) |
del 2p25 3 | 26 (5%) | 502 |
0.0429 (0.0855) |
0.071 (0.132) |
0.0104 (0.0254) |
0.109 (0.185) |
0.291 (0.396) |
0.449 (0.553) |
1 (1.00) |
del 3p14 2 | 77 (15%) | 451 |
0.264 (0.369) |
0.00112 (0.00385) |
1e-05 (5.88e-05) |
0.264 (0.369) |
0.774 (0.833) |
0.022 (0.0482) |
0.141 (0.228) |
del 4p15 2 | 93 (18%) | 435 |
0.00057 (0.00212) |
7.19e-05 (0.000362) |
1e-05 (5.88e-05) |
0.0929 (0.163) |
0.491 (0.587) |
0.349 (0.455) |
0.306 (0.412) |
del 5q12 1 | 109 (21%) | 419 |
0.00485 (0.0135) |
6.11e-06 (5.88e-05) |
1e-05 (5.88e-05) |
0.227 (0.327) |
0.705 (0.783) |
0.0747 (0.137) |
0.192 (0.291) |
del 7p22 3 | 70 (13%) | 458 |
0.00112 (0.00385) |
6.52e-05 (0.000336) |
1e-05 (5.88e-05) |
0.472 (0.572) |
0.274 (0.381) |
0.119 (0.201) |
0.692 (0.778) |
del 7q31 1 | 53 (10%) | 475 |
0.0267 (0.0567) |
5.65e-05 (0.000295) |
1e-05 (5.88e-05) |
1 (1.00) |
0.413 (0.518) |
0.114 (0.192) |
1 (1.00) |
del 9q34 2 | 128 (24%) | 400 |
0.000133 (0.000615) |
2.65e-08 (1.42e-06) |
1e-05 (5.88e-05) |
0.109 (0.185) |
0.21 (0.309) |
0.159 (0.25) |
1 (1.00) |
del 10q23 31 | 75 (14%) | 453 |
0.00423 (0.012) |
0.000879 (0.00317) |
1e-05 (5.88e-05) |
0.00452 (0.0128) |
0.221 (0.321) |
0.319 (0.422) |
1 (1.00) |
del 13q11 | 94 (18%) | 434 |
0.00311 (0.00928) |
0.00111 (0.00385) |
1e-05 (5.88e-05) |
0.0397 (0.0806) |
0.193 (0.291) |
0.319 (0.422) |
0.306 (0.412) |
del 14q13 1 | 71 (13%) | 457 |
0.00804 (0.0202) |
0.00402 (0.0115) |
1e-05 (5.88e-05) |
0.471 (0.572) |
1 (1.00) |
0.00394 (0.0113) |
0.409 (0.513) |
del 16q22 3 | 154 (29%) | 374 |
0.0289 (0.0605) |
5.81e-09 (6.78e-07) |
1e-05 (5.88e-05) |
0.196 (0.293) |
0.2 (0.298) |
0.0323 (0.0665) |
1 (1.00) |
del 19q13 43 | 65 (12%) | 463 |
0.00191 (0.00608) |
0.000307 (0.00122) |
1e-05 (5.88e-05) |
0.37 (0.476) |
0.0255 (0.0548) |
0.191 (0.29) |
0.232 (0.333) |
del 20p12 1 | 35 (7%) | 493 |
8.85e-05 (0.00043) |
0.14 (0.228) |
0.0002 (0.000864) |
1 (1.00) |
0.106 (0.182) |
0.178 (0.272) |
0.289 (0.396) |
amp 1p35 2 | 55 (10%) | 473 |
0.209 (0.307) |
0.000173 (0.000783) |
1e-05 (5.88e-05) |
0.747 (0.81) |
0.257 (0.361) |
0.144 (0.231) |
0.635 (0.727) |
amp 1p22 3 | 95 (18%) | 433 |
0.457 (0.558) |
0.00124 (0.00421) |
0.00018 (0.000803) |
0.443 (0.548) |
0.898 (0.947) |
0.343 (0.451) |
0.14 (0.227) |
amp 2q13 | 116 (22%) | 412 |
4.22e-05 (0.000225) |
0.00032 (0.00126) |
1e-05 (5.88e-05) |
0.406 (0.511) |
0.246 (0.349) |
0.211 (0.309) |
0.743 (0.808) |
amp 11p11 2 | 50 (9%) | 478 |
0.00175 (0.00563) |
0.000211 (0.000903) |
1e-05 (5.88e-05) |
0.738 (0.806) |
0.648 (0.738) |
0.358 (0.465) |
0.36 (0.465) |
amp 11q13 2 | 70 (13%) | 458 |
0.00465 (0.0131) |
0.000622 (0.00228) |
1e-05 (5.88e-05) |
0.472 (0.572) |
0.176 (0.269) |
0.665 (0.752) |
1 (1.00) |
amp 12q13 11 | 84 (16%) | 444 |
0.592 (0.685) |
0.651 (0.738) |
1e-05 (5.88e-05) |
0.106 (0.182) |
0.308 (0.413) |
0.0178 (0.04) |
0.482 (0.581) |
amp 14q24 3 | 63 (12%) | 465 |
0.000162 (0.000736) |
0.00117 (0.00398) |
1e-05 (5.88e-05) |
0.172 (0.267) |
0.388 (0.495) |
0.399 (0.507) |
0.681 (0.767) |
amp xq28 | 89 (17%) | 439 |
0.000466 (0.00176) |
0.0513 (0.0994) |
0.00059 (0.00217) |
0.896 (0.946) |
0.207 (0.304) |
0.527 (0.622) |
0.713 (0.789) |
del 4p16 3 | 89 (17%) | 439 |
0.00202 (0.00633) |
0.000181 (0.000803) |
1e-05 (5.88e-05) |
0.359 (0.465) |
0.855 (0.908) |
0.31 (0.415) |
0.728 (0.8) |
del 7q36 1 | 62 (12%) | 466 |
0.00848 (0.0211) |
3.24e-07 (1.26e-05) |
1e-05 (5.88e-05) |
0.649 (0.738) |
0.369 (0.476) |
0.389 (0.495) |
1 (1.00) |
del 17q11 2 | 101 (19%) | 427 |
0.0291 (0.0605) |
8.58e-07 (2.73e-05) |
1e-05 (5.88e-05) |
0.169 (0.263) |
0.23 (0.331) |
0.777 (0.833) |
0.737 (0.806) |
amp 1q44 | 213 (40%) | 315 |
0.0718 (0.132) |
0.00104 (0.00369) |
0.45 (0.553) |
0.616 (0.707) |
0.496 (0.592) |
0.195 (0.293) |
0.169 (0.263) |
amp 4p16 3 | 52 (10%) | 476 |
0.24 (0.342) |
2.74e-05 (0.000149) |
1e-05 (5.88e-05) |
0.51 (0.607) |
0.197 (0.294) |
0.543 (0.638) |
0.36 (0.465) |
amp 10q22 2 | 143 (27%) | 385 |
0.0931 (0.163) |
0.213 (0.312) |
0.00337 (0.00987) |
0.378 (0.485) |
0.447 (0.552) |
0.575 (0.667) |
0.766 (0.825) |
del 1p36 21 | 69 (13%) | 459 |
0.22 (0.32) |
0.000199 (0.000864) |
1e-05 (5.88e-05) |
0.884 (0.937) |
0.567 (0.658) |
0.204 (0.302) |
0.399 (0.507) |
del 3q13 31 | 42 (8%) | 486 |
0.776 (0.833) |
0.000389 (0.0015) |
1e-05 (5.88e-05) |
0.28 (0.387) |
0.823 (0.877) |
0.784 (0.839) |
1 (1.00) |
del 6q26 | 45 (9%) | 483 |
0.174 (0.267) |
0.00651 (0.0169) |
1e-05 (5.88e-05) |
0.598 (0.69) |
0.931 (0.978) |
0.887 (0.938) |
0.614 (0.706) |
del 7q11 22 | 39 (7%) | 489 |
0.987 (1.00) |
5.17e-05 (0.000272) |
1e-05 (5.88e-05) |
0.708 (0.785) |
0.607 (0.7) |
0.464 (0.566) |
1 (1.00) |
amp 8p11 22 | 125 (24%) | 403 |
0.00209 (0.00652) |
0.217 (0.316) |
0.828 (0.881) |
0.355 (0.462) |
0.727 (0.8) |
0.292 (0.397) |
0.532 (0.627) |
P value = 0.000173 (Wilcoxon-test), Q value = 0.00078
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 526 | 64.0 (11.2) |
AMP PEAK 1(1P35.2) MUTATED | 54 | 68.7 (8.8) |
AMP PEAK 1(1P35.2) WILD-TYPE | 472 | 63.5 (11.3) |
P value = 1e-05 (Fisher's exact test), Q value = 5.9e-05
nPatients | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA | MIXED SEROUS AND ENDOMETRIOID | SEROUS ENDOMETRIAL ADENOCARCINOMA |
---|---|---|---|
ALL | 395 | 21 | 112 |
AMP PEAK 1(1P35.2) MUTATED | 16 | 5 | 34 |
AMP PEAK 1(1P35.2) WILD-TYPE | 379 | 16 | 78 |
P value = 0.144 (Fisher's exact test), Q value = 0.23
nPatients | AMERICAN INDIAN OR ALASKA NATIVE | ASIAN | BLACK OR AFRICAN AMERICAN | NATIVE HAWAIIAN OR OTHER PACIFIC ISLANDER | WHITE |
---|---|---|---|---|---|
ALL | 4 | 20 | 101 | 9 | 366 |
AMP PEAK 1(1P35.2) MUTATED | 0 | 1 | 15 | 2 | 30 |
AMP PEAK 1(1P35.2) WILD-TYPE | 4 | 19 | 86 | 7 | 336 |
P value = 0.00499 (logrank test), Q value = 0.014
nPatients | nDeath | Duration Range (Median), Month | |
---|---|---|---|
ALL | 526 | 69 | 0.1 - 191.8 (23.3) |
AMP PEAK 2(1P34.2) MUTATED | 72 | 17 | 0.1 - 125.4 (22.1) |
AMP PEAK 2(1P34.2) WILD-TYPE | 454 | 52 | 0.1 - 191.8 (23.4) |
P value = 9.18e-05 (Wilcoxon-test), Q value = 0.00044
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 526 | 64.0 (11.2) |
AMP PEAK 2(1P34.2) MUTATED | 71 | 68.6 (9.4) |
AMP PEAK 2(1P34.2) WILD-TYPE | 455 | 63.3 (11.3) |
P value = 1e-05 (Fisher's exact test), Q value = 5.9e-05
nPatients | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA | MIXED SEROUS AND ENDOMETRIOID | SEROUS ENDOMETRIAL ADENOCARCINOMA |
---|---|---|---|
ALL | 395 | 21 | 112 |
AMP PEAK 2(1P34.2) MUTATED | 21 | 7 | 44 |
AMP PEAK 2(1P34.2) WILD-TYPE | 374 | 14 | 68 |
P value = 0.0924 (Fisher's exact test), Q value = 0.16
nPatients | R0 | R1 | R2 | RX |
---|---|---|---|---|
ALL | 363 | 23 | 17 | 35 |
AMP PEAK 2(1P34.2) MUTATED | 44 | 4 | 5 | 7 |
AMP PEAK 2(1P34.2) WILD-TYPE | 319 | 19 | 12 | 28 |
P value = 0.0283 (Fisher's exact test), Q value = 0.06
nPatients | AMERICAN INDIAN OR ALASKA NATIVE | ASIAN | BLACK OR AFRICAN AMERICAN | NATIVE HAWAIIAN OR OTHER PACIFIC ISLANDER | WHITE |
---|---|---|---|---|---|
ALL | 4 | 20 | 101 | 9 | 366 |
AMP PEAK 2(1P34.2) MUTATED | 0 | 1 | 22 | 2 | 39 |
AMP PEAK 2(1P34.2) WILD-TYPE | 4 | 19 | 79 | 7 | 327 |
P value = 0.00124 (Wilcoxon-test), Q value = 0.0042
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 526 | 64.0 (11.2) |
AMP PEAK 3(1P22.3) MUTATED | 95 | 67.2 (9.6) |
AMP PEAK 3(1P22.3) WILD-TYPE | 431 | 63.3 (11.4) |
P value = 0.00018 (Fisher's exact test), Q value = 8e-04
nPatients | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA | MIXED SEROUS AND ENDOMETRIOID | SEROUS ENDOMETRIAL ADENOCARCINOMA |
---|---|---|---|
ALL | 395 | 21 | 112 |
AMP PEAK 3(1P22.3) MUTATED | 55 | 5 | 35 |
AMP PEAK 3(1P22.3) WILD-TYPE | 340 | 16 | 77 |
P value = 0.14 (Fisher's exact test), Q value = 0.23
nPatients | HISPANIC OR LATINO | NOT HISPANIC OR LATINO |
---|---|---|
ALL | 14 | 367 |
AMP PEAK 3(1P22.3) MUTATED | 0 | 64 |
AMP PEAK 3(1P22.3) WILD-TYPE | 14 | 303 |
P value = 0.0153 (logrank test), Q value = 0.035
nPatients | nDeath | Duration Range (Median), Month | |
---|---|---|---|
ALL | 526 | 69 | 0.1 - 191.8 (23.3) |
AMP PEAK 4(1Q21.3) MUTATED | 235 | 39 | 0.1 - 149.6 (20.8) |
AMP PEAK 4(1Q21.3) WILD-TYPE | 291 | 30 | 0.2 - 191.8 (24.3) |
P value = 5.3e-06 (Wilcoxon-test), Q value = 5.9e-05
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 526 | 64.0 (11.2) |
AMP PEAK 4(1Q21.3) MUTATED | 236 | 66.6 (10.3) |
AMP PEAK 4(1Q21.3) WILD-TYPE | 290 | 61.9 (11.5) |
P value = 2e-05 (Fisher's exact test), Q value = 0.00011
nPatients | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA | MIXED SEROUS AND ENDOMETRIOID | SEROUS ENDOMETRIAL ADENOCARCINOMA |
---|---|---|---|
ALL | 395 | 21 | 112 |
AMP PEAK 4(1Q21.3) MUTATED | 154 | 10 | 72 |
AMP PEAK 4(1Q21.3) WILD-TYPE | 241 | 11 | 40 |
P value = 0.00663 (Fisher's exact test), Q value = 0.017
nPatients | AMERICAN INDIAN OR ALASKA NATIVE | ASIAN | BLACK OR AFRICAN AMERICAN | NATIVE HAWAIIAN OR OTHER PACIFIC ISLANDER | WHITE |
---|---|---|---|---|---|
ALL | 4 | 20 | 101 | 9 | 366 |
AMP PEAK 4(1Q21.3) MUTATED | 2 | 5 | 59 | 2 | 156 |
AMP PEAK 4(1Q21.3) WILD-TYPE | 2 | 15 | 42 | 7 | 210 |
P value = 0.000798 (logrank test), Q value = 0.0029
nPatients | nDeath | Duration Range (Median), Month | |
---|---|---|---|
ALL | 526 | 69 | 0.1 - 191.8 (23.3) |
AMP PEAK 5(1Q22) MUTATED | 249 | 44 | 0.1 - 149.6 (20.9) |
AMP PEAK 5(1Q22) WILD-TYPE | 277 | 25 | 0.2 - 191.8 (24.3) |
P value = 4.65e-08 (Wilcoxon-test), Q value = 2.2e-06
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 526 | 64.0 (11.2) |
AMP PEAK 5(1Q22) MUTATED | 249 | 66.9 (10.4) |
AMP PEAK 5(1Q22) WILD-TYPE | 277 | 61.4 (11.3) |
P value = 1e-05 (Fisher's exact test), Q value = 5.9e-05
nPatients | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA | MIXED SEROUS AND ENDOMETRIOID | SEROUS ENDOMETRIAL ADENOCARCINOMA |
---|---|---|---|
ALL | 395 | 21 | 112 |
AMP PEAK 5(1Q22) MUTATED | 160 | 10 | 79 |
AMP PEAK 5(1Q22) WILD-TYPE | 235 | 11 | 33 |
P value = 0.0165 (Fisher's exact test), Q value = 0.037
nPatients | AMERICAN INDIAN OR ALASKA NATIVE | ASIAN | BLACK OR AFRICAN AMERICAN | NATIVE HAWAIIAN OR OTHER PACIFIC ISLANDER | WHITE |
---|---|---|---|---|---|
ALL | 4 | 20 | 101 | 9 | 366 |
AMP PEAK 5(1Q22) MUTATED | 2 | 5 | 59 | 2 | 170 |
AMP PEAK 5(1Q22) WILD-TYPE | 2 | 15 | 42 | 7 | 196 |
P value = 0.0718 (logrank test), Q value = 0.13
nPatients | nDeath | Duration Range (Median), Month | |
---|---|---|---|
ALL | 526 | 69 | 0.1 - 191.8 (23.3) |
AMP PEAK 6(1Q44) MUTATED | 212 | 34 | 0.1 - 149.6 (21.1) |
AMP PEAK 6(1Q44) WILD-TYPE | 314 | 35 | 0.2 - 191.8 (23.9) |
P value = 0.00104 (Wilcoxon-test), Q value = 0.0037
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 526 | 64.0 (11.2) |
AMP PEAK 6(1Q44) MUTATED | 213 | 66.0 (10.4) |
AMP PEAK 6(1Q44) WILD-TYPE | 313 | 62.6 (11.6) |
P value = 6.26e-05 (logrank test), Q value = 0.00032
nPatients | nDeath | Duration Range (Median), Month | |
---|---|---|---|
ALL | 526 | 69 | 0.1 - 191.8 (23.3) |
AMP PEAK 7(2P24.3) MUTATED | 117 | 28 | 0.1 - 149.6 (22.3) |
AMP PEAK 7(2P24.3) WILD-TYPE | 409 | 41 | 0.1 - 191.8 (23.4) |
P value = 0.0135 (Wilcoxon-test), Q value = 0.032
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 526 | 64.0 (11.2) |
AMP PEAK 7(2P24.3) MUTATED | 117 | 66.2 (10.4) |
AMP PEAK 7(2P24.3) WILD-TYPE | 409 | 63.4 (11.4) |
P value = 1e-05 (Fisher's exact test), Q value = 5.9e-05
nPatients | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA | MIXED SEROUS AND ENDOMETRIOID | SEROUS ENDOMETRIAL ADENOCARCINOMA |
---|---|---|---|
ALL | 395 | 21 | 112 |
AMP PEAK 7(2P24.3) MUTATED | 54 | 7 | 57 |
AMP PEAK 7(2P24.3) WILD-TYPE | 341 | 14 | 55 |
P value = 0.0251 (Fisher's exact test), Q value = 0.054
nPatients | NO | YES |
---|---|---|
ALL | 141 | 387 |
AMP PEAK 7(2P24.3) MUTATED | 22 | 96 |
AMP PEAK 7(2P24.3) WILD-TYPE | 119 | 291 |
P value = 4.22e-05 (logrank test), Q value = 0.00023
nPatients | nDeath | Duration Range (Median), Month | |
---|---|---|---|
ALL | 526 | 69 | 0.1 - 191.8 (23.3) |
AMP PEAK 8(2Q13) MUTATED | 115 | 28 | 0.3 - 149.6 (20.9) |
AMP PEAK 8(2Q13) WILD-TYPE | 411 | 41 | 0.1 - 191.8 (23.9) |
P value = 0.00032 (Wilcoxon-test), Q value = 0.0013
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 526 | 64.0 (11.2) |
AMP PEAK 8(2Q13) MUTATED | 115 | 67.1 (9.1) |
AMP PEAK 8(2Q13) WILD-TYPE | 411 | 63.2 (11.6) |
P value = 1e-05 (Fisher's exact test), Q value = 5.9e-05
nPatients | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA | MIXED SEROUS AND ENDOMETRIOID | SEROUS ENDOMETRIAL ADENOCARCINOMA |
---|---|---|---|
ALL | 395 | 21 | 112 |
AMP PEAK 8(2Q13) MUTATED | 44 | 5 | 67 |
AMP PEAK 8(2Q13) WILD-TYPE | 351 | 16 | 45 |
P value = 0.031 (logrank test), Q value = 0.064
nPatients | nDeath | Duration Range (Median), Month | |
---|---|---|---|
ALL | 526 | 69 | 0.1 - 191.8 (23.3) |
AMP PEAK 9(3P25.1) MUTATED | 80 | 18 | 0.1 - 191.8 (27.1) |
AMP PEAK 9(3P25.1) WILD-TYPE | 446 | 51 | 0.1 - 185.8 (23.2) |
P value = 0.000276 (Wilcoxon-test), Q value = 0.0011
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 526 | 64.0 (11.2) |
AMP PEAK 9(3P25.1) MUTATED | 80 | 68.5 (10.6) |
AMP PEAK 9(3P25.1) WILD-TYPE | 446 | 63.2 (11.2) |
P value = 1e-05 (Fisher's exact test), Q value = 5.9e-05
nPatients | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA | MIXED SEROUS AND ENDOMETRIOID | SEROUS ENDOMETRIAL ADENOCARCINOMA |
---|---|---|---|
ALL | 395 | 21 | 112 |
AMP PEAK 9(3P25.1) MUTATED | 36 | 1 | 43 |
AMP PEAK 9(3P25.1) WILD-TYPE | 359 | 20 | 69 |
P value = 0.0992 (Fisher's exact test), Q value = 0.17
nPatients | NO | YES |
---|---|---|
ALL | 141 | 387 |
AMP PEAK 9(3P25.1) MUTATED | 15 | 65 |
AMP PEAK 9(3P25.1) WILD-TYPE | 126 | 322 |
P value = 0.00328 (Fisher's exact test), Q value = 0.0097
nPatients | AMERICAN INDIAN OR ALASKA NATIVE | ASIAN | BLACK OR AFRICAN AMERICAN | NATIVE HAWAIIAN OR OTHER PACIFIC ISLANDER | WHITE |
---|---|---|---|---|---|
ALL | 4 | 20 | 101 | 9 | 366 |
AMP PEAK 9(3P25.1) MUTATED | 0 | 0 | 23 | 4 | 47 |
AMP PEAK 9(3P25.1) WILD-TYPE | 4 | 20 | 78 | 5 | 319 |
P value = 0.00125 (logrank test), Q value = 0.0042
nPatients | nDeath | Duration Range (Median), Month | |
---|---|---|---|
ALL | 526 | 69 | 0.1 - 191.8 (23.3) |
AMP PEAK 10(3P14.1) MUTATED | 63 | 17 | 0.1 - 191.8 (27.2) |
AMP PEAK 10(3P14.1) WILD-TYPE | 463 | 52 | 0.1 - 185.8 (23.3) |
P value = 0.00377 (Wilcoxon-test), Q value = 0.011
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 526 | 64.0 (11.2) |
AMP PEAK 10(3P14.1) MUTATED | 63 | 68.1 (10.3) |
AMP PEAK 10(3P14.1) WILD-TYPE | 463 | 63.5 (11.2) |
P value = 8e-05 (Fisher's exact test), Q value = 4e-04
nPatients | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA | MIXED SEROUS AND ENDOMETRIOID | SEROUS ENDOMETRIAL ADENOCARCINOMA |
---|---|---|---|
ALL | 395 | 21 | 112 |
AMP PEAK 10(3P14.1) MUTATED | 33 | 3 | 27 |
AMP PEAK 10(3P14.1) WILD-TYPE | 362 | 18 | 85 |
P value = 0.0476 (Fisher's exact test), Q value = 0.093
nPatients | NO | YES |
---|---|---|
ALL | 141 | 387 |
AMP PEAK 10(3P14.1) MUTATED | 10 | 53 |
AMP PEAK 10(3P14.1) WILD-TYPE | 131 | 334 |
P value = 0.0109 (Fisher's exact test), Q value = 0.026
nPatients | AMERICAN INDIAN OR ALASKA NATIVE | ASIAN | BLACK OR AFRICAN AMERICAN | NATIVE HAWAIIAN OR OTHER PACIFIC ISLANDER | WHITE |
---|---|---|---|---|---|
ALL | 4 | 20 | 101 | 9 | 366 |
AMP PEAK 10(3P14.1) MUTATED | 1 | 0 | 15 | 4 | 39 |
AMP PEAK 10(3P14.1) WILD-TYPE | 3 | 20 | 86 | 5 | 327 |
P value = 0.0802 (Fisher's exact test), Q value = 0.15
nPatients | HISPANIC OR LATINO | NOT HISPANIC OR LATINO |
---|---|---|
ALL | 14 | 367 |
AMP PEAK 10(3P14.1) MUTATED | 4 | 43 |
AMP PEAK 10(3P14.1) WILD-TYPE | 10 | 324 |
P value = 0.000911 (logrank test), Q value = 0.0033
nPatients | nDeath | Duration Range (Median), Month | |
---|---|---|---|
ALL | 526 | 69 | 0.1 - 191.8 (23.3) |
AMP PEAK 11(3Q26.2) MUTATED | 171 | 34 | 0.1 - 191.8 (22.1) |
AMP PEAK 11(3Q26.2) WILD-TYPE | 355 | 35 | 0.2 - 185.8 (23.5) |
P value = 2.54e-11 (Wilcoxon-test), Q value = 1.8e-08
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 526 | 64.0 (11.2) |
AMP PEAK 11(3Q26.2) MUTATED | 170 | 68.4 (9.3) |
AMP PEAK 11(3Q26.2) WILD-TYPE | 356 | 61.9 (11.4) |
P value = 1e-05 (Fisher's exact test), Q value = 5.9e-05
nPatients | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA | MIXED SEROUS AND ENDOMETRIOID | SEROUS ENDOMETRIAL ADENOCARCINOMA |
---|---|---|---|
ALL | 395 | 21 | 112 |
AMP PEAK 11(3Q26.2) MUTATED | 73 | 8 | 90 |
AMP PEAK 11(3Q26.2) WILD-TYPE | 322 | 13 | 22 |
P value = 0.0273 (Fisher's exact test), Q value = 0.058
nPatients | NO | YES |
---|---|---|
ALL | 141 | 387 |
AMP PEAK 11(3Q26.2) MUTATED | 35 | 136 |
AMP PEAK 11(3Q26.2) WILD-TYPE | 106 | 251 |
P value = 2e-05 (Fisher's exact test), Q value = 0.00011
nPatients | AMERICAN INDIAN OR ALASKA NATIVE | ASIAN | BLACK OR AFRICAN AMERICAN | NATIVE HAWAIIAN OR OTHER PACIFIC ISLANDER | WHITE |
---|---|---|---|---|---|
ALL | 4 | 20 | 101 | 9 | 366 |
AMP PEAK 11(3Q26.2) MUTATED | 0 | 3 | 52 | 4 | 100 |
AMP PEAK 11(3Q26.2) WILD-TYPE | 4 | 17 | 49 | 5 | 266 |
P value = 0.00286 (logrank test), Q value = 0.0086
nPatients | nDeath | Duration Range (Median), Month | |
---|---|---|---|
ALL | 526 | 69 | 0.1 - 191.8 (23.3) |
AMP PEAK 12(3Q26.2) MUTATED | 159 | 31 | 0.1 - 191.8 (22.1) |
AMP PEAK 12(3Q26.2) WILD-TYPE | 367 | 38 | 0.2 - 185.8 (23.5) |
P value = 3.3e-09 (Wilcoxon-test), Q value = 4.6e-07
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 526 | 64.0 (11.2) |
AMP PEAK 12(3Q26.2) MUTATED | 158 | 68.2 (9.4) |
AMP PEAK 12(3Q26.2) WILD-TYPE | 368 | 62.2 (11.5) |
P value = 1e-05 (Fisher's exact test), Q value = 5.9e-05
nPatients | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA | MIXED SEROUS AND ENDOMETRIOID | SEROUS ENDOMETRIAL ADENOCARCINOMA |
---|---|---|---|
ALL | 395 | 21 | 112 |
AMP PEAK 12(3Q26.2) MUTATED | 65 | 7 | 87 |
AMP PEAK 12(3Q26.2) WILD-TYPE | 330 | 14 | 25 |
P value = 0.0533 (Fisher's exact test), Q value = 0.1
nPatients | NO | YES |
---|---|---|
ALL | 141 | 387 |
AMP PEAK 12(3Q26.2) MUTATED | 33 | 126 |
AMP PEAK 12(3Q26.2) WILD-TYPE | 108 | 261 |
P value = 0.00015 (Fisher's exact test), Q value = 0.00069
nPatients | AMERICAN INDIAN OR ALASKA NATIVE | ASIAN | BLACK OR AFRICAN AMERICAN | NATIVE HAWAIIAN OR OTHER PACIFIC ISLANDER | WHITE |
---|---|---|---|---|---|
ALL | 4 | 20 | 101 | 9 | 366 |
AMP PEAK 12(3Q26.2) MUTATED | 0 | 3 | 48 | 4 | 93 |
AMP PEAK 12(3Q26.2) WILD-TYPE | 4 | 17 | 53 | 5 | 273 |
P value = 2.74e-05 (Wilcoxon-test), Q value = 0.00015
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 526 | 64.0 (11.2) |
AMP PEAK 13(4P16.3) MUTATED | 52 | 69.7 (9.0) |
AMP PEAK 13(4P16.3) WILD-TYPE | 474 | 63.4 (11.3) |
P value = 1e-05 (Fisher's exact test), Q value = 5.9e-05
nPatients | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA | MIXED SEROUS AND ENDOMETRIOID | SEROUS ENDOMETRIAL ADENOCARCINOMA |
---|---|---|---|
ALL | 395 | 21 | 112 |
AMP PEAK 13(4P16.3) MUTATED | 15 | 1 | 36 |
AMP PEAK 13(4P16.3) WILD-TYPE | 380 | 20 | 76 |
P value = 0.000241 (logrank test), Q value = 0.001
nPatients | nDeath | Duration Range (Median), Month | |
---|---|---|---|
ALL | 526 | 69 | 0.1 - 191.8 (23.3) |
AMP PEAK 14(5P15.33) MUTATED | 87 | 21 | 0.2 - 125.4 (20.8) |
AMP PEAK 14(5P15.33) WILD-TYPE | 439 | 48 | 0.1 - 191.8 (23.5) |
P value = 0.000107 (Wilcoxon-test), Q value = 5e-04
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 526 | 64.0 (11.2) |
AMP PEAK 14(5P15.33) MUTATED | 88 | 67.7 (10.0) |
AMP PEAK 14(5P15.33) WILD-TYPE | 438 | 63.3 (11.3) |
P value = 1e-05 (Fisher's exact test), Q value = 5.9e-05
nPatients | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA | MIXED SEROUS AND ENDOMETRIOID | SEROUS ENDOMETRIAL ADENOCARCINOMA |
---|---|---|---|
ALL | 395 | 21 | 112 |
AMP PEAK 14(5P15.33) MUTATED | 30 | 3 | 55 |
AMP PEAK 14(5P15.33) WILD-TYPE | 365 | 18 | 57 |
P value = 0.113 (Fisher's exact test), Q value = 0.19
nPatients | NO | YES |
---|---|---|
ALL | 141 | 387 |
AMP PEAK 14(5P15.33) MUTATED | 17 | 71 |
AMP PEAK 14(5P15.33) WILD-TYPE | 124 | 316 |
P value = 0.133 (Fisher's exact test), Q value = 0.22
nPatients | R0 | R1 | R2 | RX |
---|---|---|---|---|
ALL | 363 | 23 | 17 | 35 |
AMP PEAK 14(5P15.33) MUTATED | 57 | 3 | 6 | 8 |
AMP PEAK 14(5P15.33) WILD-TYPE | 306 | 20 | 11 | 27 |
P value = 0.00247 (Fisher's exact test), Q value = 0.0076
nPatients | AMERICAN INDIAN OR ALASKA NATIVE | ASIAN | BLACK OR AFRICAN AMERICAN | NATIVE HAWAIIAN OR OTHER PACIFIC ISLANDER | WHITE |
---|---|---|---|---|---|
ALL | 4 | 20 | 101 | 9 | 366 |
AMP PEAK 14(5P15.33) MUTATED | 1 | 2 | 30 | 2 | 49 |
AMP PEAK 14(5P15.33) WILD-TYPE | 3 | 18 | 71 | 7 | 317 |
P value = 0.00614 (logrank test), Q value = 0.016
nPatients | nDeath | Duration Range (Median), Month | |
---|---|---|---|
ALL | 526 | 69 | 0.1 - 191.8 (23.3) |
AMP PEAK 15(5Q35.3) MUTATED | 52 | 11 | 0.4 - 96.7 (16.2) |
AMP PEAK 15(5Q35.3) WILD-TYPE | 474 | 58 | 0.1 - 191.8 (23.8) |
P value = 0.000282 (Wilcoxon-test), Q value = 0.0011
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 526 | 64.0 (11.2) |
AMP PEAK 15(5Q35.3) MUTATED | 53 | 69.3 (10.3) |
AMP PEAK 15(5Q35.3) WILD-TYPE | 473 | 63.4 (11.2) |
P value = 1e-05 (Fisher's exact test), Q value = 5.9e-05
nPatients | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA | MIXED SEROUS AND ENDOMETRIOID | SEROUS ENDOMETRIAL ADENOCARCINOMA |
---|---|---|---|
ALL | 395 | 21 | 112 |
AMP PEAK 15(5Q35.3) MUTATED | 20 | 2 | 31 |
AMP PEAK 15(5Q35.3) WILD-TYPE | 375 | 19 | 81 |
P value = 0.0197 (Fisher's exact test), Q value = 0.044
nPatients | AMERICAN INDIAN OR ALASKA NATIVE | ASIAN | BLACK OR AFRICAN AMERICAN | NATIVE HAWAIIAN OR OTHER PACIFIC ISLANDER | WHITE |
---|---|---|---|---|---|
ALL | 4 | 20 | 101 | 9 | 366 |
AMP PEAK 15(5Q35.3) MUTATED | 0 | 1 | 20 | 0 | 30 |
AMP PEAK 15(5Q35.3) WILD-TYPE | 4 | 19 | 81 | 9 | 336 |
P value = 0.0559 (logrank test), Q value = 0.11
nPatients | nDeath | Duration Range (Median), Month | |
---|---|---|---|
ALL | 526 | 69 | 0.1 - 191.8 (23.3) |
AMP PEAK 16(6P24.2) MUTATED | 114 | 22 | 0.1 - 125.4 (27.3) |
AMP PEAK 16(6P24.2) WILD-TYPE | 412 | 47 | 0.2 - 191.8 (22.7) |
P value = 2.5e-06 (Wilcoxon-test), Q value = 5.9e-05
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 526 | 64.0 (11.2) |
AMP PEAK 16(6P24.2) MUTATED | 114 | 68.1 (9.9) |
AMP PEAK 16(6P24.2) WILD-TYPE | 412 | 62.9 (11.3) |
P value = 1e-05 (Fisher's exact test), Q value = 5.9e-05
nPatients | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA | MIXED SEROUS AND ENDOMETRIOID | SEROUS ENDOMETRIAL ADENOCARCINOMA |
---|---|---|---|
ALL | 395 | 21 | 112 |
AMP PEAK 16(6P24.2) MUTATED | 45 | 5 | 64 |
AMP PEAK 16(6P24.2) WILD-TYPE | 350 | 16 | 48 |
P value = 0.0937 (Fisher's exact test), Q value = 0.16
nPatients | NO | YES |
---|---|---|
ALL | 141 | 387 |
AMP PEAK 16(6P24.2) MUTATED | 23 | 91 |
AMP PEAK 16(6P24.2) WILD-TYPE | 118 | 296 |
P value = 0.000195 (Wilcoxon-test), Q value = 0.00086
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 526 | 64.0 (11.2) |
AMP PEAK 17(6P22.3) MUTATED | 104 | 67.4 (9.9) |
AMP PEAK 17(6P22.3) WILD-TYPE | 422 | 63.2 (11.4) |
P value = 1e-05 (Fisher's exact test), Q value = 5.9e-05
nPatients | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA | MIXED SEROUS AND ENDOMETRIOID | SEROUS ENDOMETRIAL ADENOCARCINOMA |
---|---|---|---|
ALL | 395 | 21 | 112 |
AMP PEAK 17(6P22.3) MUTATED | 40 | 4 | 60 |
AMP PEAK 17(6P22.3) WILD-TYPE | 355 | 17 | 52 |
P value = 0.108 (Fisher's exact test), Q value = 0.18
nPatients | NO | YES |
---|---|---|
ALL | 141 | 387 |
AMP PEAK 17(6P22.3) MUTATED | 21 | 83 |
AMP PEAK 17(6P22.3) WILD-TYPE | 120 | 304 |
P value = 0.00738 (Fisher's exact test), Q value = 0.019
nPatients | AMERICAN INDIAN OR ALASKA NATIVE | ASIAN | BLACK OR AFRICAN AMERICAN | NATIVE HAWAIIAN OR OTHER PACIFIC ISLANDER | WHITE |
---|---|---|---|---|---|
ALL | 4 | 20 | 101 | 9 | 366 |
AMP PEAK 17(6P22.3) MUTATED | 0 | 2 | 33 | 2 | 62 |
AMP PEAK 17(6P22.3) WILD-TYPE | 4 | 18 | 68 | 7 | 304 |
P value = 0.0921 (logrank test), Q value = 0.16
nPatients | nDeath | Duration Range (Median), Month | |
---|---|---|---|
ALL | 526 | 69 | 0.1 - 191.8 (23.3) |
AMP PEAK 18(6Q25.1) MUTATED | 84 | 15 | 0.1 - 97.7 (22.8) |
AMP PEAK 18(6Q25.1) WILD-TYPE | 442 | 54 | 0.2 - 191.8 (23.4) |
P value = 0.00172 (Wilcoxon-test), Q value = 0.0055
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 526 | 64.0 (11.2) |
AMP PEAK 18(6Q25.1) MUTATED | 84 | 67.0 (10.5) |
AMP PEAK 18(6Q25.1) WILD-TYPE | 442 | 63.4 (11.3) |
P value = 1e-05 (Fisher's exact test), Q value = 5.9e-05
nPatients | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA | MIXED SEROUS AND ENDOMETRIOID | SEROUS ENDOMETRIAL ADENOCARCINOMA |
---|---|---|---|
ALL | 395 | 21 | 112 |
AMP PEAK 18(6Q25.1) MUTATED | 44 | 2 | 38 |
AMP PEAK 18(6Q25.1) WILD-TYPE | 351 | 19 | 74 |
P value = 0.00526 (Fisher's exact test), Q value = 0.014
nPatients | AMERICAN INDIAN OR ALASKA NATIVE | ASIAN | BLACK OR AFRICAN AMERICAN | NATIVE HAWAIIAN OR OTHER PACIFIC ISLANDER | WHITE |
---|---|---|---|---|---|
ALL | 4 | 20 | 101 | 9 | 366 |
AMP PEAK 18(6Q25.1) MUTATED | 0 | 1 | 28 | 2 | 48 |
AMP PEAK 18(6Q25.1) WILD-TYPE | 4 | 19 | 73 | 7 | 318 |
P value = 8.52e-07 (logrank test), Q value = 2.7e-05
nPatients | nDeath | Duration Range (Median), Month | |
---|---|---|---|
ALL | 526 | 69 | 0.1 - 191.8 (23.3) |
AMP PEAK 19(7Q31.2) MUTATED | 89 | 23 | 0.2 - 125.4 (16.9) |
AMP PEAK 19(7Q31.2) WILD-TYPE | 437 | 46 | 0.1 - 191.8 (24.4) |
P value = 0.0795 (Wilcoxon-test), Q value = 0.14
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 526 | 64.0 (11.2) |
AMP PEAK 19(7Q31.2) MUTATED | 89 | 65.9 (11.9) |
AMP PEAK 19(7Q31.2) WILD-TYPE | 437 | 63.6 (11.1) |
P value = 7e-05 (Fisher's exact test), Q value = 0.00036
nPatients | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA | MIXED SEROUS AND ENDOMETRIOID | SEROUS ENDOMETRIAL ADENOCARCINOMA |
---|---|---|---|
ALL | 395 | 21 | 112 |
AMP PEAK 19(7Q31.2) MUTATED | 51 | 5 | 34 |
AMP PEAK 19(7Q31.2) WILD-TYPE | 344 | 16 | 78 |
P value = 0.0184 (Fisher's exact test), Q value = 0.041
nPatients | NO | YES |
---|---|---|
ALL | 141 | 387 |
AMP PEAK 19(7Q31.2) MUTATED | 15 | 75 |
AMP PEAK 19(7Q31.2) WILD-TYPE | 126 | 312 |
P value = 0.00209 (logrank test), Q value = 0.0065
nPatients | nDeath | Duration Range (Median), Month | |
---|---|---|---|
ALL | 526 | 69 | 0.1 - 191.8 (23.3) |
AMP PEAK 20(8P11.22) MUTATED | 125 | 25 | 0.1 - 118.0 (19.6) |
AMP PEAK 20(8P11.22) WILD-TYPE | 401 | 44 | 0.1 - 191.8 (24.0) |
P value = 1.13e-05 (logrank test), Q value = 6.6e-05
nPatients | nDeath | Duration Range (Median), Month | |
---|---|---|---|
ALL | 526 | 69 | 0.1 - 191.8 (23.3) |
AMP PEAK 21(8P11.21) MUTATED | 161 | 35 | 0.1 - 125.4 (19.4) |
AMP PEAK 21(8P11.21) WILD-TYPE | 365 | 34 | 0.2 - 191.8 (25.0) |
P value = 1e-05 (Fisher's exact test), Q value = 5.9e-05
nPatients | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA | MIXED SEROUS AND ENDOMETRIOID | SEROUS ENDOMETRIAL ADENOCARCINOMA |
---|---|---|---|
ALL | 395 | 21 | 112 |
AMP PEAK 21(8P11.21) MUTATED | 94 | 7 | 60 |
AMP PEAK 21(8P11.21) WILD-TYPE | 301 | 14 | 52 |
P value = 0.019 (Fisher's exact test), Q value = 0.042
nPatients | NO | YES |
---|---|---|
ALL | 141 | 387 |
AMP PEAK 21(8P11.21) MUTATED | 32 | 129 |
AMP PEAK 21(8P11.21) WILD-TYPE | 109 | 258 |
P value = 0.00642 (Fisher's exact test), Q value = 0.017
nPatients | R0 | R1 | R2 | RX |
---|---|---|---|---|
ALL | 363 | 23 | 17 | 35 |
AMP PEAK 21(8P11.21) MUTATED | 106 | 4 | 11 | 14 |
AMP PEAK 21(8P11.21) WILD-TYPE | 257 | 19 | 6 | 21 |
P value = 0.000217 (logrank test), Q value = 0.00092
nPatients | nDeath | Duration Range (Median), Month | |
---|---|---|---|
ALL | 526 | 69 | 0.1 - 191.8 (23.3) |
AMP PEAK 22(8Q24.21) MUTATED | 204 | 40 | 0.1 - 191.8 (20.7) |
AMP PEAK 22(8Q24.21) WILD-TYPE | 322 | 29 | 0.2 - 185.8 (24.8) |
P value = 0.0412 (Wilcoxon-test), Q value = 0.083
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 526 | 64.0 (11.2) |
AMP PEAK 22(8Q24.21) MUTATED | 204 | 64.8 (11.7) |
AMP PEAK 22(8Q24.21) WILD-TYPE | 322 | 63.5 (10.9) |
P value = 1e-05 (Fisher's exact test), Q value = 5.9e-05
nPatients | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA | MIXED SEROUS AND ENDOMETRIOID | SEROUS ENDOMETRIAL ADENOCARCINOMA |
---|---|---|---|
ALL | 395 | 21 | 112 |
AMP PEAK 22(8Q24.21) MUTATED | 116 | 10 | 80 |
AMP PEAK 22(8Q24.21) WILD-TYPE | 279 | 11 | 32 |
P value = 0.00478 (Fisher's exact test), Q value = 0.013
nPatients | NO | YES |
---|---|---|
ALL | 141 | 387 |
AMP PEAK 22(8Q24.21) MUTATED | 41 | 165 |
AMP PEAK 22(8Q24.21) WILD-TYPE | 100 | 222 |
P value = 0.000397 (logrank test), Q value = 0.0015
nPatients | nDeath | Duration Range (Median), Month | |
---|---|---|---|
ALL | 526 | 69 | 0.1 - 191.8 (23.3) |
AMP PEAK 23(8Q24.21) MUTATED | 210 | 40 | 0.1 - 191.8 (20.7) |
AMP PEAK 23(8Q24.21) WILD-TYPE | 316 | 29 | 0.2 - 185.8 (25.0) |
P value = 0.0149 (Wilcoxon-test), Q value = 0.034
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 526 | 64.0 (11.2) |
AMP PEAK 23(8Q24.21) MUTATED | 210 | 65.1 (11.6) |
AMP PEAK 23(8Q24.21) WILD-TYPE | 316 | 63.3 (10.9) |
P value = 1e-05 (Fisher's exact test), Q value = 5.9e-05
nPatients | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA | MIXED SEROUS AND ENDOMETRIOID | SEROUS ENDOMETRIAL ADENOCARCINOMA |
---|---|---|---|
ALL | 395 | 21 | 112 |
AMP PEAK 23(8Q24.21) MUTATED | 119 | 9 | 84 |
AMP PEAK 23(8Q24.21) WILD-TYPE | 276 | 12 | 28 |
P value = 0.00359 (Fisher's exact test), Q value = 0.01
nPatients | NO | YES |
---|---|---|
ALL | 141 | 387 |
AMP PEAK 23(8Q24.21) MUTATED | 42 | 170 |
AMP PEAK 23(8Q24.21) WILD-TYPE | 99 | 217 |
P value = 0.0114 (Fisher's exact test), Q value = 0.028
nPatients | R0 | R1 | R2 | RX |
---|---|---|---|---|
ALL | 363 | 23 | 17 | 35 |
AMP PEAK 23(8Q24.21) MUTATED | 143 | 6 | 13 | 14 |
AMP PEAK 23(8Q24.21) WILD-TYPE | 220 | 17 | 4 | 21 |
P value = 0.0302 (logrank test), Q value = 0.062
nPatients | nDeath | Duration Range (Median), Month | |
---|---|---|---|
ALL | 526 | 69 | 0.1 - 191.8 (23.3) |
AMP PEAK 24(9P24.2) MUTATED | 63 | 14 | 0.1 - 125.4 (24.0) |
AMP PEAK 24(9P24.2) WILD-TYPE | 463 | 55 | 0.1 - 191.8 (23.3) |
P value = 0.00194 (Wilcoxon-test), Q value = 0.0061
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 526 | 64.0 (11.2) |
AMP PEAK 24(9P24.2) MUTATED | 64 | 67.4 (9.2) |
AMP PEAK 24(9P24.2) WILD-TYPE | 462 | 63.5 (11.4) |
P value = 1e-05 (Fisher's exact test), Q value = 5.9e-05
nPatients | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA | MIXED SEROUS AND ENDOMETRIOID | SEROUS ENDOMETRIAL ADENOCARCINOMA |
---|---|---|---|
ALL | 395 | 21 | 112 |
AMP PEAK 24(9P24.2) MUTATED | 25 | 3 | 36 |
AMP PEAK 24(9P24.2) WILD-TYPE | 370 | 18 | 76 |
P value = 0.135 (Fisher's exact test), Q value = 0.22
nPatients | R0 | R1 | R2 | RX |
---|---|---|---|---|
ALL | 363 | 23 | 17 | 35 |
AMP PEAK 24(9P24.2) MUTATED | 39 | 3 | 3 | 8 |
AMP PEAK 24(9P24.2) WILD-TYPE | 324 | 20 | 14 | 27 |
P value = 0.0214 (Fisher's exact test), Q value = 0.047
nPatients | HISPANIC OR LATINO | NOT HISPANIC OR LATINO |
---|---|---|
ALL | 14 | 367 |
AMP PEAK 24(9P24.2) MUTATED | 5 | 43 |
AMP PEAK 24(9P24.2) WILD-TYPE | 9 | 324 |
P value = 0.0429 (logrank test), Q value = 0.086
nPatients | nDeath | Duration Range (Median), Month | |
---|---|---|---|
ALL | 526 | 69 | 0.1 - 191.8 (23.3) |
AMP PEAK 25(9Q34.3) MUTATED | 38 | 8 | 0.1 - 71.2 (20.1) |
AMP PEAK 25(9Q34.3) WILD-TYPE | 488 | 61 | 0.1 - 191.8 (23.4) |
P value = 0.00159 (Wilcoxon-test), Q value = 0.0052
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 526 | 64.0 (11.2) |
AMP PEAK 25(9Q34.3) MUTATED | 38 | 69.3 (8.1) |
AMP PEAK 25(9Q34.3) WILD-TYPE | 488 | 63.6 (11.3) |
P value = 1e-05 (Fisher's exact test), Q value = 5.9e-05
nPatients | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA | MIXED SEROUS AND ENDOMETRIOID | SEROUS ENDOMETRIAL ADENOCARCINOMA |
---|---|---|---|
ALL | 395 | 21 | 112 |
AMP PEAK 25(9Q34.3) MUTATED | 13 | 4 | 21 |
AMP PEAK 25(9Q34.3) WILD-TYPE | 382 | 17 | 91 |
P value = 0.00983 (Fisher's exact test), Q value = 0.024
nPatients | AMERICAN INDIAN OR ALASKA NATIVE | ASIAN | BLACK OR AFRICAN AMERICAN | NATIVE HAWAIIAN OR OTHER PACIFIC ISLANDER | WHITE |
---|---|---|---|---|---|
ALL | 4 | 20 | 101 | 9 | 366 |
AMP PEAK 25(9Q34.3) MUTATED | 0 | 1 | 17 | 0 | 20 |
AMP PEAK 25(9Q34.3) WILD-TYPE | 4 | 19 | 84 | 9 | 346 |
P value = 0.0931 (logrank test), Q value = 0.16
nPatients | nDeath | Duration Range (Median), Month | |
---|---|---|---|
ALL | 526 | 69 | 0.1 - 191.8 (23.3) |
AMP PEAK 26(10Q22.2) MUTATED | 142 | 24 | 0.6 - 185.8 (22.8) |
AMP PEAK 26(10Q22.2) WILD-TYPE | 384 | 45 | 0.1 - 191.8 (23.4) |
P value = 0.00337 (Fisher's exact test), Q value = 0.0099
nPatients | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA | MIXED SEROUS AND ENDOMETRIOID | SEROUS ENDOMETRIAL ADENOCARCINOMA |
---|---|---|---|
ALL | 395 | 21 | 112 |
AMP PEAK 26(10Q22.2) MUTATED | 96 | 3 | 44 |
AMP PEAK 26(10Q22.2) WILD-TYPE | 299 | 18 | 68 |
P value = 0.00175 (logrank test), Q value = 0.0056
nPatients | nDeath | Duration Range (Median), Month | |
---|---|---|---|
ALL | 526 | 69 | 0.1 - 191.8 (23.3) |
AMP PEAK 27(11P11.2) MUTATED | 50 | 13 | 1.4 - 110.1 (20.1) |
AMP PEAK 27(11P11.2) WILD-TYPE | 476 | 56 | 0.1 - 191.8 (23.6) |
P value = 0.000211 (Wilcoxon-test), Q value = 9e-04
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 526 | 64.0 (11.2) |
AMP PEAK 27(11P11.2) MUTATED | 50 | 69.7 (9.5) |
AMP PEAK 27(11P11.2) WILD-TYPE | 476 | 63.4 (11.2) |
P value = 1e-05 (Fisher's exact test), Q value = 5.9e-05
nPatients | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA | MIXED SEROUS AND ENDOMETRIOID | SEROUS ENDOMETRIAL ADENOCARCINOMA |
---|---|---|---|
ALL | 395 | 21 | 112 |
AMP PEAK 27(11P11.2) MUTATED | 16 | 4 | 30 |
AMP PEAK 27(11P11.2) WILD-TYPE | 379 | 17 | 82 |
P value = 0.00465 (logrank test), Q value = 0.013
nPatients | nDeath | Duration Range (Median), Month | |
---|---|---|---|
ALL | 526 | 69 | 0.1 - 191.8 (23.3) |
AMP PEAK 28(11Q13.2) MUTATED | 70 | 16 | 0.1 - 80.4 (24.0) |
AMP PEAK 28(11Q13.2) WILD-TYPE | 456 | 53 | 0.1 - 191.8 (23.3) |
P value = 0.000622 (Wilcoxon-test), Q value = 0.0023
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 526 | 64.0 (11.2) |
AMP PEAK 28(11Q13.2) MUTATED | 70 | 68.1 (9.9) |
AMP PEAK 28(11Q13.2) WILD-TYPE | 456 | 63.4 (11.3) |
P value = 1e-05 (Fisher's exact test), Q value = 5.9e-05
nPatients | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA | MIXED SEROUS AND ENDOMETRIOID | SEROUS ENDOMETRIAL ADENOCARCINOMA |
---|---|---|---|
ALL | 395 | 21 | 112 |
AMP PEAK 28(11Q13.2) MUTATED | 33 | 3 | 34 |
AMP PEAK 28(11Q13.2) WILD-TYPE | 362 | 18 | 78 |
P value = 5.34e-07 (logrank test), Q value = 2e-05
nPatients | nDeath | Duration Range (Median), Month | |
---|---|---|---|
ALL | 526 | 69 | 0.1 - 191.8 (23.3) |
AMP PEAK 29(11Q14.1) MUTATED | 56 | 18 | 0.4 - 102.3 (20.4) |
AMP PEAK 29(11Q14.1) WILD-TYPE | 470 | 51 | 0.1 - 191.8 (23.6) |
P value = 0.0108 (Wilcoxon-test), Q value = 0.026
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 526 | 64.0 (11.2) |
AMP PEAK 29(11Q14.1) MUTATED | 56 | 67.7 (10.7) |
AMP PEAK 29(11Q14.1) WILD-TYPE | 470 | 63.6 (11.2) |
P value = 1e-05 (Fisher's exact test), Q value = 5.9e-05
nPatients | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA | MIXED SEROUS AND ENDOMETRIOID | SEROUS ENDOMETRIAL ADENOCARCINOMA |
---|---|---|---|
ALL | 395 | 21 | 112 |
AMP PEAK 29(11Q14.1) MUTATED | 21 | 1 | 34 |
AMP PEAK 29(11Q14.1) WILD-TYPE | 374 | 20 | 78 |
P value = 0.15 (Fisher's exact test), Q value = 0.24
nPatients | NO | YES |
---|---|---|
ALL | 141 | 387 |
AMP PEAK 29(11Q14.1) MUTATED | 10 | 46 |
AMP PEAK 29(11Q14.1) WILD-TYPE | 131 | 341 |
P value = 0.101 (Fisher's exact test), Q value = 0.18
nPatients | AMERICAN INDIAN OR ALASKA NATIVE | ASIAN | BLACK OR AFRICAN AMERICAN | NATIVE HAWAIIAN OR OTHER PACIFIC ISLANDER | WHITE |
---|---|---|---|---|---|
ALL | 4 | 20 | 101 | 9 | 366 |
AMP PEAK 29(11Q14.1) MUTATED | 1 | 0 | 16 | 1 | 35 |
AMP PEAK 29(11Q14.1) WILD-TYPE | 3 | 20 | 85 | 8 | 331 |
P value = 0.145 (Wilcoxon-test), Q value = 0.23
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 526 | 64.0 (11.2) |
AMP PEAK 30(12P12.1) MUTATED | 91 | 65.4 (11.5) |
AMP PEAK 30(12P12.1) WILD-TYPE | 435 | 63.7 (11.2) |
P value = 1e-05 (Fisher's exact test), Q value = 5.9e-05
nPatients | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA | MIXED SEROUS AND ENDOMETRIOID | SEROUS ENDOMETRIAL ADENOCARCINOMA |
---|---|---|---|
ALL | 395 | 21 | 112 |
AMP PEAK 30(12P12.1) MUTATED | 44 | 4 | 44 |
AMP PEAK 30(12P12.1) WILD-TYPE | 351 | 17 | 68 |
P value = 0.117 (Fisher's exact test), Q value = 0.2
nPatients | AMERICAN INDIAN OR ALASKA NATIVE | ASIAN | BLACK OR AFRICAN AMERICAN | NATIVE HAWAIIAN OR OTHER PACIFIC ISLANDER | WHITE |
---|---|---|---|---|---|
ALL | 4 | 20 | 101 | 9 | 366 |
AMP PEAK 30(12P12.1) MUTATED | 0 | 6 | 24 | 2 | 56 |
AMP PEAK 30(12P12.1) WILD-TYPE | 4 | 14 | 77 | 7 | 310 |
P value = 0.145 (Fisher's exact test), Q value = 0.23
nPatients | HISPANIC OR LATINO | NOT HISPANIC OR LATINO |
---|---|---|
ALL | 14 | 367 |
AMP PEAK 30(12P12.1) MUTATED | 0 | 68 |
AMP PEAK 30(12P12.1) WILD-TYPE | 14 | 299 |
P value = 1e-05 (Fisher's exact test), Q value = 5.9e-05
nPatients | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA | MIXED SEROUS AND ENDOMETRIOID | SEROUS ENDOMETRIAL ADENOCARCINOMA |
---|---|---|---|
ALL | 395 | 21 | 112 |
AMP PEAK 31(12Q13.11) MUTATED | 39 | 4 | 41 |
AMP PEAK 31(12Q13.11) WILD-TYPE | 356 | 17 | 71 |
P value = 0.106 (Fisher's exact test), Q value = 0.18
nPatients | NO | YES |
---|---|---|
ALL | 141 | 387 |
AMP PEAK 31(12Q13.11) MUTATED | 16 | 68 |
AMP PEAK 31(12Q13.11) WILD-TYPE | 125 | 319 |
P value = 0.0178 (Fisher's exact test), Q value = 0.04
nPatients | AMERICAN INDIAN OR ALASKA NATIVE | ASIAN | BLACK OR AFRICAN AMERICAN | NATIVE HAWAIIAN OR OTHER PACIFIC ISLANDER | WHITE |
---|---|---|---|---|---|
ALL | 4 | 20 | 101 | 9 | 366 |
AMP PEAK 31(12Q13.11) MUTATED | 1 | 6 | 23 | 3 | 49 |
AMP PEAK 31(12Q13.11) WILD-TYPE | 3 | 14 | 78 | 6 | 317 |
P value = 0.113 (Wilcoxon-test), Q value = 0.19
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 526 | 64.0 (11.2) |
AMP PEAK 32(12Q13.2) MUTATED | 97 | 65.4 (11.7) |
AMP PEAK 32(12Q13.2) WILD-TYPE | 429 | 63.7 (11.1) |
P value = 1e-05 (Fisher's exact test), Q value = 5.9e-05
nPatients | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA | MIXED SEROUS AND ENDOMETRIOID | SEROUS ENDOMETRIAL ADENOCARCINOMA |
---|---|---|---|
ALL | 395 | 21 | 112 |
AMP PEAK 32(12Q13.2) MUTATED | 49 | 4 | 44 |
AMP PEAK 32(12Q13.2) WILD-TYPE | 346 | 17 | 68 |
P value = 0.0561 (Fisher's exact test), Q value = 0.11
nPatients | NO | YES |
---|---|---|
ALL | 141 | 387 |
AMP PEAK 32(12Q13.2) MUTATED | 18 | 79 |
AMP PEAK 32(12Q13.2) WILD-TYPE | 123 | 308 |
P value = 0.124 (Fisher's exact test), Q value = 0.21
nPatients | R0 | R1 | R2 | RX |
---|---|---|---|---|
ALL | 363 | 23 | 17 | 35 |
AMP PEAK 32(12Q13.2) MUTATED | 69 | 3 | 7 | 5 |
AMP PEAK 32(12Q13.2) WILD-TYPE | 294 | 20 | 10 | 30 |
P value = 0.124 (Fisher's exact test), Q value = 0.21
nPatients | AMERICAN INDIAN OR ALASKA NATIVE | ASIAN | BLACK OR AFRICAN AMERICAN | NATIVE HAWAIIAN OR OTHER PACIFIC ISLANDER | WHITE |
---|---|---|---|---|---|
ALL | 4 | 20 | 101 | 9 | 366 |
AMP PEAK 32(12Q13.2) MUTATED | 1 | 6 | 25 | 2 | 59 |
AMP PEAK 32(12Q13.2) WILD-TYPE | 3 | 14 | 76 | 7 | 307 |
P value = 8.49e-05 (Wilcoxon-test), Q value = 0.00042
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 526 | 64.0 (11.2) |
AMP PEAK 33(13Q34) MUTATED | 57 | 69.1 (7.4) |
AMP PEAK 33(13Q34) WILD-TYPE | 469 | 63.4 (11.4) |
P value = 1e-05 (Fisher's exact test), Q value = 5.9e-05
nPatients | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA | MIXED SEROUS AND ENDOMETRIOID | SEROUS ENDOMETRIAL ADENOCARCINOMA |
---|---|---|---|
ALL | 395 | 21 | 112 |
AMP PEAK 33(13Q34) MUTATED | 14 | 4 | 39 |
AMP PEAK 33(13Q34) WILD-TYPE | 381 | 17 | 73 |
P value = 0.0141 (Fisher's exact test), Q value = 0.033
nPatients | R0 | R1 | R2 | RX |
---|---|---|---|---|
ALL | 363 | 23 | 17 | 35 |
AMP PEAK 33(13Q34) MUTATED | 34 | 6 | 4 | 6 |
AMP PEAK 33(13Q34) WILD-TYPE | 329 | 17 | 13 | 29 |
P value = 0.0622 (Fisher's exact test), Q value = 0.12
nPatients | AMERICAN INDIAN OR ALASKA NATIVE | ASIAN | BLACK OR AFRICAN AMERICAN | NATIVE HAWAIIAN OR OTHER PACIFIC ISLANDER | WHITE |
---|---|---|---|---|---|
ALL | 4 | 20 | 101 | 9 | 366 |
AMP PEAK 33(13Q34) MUTATED | 0 | 2 | 18 | 2 | 32 |
AMP PEAK 33(13Q34) WILD-TYPE | 4 | 18 | 83 | 7 | 334 |
P value = 0.000162 (logrank test), Q value = 0.00074
nPatients | nDeath | Duration Range (Median), Month | |
---|---|---|---|
ALL | 526 | 69 | 0.1 - 191.8 (23.3) |
AMP PEAK 34(14Q24.3) MUTATED | 63 | 19 | 0.4 - 125.4 (23.7) |
AMP PEAK 34(14Q24.3) WILD-TYPE | 463 | 50 | 0.1 - 191.8 (23.3) |
P value = 0.00117 (Wilcoxon-test), Q value = 0.004
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 526 | 64.0 (11.2) |
AMP PEAK 34(14Q24.3) MUTATED | 63 | 68.1 (9.0) |
AMP PEAK 34(14Q24.3) WILD-TYPE | 463 | 63.5 (11.4) |
P value = 1e-05 (Fisher's exact test), Q value = 5.9e-05
nPatients | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA | MIXED SEROUS AND ENDOMETRIOID | SEROUS ENDOMETRIAL ADENOCARCINOMA |
---|---|---|---|
ALL | 395 | 21 | 112 |
AMP PEAK 34(14Q24.3) MUTATED | 21 | 4 | 38 |
AMP PEAK 34(14Q24.3) WILD-TYPE | 374 | 17 | 74 |
P value = 0.00433 (logrank test), Q value = 0.012
nPatients | nDeath | Duration Range (Median), Month | |
---|---|---|---|
ALL | 526 | 69 | 0.1 - 191.8 (23.3) |
AMP PEAK 35(14Q32.33) MUTATED | 75 | 18 | 0.3 - 110.1 (23.9) |
AMP PEAK 35(14Q32.33) WILD-TYPE | 451 | 51 | 0.1 - 191.8 (23.3) |
P value = 0.00112 (Wilcoxon-test), Q value = 0.0039
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 526 | 64.0 (11.2) |
AMP PEAK 35(14Q32.33) MUTATED | 76 | 67.6 (9.2) |
AMP PEAK 35(14Q32.33) WILD-TYPE | 450 | 63.4 (11.4) |
P value = 1e-05 (Fisher's exact test), Q value = 5.9e-05
nPatients | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA | MIXED SEROUS AND ENDOMETRIOID | SEROUS ENDOMETRIAL ADENOCARCINOMA |
---|---|---|---|
ALL | 395 | 21 | 112 |
AMP PEAK 35(14Q32.33) MUTATED | 30 | 5 | 41 |
AMP PEAK 35(14Q32.33) WILD-TYPE | 365 | 16 | 71 |
P value = 0.00784 (Fisher's exact test), Q value = 0.02
nPatients | NO | YES |
---|---|---|
ALL | 141 | 387 |
AMP PEAK 35(14Q32.33) MUTATED | 11 | 65 |
AMP PEAK 35(14Q32.33) WILD-TYPE | 130 | 322 |
P value = 0.0198 (Fisher's exact test), Q value = 0.044
nPatients | AMERICAN INDIAN OR ALASKA NATIVE | ASIAN | BLACK OR AFRICAN AMERICAN | NATIVE HAWAIIAN OR OTHER PACIFIC ISLANDER | WHITE |
---|---|---|---|---|---|
ALL | 4 | 20 | 101 | 9 | 366 |
AMP PEAK 35(14Q32.33) MUTATED | 0 | 0 | 23 | 2 | 46 |
AMP PEAK 35(14Q32.33) WILD-TYPE | 4 | 20 | 78 | 7 | 320 |
P value = 0.00146 (logrank test), Q value = 0.0048
nPatients | nDeath | Duration Range (Median), Month | |
---|---|---|---|
ALL | 526 | 69 | 0.1 - 191.8 (23.3) |
AMP PEAK 36(15Q26.3) MUTATED | 37 | 12 | 1.7 - 110.1 (28.1) |
AMP PEAK 36(15Q26.3) WILD-TYPE | 489 | 57 | 0.1 - 191.8 (23.3) |
P value = 0.00329 (Wilcoxon-test), Q value = 0.0097
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 526 | 64.0 (11.2) |
AMP PEAK 36(15Q26.3) MUTATED | 37 | 68.9 (11.2) |
AMP PEAK 36(15Q26.3) WILD-TYPE | 489 | 63.6 (11.1) |
P value = 9e-05 (Fisher's exact test), Q value = 0.00043
nPatients | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA | MIXED SEROUS AND ENDOMETRIOID | SEROUS ENDOMETRIAL ADENOCARCINOMA |
---|---|---|---|
ALL | 395 | 21 | 112 |
AMP PEAK 36(15Q26.3) MUTATED | 17 | 1 | 19 |
AMP PEAK 36(15Q26.3) WILD-TYPE | 378 | 20 | 93 |
P value = 0.081 (Fisher's exact test), Q value = 0.15
nPatients | NO | YES |
---|---|---|
ALL | 141 | 387 |
AMP PEAK 36(15Q26.3) MUTATED | 5 | 32 |
AMP PEAK 36(15Q26.3) WILD-TYPE | 136 | 355 |
P value = 0.0122 (Fisher's exact test), Q value = 0.029
nPatients | R0 | R1 | R2 | RX |
---|---|---|---|---|
ALL | 363 | 23 | 17 | 35 |
AMP PEAK 36(15Q26.3) MUTATED | 20 | 3 | 4 | 4 |
AMP PEAK 36(15Q26.3) WILD-TYPE | 343 | 20 | 13 | 31 |
P value = 0.0156 (logrank test), Q value = 0.036
nPatients | nDeath | Duration Range (Median), Month | |
---|---|---|---|
ALL | 526 | 69 | 0.1 - 191.8 (23.3) |
AMP PEAK 37(16P11.2) MUTATED | 64 | 14 | 0.1 - 102.3 (22.0) |
AMP PEAK 37(16P11.2) WILD-TYPE | 462 | 55 | 0.1 - 191.8 (23.4) |
P value = 0.000343 (Wilcoxon-test), Q value = 0.0013
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 526 | 64.0 (11.2) |
AMP PEAK 37(16P11.2) MUTATED | 64 | 68.3 (8.9) |
AMP PEAK 37(16P11.2) WILD-TYPE | 462 | 63.4 (11.4) |
P value = 1e-05 (Fisher's exact test), Q value = 5.9e-05
nPatients | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA | MIXED SEROUS AND ENDOMETRIOID | SEROUS ENDOMETRIAL ADENOCARCINOMA |
---|---|---|---|
ALL | 395 | 21 | 112 |
AMP PEAK 37(16P11.2) MUTATED | 22 | 2 | 40 |
AMP PEAK 37(16P11.2) WILD-TYPE | 373 | 19 | 72 |
P value = 0.0732 (Fisher's exact test), Q value = 0.13
nPatients | R0 | R1 | R2 | RX |
---|---|---|---|---|
ALL | 363 | 23 | 17 | 35 |
AMP PEAK 37(16P11.2) MUTATED | 40 | 3 | 3 | 9 |
AMP PEAK 37(16P11.2) WILD-TYPE | 323 | 20 | 14 | 26 |
P value = 0.0954 (Fisher's exact test), Q value = 0.17
nPatients | AMERICAN INDIAN OR ALASKA NATIVE | ASIAN | BLACK OR AFRICAN AMERICAN | NATIVE HAWAIIAN OR OTHER PACIFIC ISLANDER | WHITE |
---|---|---|---|---|---|
ALL | 4 | 20 | 101 | 9 | 366 |
AMP PEAK 37(16P11.2) MUTATED | 0 | 2 | 20 | 1 | 36 |
AMP PEAK 37(16P11.2) WILD-TYPE | 4 | 18 | 81 | 8 | 330 |
P value = 0.00184 (logrank test), Q value = 0.0059
nPatients | nDeath | Duration Range (Median), Month | |
---|---|---|---|
ALL | 526 | 69 | 0.1 - 191.8 (23.3) |
AMP PEAK 38(17Q11.2) MUTATED | 71 | 16 | 0.1 - 110.1 (17.6) |
AMP PEAK 38(17Q11.2) WILD-TYPE | 455 | 53 | 0.1 - 191.8 (23.6) |
P value = 0.00579 (Wilcoxon-test), Q value = 0.015
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 526 | 64.0 (11.2) |
AMP PEAK 38(17Q11.2) MUTATED | 70 | 67.5 (8.6) |
AMP PEAK 38(17Q11.2) WILD-TYPE | 456 | 63.5 (11.5) |
P value = 1e-05 (Fisher's exact test), Q value = 5.9e-05
nPatients | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA | MIXED SEROUS AND ENDOMETRIOID | SEROUS ENDOMETRIAL ADENOCARCINOMA |
---|---|---|---|
ALL | 395 | 21 | 112 |
AMP PEAK 38(17Q11.2) MUTATED | 19 | 6 | 46 |
AMP PEAK 38(17Q11.2) WILD-TYPE | 376 | 15 | 66 |
P value = 0.00113 (Fisher's exact test), Q value = 0.0039
nPatients | R0 | R1 | R2 | RX |
---|---|---|---|---|
ALL | 363 | 23 | 17 | 35 |
AMP PEAK 38(17Q11.2) MUTATED | 39 | 7 | 6 | 7 |
AMP PEAK 38(17Q11.2) WILD-TYPE | 324 | 16 | 11 | 28 |
P value = 0.00234 (Fisher's exact test), Q value = 0.0072
nPatients | AMERICAN INDIAN OR ALASKA NATIVE | ASIAN | BLACK OR AFRICAN AMERICAN | NATIVE HAWAIIAN OR OTHER PACIFIC ISLANDER | WHITE |
---|---|---|---|---|---|
ALL | 4 | 20 | 101 | 9 | 366 |
AMP PEAK 38(17Q11.2) MUTATED | 1 | 1 | 25 | 2 | 38 |
AMP PEAK 38(17Q11.2) WILD-TYPE | 3 | 19 | 76 | 7 | 328 |
P value = 0.000384 (logrank test), Q value = 0.0015
nPatients | nDeath | Duration Range (Median), Month | |
---|---|---|---|
ALL | 526 | 69 | 0.1 - 191.8 (23.3) |
AMP PEAK 39(17Q12) MUTATED | 74 | 18 | 0.1 - 110.1 (20.4) |
AMP PEAK 39(17Q12) WILD-TYPE | 452 | 51 | 0.1 - 191.8 (23.5) |
P value = 0.0027 (Wilcoxon-test), Q value = 0.0081
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 526 | 64.0 (11.2) |
AMP PEAK 39(17Q12) MUTATED | 73 | 68.0 (9.2) |
AMP PEAK 39(17Q12) WILD-TYPE | 453 | 63.4 (11.4) |
P value = 1e-05 (Fisher's exact test), Q value = 5.9e-05
nPatients | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA | MIXED SEROUS AND ENDOMETRIOID | SEROUS ENDOMETRIAL ADENOCARCINOMA |
---|---|---|---|
ALL | 395 | 21 | 112 |
AMP PEAK 39(17Q12) MUTATED | 20 | 3 | 51 |
AMP PEAK 39(17Q12) WILD-TYPE | 375 | 18 | 61 |
P value = 0.0053 (Fisher's exact test), Q value = 0.014
nPatients | AMERICAN INDIAN OR ALASKA NATIVE | ASIAN | BLACK OR AFRICAN AMERICAN | NATIVE HAWAIIAN OR OTHER PACIFIC ISLANDER | WHITE |
---|---|---|---|---|---|
ALL | 4 | 20 | 101 | 9 | 366 |
AMP PEAK 39(17Q12) MUTATED | 1 | 0 | 25 | 0 | 47 |
AMP PEAK 39(17Q12) WILD-TYPE | 3 | 20 | 76 | 9 | 319 |
P value = 0.000212 (logrank test), Q value = 9e-04
nPatients | nDeath | Duration Range (Median), Month | |
---|---|---|---|
ALL | 526 | 69 | 0.1 - 191.8 (23.3) |
AMP PEAK 40(17Q25.1) MUTATED | 102 | 24 | 0.1 - 125.4 (21.4) |
AMP PEAK 40(17Q25.1) WILD-TYPE | 424 | 45 | 0.1 - 191.8 (23.8) |
P value = 0.00112 (Wilcoxon-test), Q value = 0.0039
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 526 | 64.0 (11.2) |
AMP PEAK 40(17Q25.1) MUTATED | 101 | 67.3 (9.2) |
AMP PEAK 40(17Q25.1) WILD-TYPE | 425 | 63.2 (11.5) |
P value = 1e-05 (Fisher's exact test), Q value = 5.9e-05
nPatients | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA | MIXED SEROUS AND ENDOMETRIOID | SEROUS ENDOMETRIAL ADENOCARCINOMA |
---|---|---|---|
ALL | 395 | 21 | 112 |
AMP PEAK 40(17Q25.1) MUTATED | 37 | 9 | 56 |
AMP PEAK 40(17Q25.1) WILD-TYPE | 358 | 12 | 56 |
P value = 8e-05 (Fisher's exact test), Q value = 4e-04
nPatients | AMERICAN INDIAN OR ALASKA NATIVE | ASIAN | BLACK OR AFRICAN AMERICAN | NATIVE HAWAIIAN OR OTHER PACIFIC ISLANDER | WHITE |
---|---|---|---|---|---|
ALL | 4 | 20 | 101 | 9 | 366 |
AMP PEAK 40(17Q25.1) MUTATED | 0 | 0 | 36 | 2 | 59 |
AMP PEAK 40(17Q25.1) WILD-TYPE | 4 | 20 | 65 | 7 | 307 |
P value = 0.00693 (logrank test), Q value = 0.018
nPatients | nDeath | Duration Range (Median), Month | |
---|---|---|---|
ALL | 526 | 69 | 0.1 - 191.8 (23.3) |
AMP PEAK 41(18P11.31) MUTATED | 94 | 21 | 0.4 - 125.4 (23.8) |
AMP PEAK 41(18P11.31) WILD-TYPE | 432 | 48 | 0.1 - 191.8 (23.3) |
P value = 8.63e-05 (Wilcoxon-test), Q value = 0.00042
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 526 | 64.0 (11.2) |
AMP PEAK 41(18P11.31) MUTATED | 93 | 67.9 (9.1) |
AMP PEAK 41(18P11.31) WILD-TYPE | 433 | 63.2 (11.5) |
P value = 1e-05 (Fisher's exact test), Q value = 5.9e-05
nPatients | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA | MIXED SEROUS AND ENDOMETRIOID | SEROUS ENDOMETRIAL ADENOCARCINOMA |
---|---|---|---|
ALL | 395 | 21 | 112 |
AMP PEAK 41(18P11.31) MUTATED | 29 | 6 | 59 |
AMP PEAK 41(18P11.31) WILD-TYPE | 366 | 15 | 53 |
P value = 0.0204 (Fisher's exact test), Q value = 0.045
nPatients | NO | YES |
---|---|---|
ALL | 141 | 387 |
AMP PEAK 41(18P11.31) MUTATED | 16 | 78 |
AMP PEAK 41(18P11.31) WILD-TYPE | 125 | 309 |
P value = 0.0266 (Fisher's exact test), Q value = 0.057
nPatients | R0 | R1 | R2 | RX |
---|---|---|---|---|
ALL | 363 | 23 | 17 | 35 |
AMP PEAK 41(18P11.31) MUTATED | 61 | 3 | 8 | 7 |
AMP PEAK 41(18P11.31) WILD-TYPE | 302 | 20 | 9 | 28 |
P value = 0.00112 (Fisher's exact test), Q value = 0.0039
nPatients | AMERICAN INDIAN OR ALASKA NATIVE | ASIAN | BLACK OR AFRICAN AMERICAN | NATIVE HAWAIIAN OR OTHER PACIFIC ISLANDER | WHITE |
---|---|---|---|---|---|
ALL | 4 | 20 | 101 | 9 | 366 |
AMP PEAK 41(18P11.31) MUTATED | 0 | 3 | 33 | 1 | 52 |
AMP PEAK 41(18P11.31) WILD-TYPE | 4 | 17 | 68 | 8 | 314 |
P value = 0.00841 (logrank test), Q value = 0.021
nPatients | nDeath | Duration Range (Median), Month | |
---|---|---|---|
ALL | 526 | 69 | 0.1 - 191.8 (23.3) |
AMP PEAK 42(18Q11.2) MUTATED | 68 | 17 | 1.4 - 125.4 (27.1) |
AMP PEAK 42(18Q11.2) WILD-TYPE | 458 | 52 | 0.1 - 191.8 (22.9) |
P value = 0.00197 (Wilcoxon-test), Q value = 0.0062
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 526 | 64.0 (11.2) |
AMP PEAK 42(18Q11.2) MUTATED | 67 | 67.9 (10.1) |
AMP PEAK 42(18Q11.2) WILD-TYPE | 459 | 63.4 (11.3) |
P value = 1e-05 (Fisher's exact test), Q value = 5.9e-05
nPatients | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA | MIXED SEROUS AND ENDOMETRIOID | SEROUS ENDOMETRIAL ADENOCARCINOMA |
---|---|---|---|
ALL | 395 | 21 | 112 |
AMP PEAK 42(18Q11.2) MUTATED | 20 | 4 | 44 |
AMP PEAK 42(18Q11.2) WILD-TYPE | 375 | 17 | 68 |
P value = 0.0755 (Fisher's exact test), Q value = 0.14
nPatients | R0 | R1 | R2 | RX |
---|---|---|---|---|
ALL | 363 | 23 | 17 | 35 |
AMP PEAK 42(18Q11.2) MUTATED | 43 | 1 | 4 | 8 |
AMP PEAK 42(18Q11.2) WILD-TYPE | 320 | 22 | 13 | 27 |
P value = 0.00519 (Fisher's exact test), Q value = 0.014
nPatients | AMERICAN INDIAN OR ALASKA NATIVE | ASIAN | BLACK OR AFRICAN AMERICAN | NATIVE HAWAIIAN OR OTHER PACIFIC ISLANDER | WHITE |
---|---|---|---|---|---|
ALL | 4 | 20 | 101 | 9 | 366 |
AMP PEAK 42(18Q11.2) MUTATED | 0 | 1 | 25 | 1 | 38 |
AMP PEAK 42(18Q11.2) WILD-TYPE | 4 | 19 | 76 | 8 | 328 |
P value = 0.0128 (logrank test), Q value = 0.03
nPatients | nDeath | Duration Range (Median), Month | |
---|---|---|---|
ALL | 526 | 69 | 0.1 - 191.8 (23.3) |
AMP PEAK 43(19P13.2) MUTATED | 96 | 20 | 0.1 - 125.4 (23.1) |
AMP PEAK 43(19P13.2) WILD-TYPE | 430 | 49 | 0.1 - 191.8 (23.3) |
P value = 4.56e-10 (Wilcoxon-test), Q value = 9.4e-08
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 526 | 64.0 (11.2) |
AMP PEAK 43(19P13.2) MUTATED | 96 | 70.2 (8.6) |
AMP PEAK 43(19P13.2) WILD-TYPE | 430 | 62.6 (11.3) |
P value = 1e-05 (Fisher's exact test), Q value = 5.9e-05
nPatients | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA | MIXED SEROUS AND ENDOMETRIOID | SEROUS ENDOMETRIAL ADENOCARCINOMA |
---|---|---|---|
ALL | 395 | 21 | 112 |
AMP PEAK 43(19P13.2) MUTATED | 26 | 7 | 64 |
AMP PEAK 43(19P13.2) WILD-TYPE | 369 | 14 | 48 |
P value = 0.0561 (Fisher's exact test), Q value = 0.11
nPatients | NO | YES |
---|---|---|
ALL | 141 | 387 |
AMP PEAK 43(19P13.2) MUTATED | 18 | 79 |
AMP PEAK 43(19P13.2) WILD-TYPE | 123 | 308 |
P value = 0.00133 (Fisher's exact test), Q value = 0.0044
nPatients | AMERICAN INDIAN OR ALASKA NATIVE | ASIAN | BLACK OR AFRICAN AMERICAN | NATIVE HAWAIIAN OR OTHER PACIFIC ISLANDER | WHITE |
---|---|---|---|---|---|
ALL | 4 | 20 | 101 | 9 | 366 |
AMP PEAK 43(19P13.2) MUTATED | 0 | 0 | 31 | 2 | 58 |
AMP PEAK 43(19P13.2) WILD-TYPE | 4 | 20 | 70 | 7 | 308 |
P value = 4.99e-05 (logrank test), Q value = 0.00026
nPatients | nDeath | Duration Range (Median), Month | |
---|---|---|---|
ALL | 526 | 69 | 0.1 - 191.8 (23.3) |
AMP PEAK 44(19Q12) MUTATED | 115 | 27 | 0.1 - 125.4 (20.5) |
AMP PEAK 44(19Q12) WILD-TYPE | 411 | 42 | 0.2 - 191.8 (23.9) |
P value = 1.44e-08 (Wilcoxon-test), Q value = 1e-06
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 526 | 64.0 (11.2) |
AMP PEAK 44(19Q12) MUTATED | 115 | 68.9 (8.6) |
AMP PEAK 44(19Q12) WILD-TYPE | 411 | 62.6 (11.5) |
P value = 1e-05 (Fisher's exact test), Q value = 5.9e-05
nPatients | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA | MIXED SEROUS AND ENDOMETRIOID | SEROUS ENDOMETRIAL ADENOCARCINOMA |
---|---|---|---|
ALL | 395 | 21 | 112 |
AMP PEAK 44(19Q12) MUTATED | 29 | 10 | 77 |
AMP PEAK 44(19Q12) WILD-TYPE | 366 | 11 | 35 |
P value = 3e-05 (Fisher's exact test), Q value = 0.00016
nPatients | AMERICAN INDIAN OR ALASKA NATIVE | ASIAN | BLACK OR AFRICAN AMERICAN | NATIVE HAWAIIAN OR OTHER PACIFIC ISLANDER | WHITE |
---|---|---|---|---|---|
ALL | 4 | 20 | 101 | 9 | 366 |
AMP PEAK 44(19Q12) MUTATED | 1 | 2 | 43 | 3 | 62 |
AMP PEAK 44(19Q12) WILD-TYPE | 3 | 18 | 58 | 6 | 304 |
P value = 2.37e-06 (Wilcoxon-test), Q value = 5.9e-05
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 526 | 64.0 (11.2) |
AMP PEAK 45(20P13) MUTATED | 116 | 67.8 (10.8) |
AMP PEAK 45(20P13) WILD-TYPE | 410 | 62.9 (11.1) |
P value = 1e-05 (Fisher's exact test), Q value = 5.9e-05
nPatients | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA | MIXED SEROUS AND ENDOMETRIOID | SEROUS ENDOMETRIAL ADENOCARCINOMA |
---|---|---|---|
ALL | 395 | 21 | 112 |
AMP PEAK 45(20P13) MUTATED | 52 | 5 | 59 |
AMP PEAK 45(20P13) WILD-TYPE | 343 | 16 | 53 |
P value = 0.033 (Fisher's exact test), Q value = 0.068
nPatients | NO | YES |
---|---|---|
ALL | 141 | 387 |
AMP PEAK 45(20P13) MUTATED | 22 | 94 |
AMP PEAK 45(20P13) WILD-TYPE | 119 | 293 |
P value = 0.0445 (Fisher's exact test), Q value = 0.088
nPatients | AMERICAN INDIAN OR ALASKA NATIVE | ASIAN | BLACK OR AFRICAN AMERICAN | NATIVE HAWAIIAN OR OTHER PACIFIC ISLANDER | WHITE |
---|---|---|---|---|---|
ALL | 4 | 20 | 101 | 9 | 366 |
AMP PEAK 45(20P13) MUTATED | 0 | 4 | 33 | 2 | 69 |
AMP PEAK 45(20P13) WILD-TYPE | 4 | 16 | 68 | 7 | 297 |
P value = 0.000289 (logrank test), Q value = 0.0012
nPatients | nDeath | Duration Range (Median), Month | |
---|---|---|---|
ALL | 526 | 69 | 0.1 - 191.8 (23.3) |
AMP PEAK 46(20Q11.21) MUTATED | 148 | 31 | 0.1 - 149.6 (20.4) |
AMP PEAK 46(20Q11.21) WILD-TYPE | 378 | 38 | 0.1 - 191.8 (23.8) |
P value = 1.88e-08 (Wilcoxon-test), Q value = 1.2e-06
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 526 | 64.0 (11.2) |
AMP PEAK 46(20Q11.21) MUTATED | 149 | 68.1 (9.7) |
AMP PEAK 46(20Q11.21) WILD-TYPE | 377 | 62.4 (11.4) |
P value = 1e-05 (Fisher's exact test), Q value = 5.9e-05
nPatients | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA | MIXED SEROUS AND ENDOMETRIOID | SEROUS ENDOMETRIAL ADENOCARCINOMA |
---|---|---|---|
ALL | 395 | 21 | 112 |
AMP PEAK 46(20Q11.21) MUTATED | 62 | 6 | 81 |
AMP PEAK 46(20Q11.21) WILD-TYPE | 333 | 15 | 31 |
P value = 0.00612 (Fisher's exact test), Q value = 0.016
nPatients | NO | YES |
---|---|---|
ALL | 141 | 387 |
AMP PEAK 46(20Q11.21) MUTATED | 27 | 122 |
AMP PEAK 46(20Q11.21) WILD-TYPE | 114 | 265 |
P value = 0.106 (Fisher's exact test), Q value = 0.18
nPatients | R0 | R1 | R2 | RX |
---|---|---|---|---|
ALL | 363 | 23 | 17 | 35 |
AMP PEAK 46(20Q11.21) MUTATED | 93 | 5 | 9 | 10 |
AMP PEAK 46(20Q11.21) WILD-TYPE | 270 | 18 | 8 | 25 |
P value = 0.00654 (Fisher's exact test), Q value = 0.017
nPatients | AMERICAN INDIAN OR ALASKA NATIVE | ASIAN | BLACK OR AFRICAN AMERICAN | NATIVE HAWAIIAN OR OTHER PACIFIC ISLANDER | WHITE |
---|---|---|---|---|---|
ALL | 4 | 20 | 101 | 9 | 366 |
AMP PEAK 46(20Q11.21) MUTATED | 1 | 5 | 43 | 3 | 88 |
AMP PEAK 46(20Q11.21) WILD-TYPE | 3 | 15 | 58 | 6 | 278 |
P value = 0.00947 (logrank test), Q value = 0.023
nPatients | nDeath | Duration Range (Median), Month | |
---|---|---|---|
ALL | 526 | 69 | 0.1 - 191.8 (23.3) |
AMP PEAK 47(20Q13.12) MUTATED | 148 | 28 | 0.1 - 191.8 (20.4) |
AMP PEAK 47(20Q13.12) WILD-TYPE | 378 | 41 | 0.1 - 185.8 (23.7) |
P value = 1.34e-08 (Wilcoxon-test), Q value = 1e-06
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 526 | 64.0 (11.2) |
AMP PEAK 47(20Q13.12) MUTATED | 148 | 68.3 (10.0) |
AMP PEAK 47(20Q13.12) WILD-TYPE | 378 | 62.3 (11.2) |
P value = 1e-05 (Fisher's exact test), Q value = 5.9e-05
nPatients | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA | MIXED SEROUS AND ENDOMETRIOID | SEROUS ENDOMETRIAL ADENOCARCINOMA |
---|---|---|---|
ALL | 395 | 21 | 112 |
AMP PEAK 47(20Q13.12) MUTATED | 64 | 7 | 78 |
AMP PEAK 47(20Q13.12) WILD-TYPE | 331 | 14 | 34 |
P value = 0.00104 (Fisher's exact test), Q value = 0.0037
nPatients | NO | YES |
---|---|---|
ALL | 141 | 387 |
AMP PEAK 47(20Q13.12) MUTATED | 25 | 124 |
AMP PEAK 47(20Q13.12) WILD-TYPE | 116 | 263 |
P value = 0.0596 (Fisher's exact test), Q value = 0.11
nPatients | R0 | R1 | R2 | RX |
---|---|---|---|---|
ALL | 363 | 23 | 17 | 35 |
AMP PEAK 47(20Q13.12) MUTATED | 91 | 7 | 9 | 12 |
AMP PEAK 47(20Q13.12) WILD-TYPE | 272 | 16 | 8 | 23 |
P value = 0.00522 (Fisher's exact test), Q value = 0.014
nPatients | AMERICAN INDIAN OR ALASKA NATIVE | ASIAN | BLACK OR AFRICAN AMERICAN | NATIVE HAWAIIAN OR OTHER PACIFIC ISLANDER | WHITE |
---|---|---|---|---|---|
ALL | 4 | 20 | 101 | 9 | 366 |
AMP PEAK 47(20Q13.12) MUTATED | 1 | 5 | 43 | 3 | 87 |
AMP PEAK 47(20Q13.12) WILD-TYPE | 3 | 15 | 58 | 6 | 279 |
P value = 0.014 (logrank test), Q value = 0.033
nPatients | nDeath | Duration Range (Median), Month | |
---|---|---|---|
ALL | 526 | 69 | 0.1 - 191.8 (23.3) |
AMP PEAK 48(20Q13.33) MUTATED | 149 | 28 | 0.1 - 191.8 (20.3) |
AMP PEAK 48(20Q13.33) WILD-TYPE | 377 | 41 | 0.1 - 185.8 (23.9) |
P value = 3.51e-08 (Wilcoxon-test), Q value = 1.8e-06
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 526 | 64.0 (11.2) |
AMP PEAK 48(20Q13.33) MUTATED | 149 | 68.1 (10.3) |
AMP PEAK 48(20Q13.33) WILD-TYPE | 377 | 62.4 (11.2) |
P value = 1e-05 (Fisher's exact test), Q value = 5.9e-05
nPatients | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA | MIXED SEROUS AND ENDOMETRIOID | SEROUS ENDOMETRIAL ADENOCARCINOMA |
---|---|---|---|
ALL | 395 | 21 | 112 |
AMP PEAK 48(20Q13.33) MUTATED | 67 | 6 | 77 |
AMP PEAK 48(20Q13.33) WILD-TYPE | 328 | 15 | 35 |
P value = 0.00101 (Fisher's exact test), Q value = 0.0036
nPatients | NO | YES |
---|---|---|
ALL | 141 | 387 |
AMP PEAK 48(20Q13.33) MUTATED | 25 | 125 |
AMP PEAK 48(20Q13.33) WILD-TYPE | 116 | 262 |
P value = 0.0133 (Fisher's exact test), Q value = 0.031
nPatients | R0 | R1 | R2 | RX |
---|---|---|---|---|
ALL | 363 | 23 | 17 | 35 |
AMP PEAK 48(20Q13.33) MUTATED | 91 | 7 | 10 | 13 |
AMP PEAK 48(20Q13.33) WILD-TYPE | 272 | 16 | 7 | 22 |
P value = 0.0395 (Fisher's exact test), Q value = 0.081
nPatients | AMERICAN INDIAN OR ALASKA NATIVE | ASIAN | BLACK OR AFRICAN AMERICAN | NATIVE HAWAIIAN OR OTHER PACIFIC ISLANDER | WHITE |
---|---|---|---|---|---|
ALL | 4 | 20 | 101 | 9 | 366 |
AMP PEAK 48(20Q13.33) MUTATED | 1 | 6 | 41 | 3 | 92 |
AMP PEAK 48(20Q13.33) WILD-TYPE | 3 | 14 | 60 | 6 | 274 |
P value = 0.000495 (logrank test), Q value = 0.0019
nPatients | nDeath | Duration Range (Median), Month | |
---|---|---|---|
ALL | 526 | 69 | 0.1 - 191.8 (23.3) |
AMP PEAK 49(22Q12.2) MUTATED | 61 | 17 | 0.4 - 191.8 (21.9) |
AMP PEAK 49(22Q12.2) WILD-TYPE | 465 | 52 | 0.1 - 185.8 (23.3) |
P value = 0.000572 (Wilcoxon-test), Q value = 0.0021
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 526 | 64.0 (11.2) |
AMP PEAK 49(22Q12.2) MUTATED | 61 | 68.3 (10.1) |
AMP PEAK 49(22Q12.2) WILD-TYPE | 465 | 63.4 (11.2) |
P value = 1e-05 (Fisher's exact test), Q value = 5.9e-05
nPatients | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA | MIXED SEROUS AND ENDOMETRIOID | SEROUS ENDOMETRIAL ADENOCARCINOMA |
---|---|---|---|
ALL | 395 | 21 | 112 |
AMP PEAK 49(22Q12.2) MUTATED | 11 | 2 | 49 |
AMP PEAK 49(22Q12.2) WILD-TYPE | 384 | 19 | 63 |
P value = 0.0474 (Fisher's exact test), Q value = 0.093
nPatients | NO | YES |
---|---|---|
ALL | 141 | 387 |
AMP PEAK 49(22Q12.2) MUTATED | 10 | 52 |
AMP PEAK 49(22Q12.2) WILD-TYPE | 131 | 335 |
P value = 0.00228 (Fisher's exact test), Q value = 0.0071
nPatients | R0 | R1 | R2 | RX |
---|---|---|---|---|
ALL | 363 | 23 | 17 | 35 |
AMP PEAK 49(22Q12.2) MUTATED | 35 | 3 | 7 | 6 |
AMP PEAK 49(22Q12.2) WILD-TYPE | 328 | 20 | 10 | 29 |
P value = 0.0256 (Fisher's exact test), Q value = 0.055
nPatients | AMERICAN INDIAN OR ALASKA NATIVE | ASIAN | BLACK OR AFRICAN AMERICAN | NATIVE HAWAIIAN OR OTHER PACIFIC ISLANDER | WHITE |
---|---|---|---|---|---|
ALL | 4 | 20 | 101 | 9 | 366 |
AMP PEAK 49(22Q12.2) MUTATED | 0 | 1 | 21 | 0 | 34 |
AMP PEAK 49(22Q12.2) WILD-TYPE | 4 | 19 | 80 | 9 | 332 |
P value = 0.0887 (logrank test), Q value = 0.16
nPatients | nDeath | Duration Range (Median), Month | |
---|---|---|---|
ALL | 526 | 69 | 0.1 - 191.8 (23.3) |
AMP PEAK 50(XP11.23) MUTATED | 89 | 16 | 0.1 - 110.1 (22.6) |
AMP PEAK 50(XP11.23) WILD-TYPE | 437 | 53 | 0.2 - 191.8 (23.4) |
P value = 0.029 (Wilcoxon-test), Q value = 0.061
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 526 | 64.0 (11.2) |
AMP PEAK 50(XP11.23) MUTATED | 89 | 66.2 (11.2) |
AMP PEAK 50(XP11.23) WILD-TYPE | 437 | 63.6 (11.2) |
P value = 0.00034 (Fisher's exact test), Q value = 0.0013
nPatients | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA | MIXED SEROUS AND ENDOMETRIOID | SEROUS ENDOMETRIAL ADENOCARCINOMA |
---|---|---|---|
ALL | 395 | 21 | 112 |
AMP PEAK 50(XP11.23) MUTATED | 52 | 4 | 33 |
AMP PEAK 50(XP11.23) WILD-TYPE | 343 | 17 | 79 |
P value = 0.025 (Fisher's exact test), Q value = 0.054
nPatients | NO | YES |
---|---|---|
ALL | 141 | 387 |
AMP PEAK 50(XP11.23) MUTATED | 15 | 74 |
AMP PEAK 50(XP11.23) WILD-TYPE | 126 | 313 |
P value = 0.000466 (logrank test), Q value = 0.0018
nPatients | nDeath | Duration Range (Median), Month | |
---|---|---|---|
ALL | 526 | 69 | 0.1 - 191.8 (23.3) |
AMP PEAK 51(XQ28) MUTATED | 88 | 21 | 0.1 - 110.1 (22.2) |
AMP PEAK 51(XQ28) WILD-TYPE | 438 | 48 | 0.1 - 191.8 (23.4) |
P value = 0.0513 (Wilcoxon-test), Q value = 0.099
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 526 | 64.0 (11.2) |
AMP PEAK 51(XQ28) MUTATED | 88 | 66.1 (12.3) |
AMP PEAK 51(XQ28) WILD-TYPE | 438 | 63.6 (11.0) |
P value = 0.00059 (Fisher's exact test), Q value = 0.0022
nPatients | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA | MIXED SEROUS AND ENDOMETRIOID | SEROUS ENDOMETRIAL ADENOCARCINOMA |
---|---|---|---|
ALL | 395 | 21 | 112 |
AMP PEAK 51(XQ28) MUTATED | 53 | 3 | 33 |
AMP PEAK 51(XQ28) WILD-TYPE | 342 | 18 | 79 |
P value = 0.000199 (Wilcoxon-test), Q value = 0.00086
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 526 | 64.0 (11.2) |
DEL PEAK 1(1P36.21) MUTATED | 69 | 69.1 (10.2) |
DEL PEAK 1(1P36.21) WILD-TYPE | 457 | 63.2 (11.2) |
P value = 1e-05 (Fisher's exact test), Q value = 5.9e-05
nPatients | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA | MIXED SEROUS AND ENDOMETRIOID | SEROUS ENDOMETRIAL ADENOCARCINOMA |
---|---|---|---|
ALL | 395 | 21 | 112 |
DEL PEAK 1(1P36.21) MUTATED | 26 | 5 | 38 |
DEL PEAK 1(1P36.21) WILD-TYPE | 369 | 16 | 74 |
P value = 0.00773 (logrank test), Q value = 0.02
nPatients | nDeath | Duration Range (Median), Month | |
---|---|---|---|
ALL | 526 | 69 | 0.1 - 191.8 (23.3) |
DEL PEAK 2(1P36.11) MUTATED | 78 | 17 | 0.4 - 149.6 (20.5) |
DEL PEAK 2(1P36.11) WILD-TYPE | 448 | 52 | 0.1 - 191.8 (23.4) |
P value = 9.85e-05 (Wilcoxon-test), Q value = 0.00047
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 526 | 64.0 (11.2) |
DEL PEAK 2(1P36.11) MUTATED | 79 | 68.7 (9.4) |
DEL PEAK 2(1P36.11) WILD-TYPE | 447 | 63.2 (11.3) |
P value = 1e-05 (Fisher's exact test), Q value = 5.9e-05
nPatients | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA | MIXED SEROUS AND ENDOMETRIOID | SEROUS ENDOMETRIAL ADENOCARCINOMA |
---|---|---|---|
ALL | 395 | 21 | 112 |
DEL PEAK 2(1P36.11) MUTATED | 25 | 5 | 49 |
DEL PEAK 2(1P36.11) WILD-TYPE | 370 | 16 | 63 |
P value = 0.0421 (Fisher's exact test), Q value = 0.085
nPatients | R0 | R1 | R2 | RX |
---|---|---|---|---|
ALL | 363 | 23 | 17 | 35 |
DEL PEAK 2(1P36.11) MUTATED | 52 | 7 | 5 | 3 |
DEL PEAK 2(1P36.11) WILD-TYPE | 311 | 16 | 12 | 32 |
P value = 0.0429 (logrank test), Q value = 0.086
nPatients | nDeath | Duration Range (Median), Month | |
---|---|---|---|
ALL | 526 | 69 | 0.1 - 191.8 (23.3) |
DEL PEAK 3(2P25.3) MUTATED | 25 | 6 | 0.6 - 125.4 (18.9) |
DEL PEAK 3(2P25.3) WILD-TYPE | 501 | 63 | 0.1 - 191.8 (23.7) |
P value = 0.071 (Wilcoxon-test), Q value = 0.13
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 526 | 64.0 (11.2) |
DEL PEAK 3(2P25.3) MUTATED | 26 | 66.8 (7.9) |
DEL PEAK 3(2P25.3) WILD-TYPE | 500 | 63.9 (11.4) |
P value = 0.0104 (Fisher's exact test), Q value = 0.025
nPatients | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA | MIXED SEROUS AND ENDOMETRIOID | SEROUS ENDOMETRIAL ADENOCARCINOMA |
---|---|---|---|
ALL | 395 | 21 | 112 |
DEL PEAK 3(2P25.3) MUTATED | 13 | 2 | 11 |
DEL PEAK 3(2P25.3) WILD-TYPE | 382 | 19 | 101 |
P value = 0.109 (Fisher's exact test), Q value = 0.19
nPatients | NO | YES |
---|---|---|
ALL | 141 | 387 |
DEL PEAK 3(2P25.3) MUTATED | 3 | 23 |
DEL PEAK 3(2P25.3) WILD-TYPE | 138 | 364 |
P value = 1.26e-07 (logrank test), Q value = 5.2e-06
nPatients | nDeath | Duration Range (Median), Month | |
---|---|---|---|
ALL | 526 | 69 | 0.1 - 191.8 (23.3) |
DEL PEAK 4(2Q22.1) MUTATED | 46 | 16 | 0.6 - 125.4 (16.9) |
DEL PEAK 4(2Q22.1) WILD-TYPE | 480 | 53 | 0.1 - 191.8 (23.9) |
P value = 0.0048 (Wilcoxon-test), Q value = 0.013
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 526 | 64.0 (11.2) |
DEL PEAK 4(2Q22.1) MUTATED | 46 | 68.0 (9.3) |
DEL PEAK 4(2Q22.1) WILD-TYPE | 480 | 63.6 (11.3) |
P value = 1e-05 (Fisher's exact test), Q value = 5.9e-05
nPatients | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA | MIXED SEROUS AND ENDOMETRIOID | SEROUS ENDOMETRIAL ADENOCARCINOMA |
---|---|---|---|
ALL | 395 | 21 | 112 |
DEL PEAK 4(2Q22.1) MUTATED | 17 | 2 | 27 |
DEL PEAK 4(2Q22.1) WILD-TYPE | 378 | 19 | 85 |
P value = 0.0027 (Fisher's exact test), Q value = 0.0081
nPatients | NO | YES |
---|---|---|
ALL | 141 | 387 |
DEL PEAK 4(2Q22.1) MUTATED | 4 | 42 |
DEL PEAK 4(2Q22.1) WILD-TYPE | 137 | 345 |
P value = 0.00162 (Fisher's exact test), Q value = 0.0052
nPatients | R0 | R1 | R2 | RX |
---|---|---|---|---|
ALL | 363 | 23 | 17 | 35 |
DEL PEAK 4(2Q22.1) MUTATED | 24 | 2 | 5 | 7 |
DEL PEAK 4(2Q22.1) WILD-TYPE | 339 | 21 | 12 | 28 |
P value = 0.0849 (Fisher's exact test), Q value = 0.15
nPatients | AMERICAN INDIAN OR ALASKA NATIVE | ASIAN | BLACK OR AFRICAN AMERICAN | NATIVE HAWAIIAN OR OTHER PACIFIC ISLANDER | WHITE |
---|---|---|---|---|---|
ALL | 4 | 20 | 101 | 9 | 366 |
DEL PEAK 4(2Q22.1) MUTATED | 0 | 1 | 16 | 1 | 26 |
DEL PEAK 4(2Q22.1) WILD-TYPE | 4 | 19 | 85 | 8 | 340 |
P value = 0.0185 (logrank test), Q value = 0.041
nPatients | nDeath | Duration Range (Median), Month | |
---|---|---|---|
ALL | 526 | 69 | 0.1 - 191.8 (23.3) |
DEL PEAK 5(2Q37.3) MUTATED | 51 | 12 | 0.6 - 102.3 (22.3) |
DEL PEAK 5(2Q37.3) WILD-TYPE | 475 | 57 | 0.1 - 191.8 (23.3) |
P value = 0.00257 (Wilcoxon-test), Q value = 0.0079
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 526 | 64.0 (11.2) |
DEL PEAK 5(2Q37.3) MUTATED | 52 | 68.2 (8.4) |
DEL PEAK 5(2Q37.3) WILD-TYPE | 474 | 63.5 (11.4) |
P value = 1e-04 (Fisher's exact test), Q value = 0.00047
nPatients | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA | MIXED SEROUS AND ENDOMETRIOID | SEROUS ENDOMETRIAL ADENOCARCINOMA |
---|---|---|---|
ALL | 395 | 21 | 112 |
DEL PEAK 5(2Q37.3) MUTATED | 26 | 2 | 24 |
DEL PEAK 5(2Q37.3) WILD-TYPE | 369 | 19 | 88 |
P value = 0.137 (Fisher's exact test), Q value = 0.22
nPatients | NO | YES |
---|---|---|
ALL | 141 | 387 |
DEL PEAK 5(2Q37.3) MUTATED | 9 | 43 |
DEL PEAK 5(2Q37.3) WILD-TYPE | 132 | 344 |
P value = 0.0439 (Fisher's exact test), Q value = 0.087
nPatients | R0 | R1 | R2 | RX |
---|---|---|---|---|
ALL | 363 | 23 | 17 | 35 |
DEL PEAK 5(2Q37.3) MUTATED | 32 | 2 | 3 | 8 |
DEL PEAK 5(2Q37.3) WILD-TYPE | 331 | 21 | 14 | 27 |
P value = 0.142 (Fisher's exact test), Q value = 0.23
nPatients | AMERICAN INDIAN OR ALASKA NATIVE | ASIAN | BLACK OR AFRICAN AMERICAN | NATIVE HAWAIIAN OR OTHER PACIFIC ISLANDER | WHITE |
---|---|---|---|---|---|
ALL | 4 | 20 | 101 | 9 | 366 |
DEL PEAK 5(2Q37.3) MUTATED | 0 | 0 | 14 | 2 | 32 |
DEL PEAK 5(2Q37.3) WILD-TYPE | 4 | 20 | 87 | 7 | 334 |
P value = 0.00112 (Wilcoxon-test), Q value = 0.0039
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 526 | 64.0 (11.2) |
DEL PEAK 6(3P14.2) MUTATED | 76 | 67.5 (8.0) |
DEL PEAK 6(3P14.2) WILD-TYPE | 450 | 63.4 (11.6) |
P value = 1e-05 (Fisher's exact test), Q value = 5.9e-05
nPatients | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA | MIXED SEROUS AND ENDOMETRIOID | SEROUS ENDOMETRIAL ADENOCARCINOMA |
---|---|---|---|
ALL | 395 | 21 | 112 |
DEL PEAK 6(3P14.2) MUTATED | 27 | 6 | 44 |
DEL PEAK 6(3P14.2) WILD-TYPE | 368 | 15 | 68 |
P value = 0.022 (Fisher's exact test), Q value = 0.048
nPatients | AMERICAN INDIAN OR ALASKA NATIVE | ASIAN | BLACK OR AFRICAN AMERICAN | NATIVE HAWAIIAN OR OTHER PACIFIC ISLANDER | WHITE |
---|---|---|---|---|---|
ALL | 4 | 20 | 101 | 9 | 366 |
DEL PEAK 6(3P14.2) MUTATED | 0 | 1 | 25 | 0 | 47 |
DEL PEAK 6(3P14.2) WILD-TYPE | 4 | 19 | 76 | 9 | 319 |
P value = 0.141 (Fisher's exact test), Q value = 0.23
nPatients | HISPANIC OR LATINO | NOT HISPANIC OR LATINO |
---|---|---|
ALL | 14 | 367 |
DEL PEAK 6(3P14.2) MUTATED | 0 | 58 |
DEL PEAK 6(3P14.2) WILD-TYPE | 14 | 309 |
P value = 0.000389 (Wilcoxon-test), Q value = 0.0015
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 526 | 64.0 (11.2) |
DEL PEAK 7(3Q13.31) MUTATED | 42 | 69.4 (10.2) |
DEL PEAK 7(3Q13.31) WILD-TYPE | 484 | 63.5 (11.2) |
P value = 1e-05 (Fisher's exact test), Q value = 5.9e-05
nPatients | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA | MIXED SEROUS AND ENDOMETRIOID | SEROUS ENDOMETRIAL ADENOCARCINOMA |
---|---|---|---|
ALL | 395 | 21 | 112 |
DEL PEAK 7(3Q13.31) MUTATED | 17 | 3 | 22 |
DEL PEAK 7(3Q13.31) WILD-TYPE | 378 | 18 | 90 |
P value = 0.00202 (logrank test), Q value = 0.0063
nPatients | nDeath | Duration Range (Median), Month | |
---|---|---|---|
ALL | 526 | 69 | 0.1 - 191.8 (23.3) |
DEL PEAK 8(4P16.3) MUTATED | 88 | 19 | 0.2 - 149.6 (20.0) |
DEL PEAK 8(4P16.3) WILD-TYPE | 438 | 50 | 0.1 - 191.8 (23.9) |
P value = 0.000181 (Wilcoxon-test), Q value = 8e-04
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 526 | 64.0 (11.2) |
DEL PEAK 8(4P16.3) MUTATED | 89 | 68.0 (9.0) |
DEL PEAK 8(4P16.3) WILD-TYPE | 437 | 63.2 (11.5) |
P value = 1e-05 (Fisher's exact test), Q value = 5.9e-05
nPatients | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA | MIXED SEROUS AND ENDOMETRIOID | SEROUS ENDOMETRIAL ADENOCARCINOMA |
---|---|---|---|
ALL | 395 | 21 | 112 |
DEL PEAK 8(4P16.3) MUTATED | 29 | 5 | 55 |
DEL PEAK 8(4P16.3) WILD-TYPE | 366 | 16 | 57 |
P value = 0.00057 (logrank test), Q value = 0.0021
nPatients | nDeath | Duration Range (Median), Month | |
---|---|---|---|
ALL | 526 | 69 | 0.1 - 191.8 (23.3) |
DEL PEAK 9(4P15.2) MUTATED | 92 | 21 | 0.2 - 149.6 (20.0) |
DEL PEAK 9(4P15.2) WILD-TYPE | 434 | 48 | 0.1 - 191.8 (23.9) |
P value = 7.19e-05 (Wilcoxon-test), Q value = 0.00036
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 526 | 64.0 (11.2) |
DEL PEAK 9(4P15.2) MUTATED | 93 | 68.2 (9.1) |
DEL PEAK 9(4P15.2) WILD-TYPE | 433 | 63.1 (11.4) |
P value = 1e-05 (Fisher's exact test), Q value = 5.9e-05
nPatients | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA | MIXED SEROUS AND ENDOMETRIOID | SEROUS ENDOMETRIAL ADENOCARCINOMA |
---|---|---|---|
ALL | 395 | 21 | 112 |
DEL PEAK 9(4P15.2) MUTATED | 31 | 5 | 57 |
DEL PEAK 9(4P15.2) WILD-TYPE | 364 | 16 | 55 |
P value = 0.0929 (Fisher's exact test), Q value = 0.16
nPatients | NO | YES |
---|---|---|
ALL | 141 | 387 |
DEL PEAK 9(4P15.2) MUTATED | 18 | 75 |
DEL PEAK 9(4P15.2) WILD-TYPE | 123 | 312 |
P value = 0.00539 (logrank test), Q value = 0.015
nPatients | nDeath | Duration Range (Median), Month | |
---|---|---|---|
ALL | 526 | 69 | 0.1 - 191.8 (23.3) |
DEL PEAK 10(4Q22.1) MUTATED | 101 | 22 | 0.2 - 149.6 (21.2) |
DEL PEAK 10(4Q22.1) WILD-TYPE | 425 | 47 | 0.1 - 191.8 (23.5) |
P value = 8e-06 (Wilcoxon-test), Q value = 5.9e-05
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 526 | 64.0 (11.2) |
DEL PEAK 10(4Q22.1) MUTATED | 102 | 68.3 (8.9) |
DEL PEAK 10(4Q22.1) WILD-TYPE | 424 | 63.0 (11.5) |
P value = 1e-05 (Fisher's exact test), Q value = 5.9e-05
nPatients | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA | MIXED SEROUS AND ENDOMETRIOID | SEROUS ENDOMETRIAL ADENOCARCINOMA |
---|---|---|---|
ALL | 395 | 21 | 112 |
DEL PEAK 10(4Q22.1) MUTATED | 30 | 6 | 66 |
DEL PEAK 10(4Q22.1) WILD-TYPE | 365 | 15 | 46 |
P value = 0.135 (Fisher's exact test), Q value = 0.22
nPatients | NO | YES |
---|---|---|
ALL | 141 | 387 |
DEL PEAK 10(4Q22.1) MUTATED | 21 | 81 |
DEL PEAK 10(4Q22.1) WILD-TYPE | 120 | 306 |
P value = 0.0787 (Fisher's exact test), Q value = 0.14
nPatients | R0 | R1 | R2 | RX |
---|---|---|---|---|
ALL | 363 | 23 | 17 | 35 |
DEL PEAK 10(4Q22.1) MUTATED | 63 | 6 | 7 | 7 |
DEL PEAK 10(4Q22.1) WILD-TYPE | 300 | 17 | 10 | 28 |
P value = 0.00667 (logrank test), Q value = 0.017
nPatients | nDeath | Duration Range (Median), Month | |
---|---|---|---|
ALL | 526 | 69 | 0.1 - 191.8 (23.3) |
DEL PEAK 11(4Q34.3) MUTATED | 126 | 25 | 0.2 - 149.6 (20.8) |
DEL PEAK 11(4Q34.3) WILD-TYPE | 400 | 44 | 0.1 - 191.8 (23.7) |
P value = 6.72e-07 (Wilcoxon-test), Q value = 2.4e-05
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 526 | 64.0 (11.2) |
DEL PEAK 11(4Q34.3) MUTATED | 127 | 68.0 (9.8) |
DEL PEAK 11(4Q34.3) WILD-TYPE | 399 | 62.7 (11.4) |
P value = 1e-05 (Fisher's exact test), Q value = 5.9e-05
nPatients | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA | MIXED SEROUS AND ENDOMETRIOID | SEROUS ENDOMETRIAL ADENOCARCINOMA |
---|---|---|---|
ALL | 395 | 21 | 112 |
DEL PEAK 11(4Q34.3) MUTATED | 43 | 8 | 76 |
DEL PEAK 11(4Q34.3) WILD-TYPE | 352 | 13 | 36 |
P value = 0.134 (Fisher's exact test), Q value = 0.22
nPatients | NO | YES |
---|---|---|
ALL | 141 | 387 |
DEL PEAK 11(4Q34.3) MUTATED | 27 | 100 |
DEL PEAK 11(4Q34.3) WILD-TYPE | 114 | 287 |
P value = 0.137 (Fisher's exact test), Q value = 0.22
nPatients | R0 | R1 | R2 | RX |
---|---|---|---|---|
ALL | 363 | 23 | 17 | 35 |
DEL PEAK 11(4Q34.3) MUTATED | 81 | 6 | 8 | 7 |
DEL PEAK 11(4Q34.3) WILD-TYPE | 282 | 17 | 9 | 28 |
P value = 0.0115 (Fisher's exact test), Q value = 0.028
nPatients | AMERICAN INDIAN OR ALASKA NATIVE | ASIAN | BLACK OR AFRICAN AMERICAN | NATIVE HAWAIIAN OR OTHER PACIFIC ISLANDER | WHITE |
---|---|---|---|---|---|
ALL | 4 | 20 | 101 | 9 | 366 |
DEL PEAK 11(4Q34.3) MUTATED | 0 | 4 | 37 | 3 | 75 |
DEL PEAK 11(4Q34.3) WILD-TYPE | 4 | 16 | 64 | 6 | 291 |
P value = 0.00485 (logrank test), Q value = 0.013
nPatients | nDeath | Duration Range (Median), Month | |
---|---|---|---|
ALL | 526 | 69 | 0.1 - 191.8 (23.3) |
DEL PEAK 12(5Q12.1) MUTATED | 108 | 23 | 0.2 - 149.6 (22.0) |
DEL PEAK 12(5Q12.1) WILD-TYPE | 418 | 46 | 0.1 - 191.8 (23.6) |
P value = 6.11e-06 (Wilcoxon-test), Q value = 5.9e-05
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 526 | 64.0 (11.2) |
DEL PEAK 12(5Q12.1) MUTATED | 108 | 67.9 (9.7) |
DEL PEAK 12(5Q12.1) WILD-TYPE | 418 | 63.0 (11.4) |
P value = 1e-05 (Fisher's exact test), Q value = 5.9e-05
nPatients | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA | MIXED SEROUS AND ENDOMETRIOID | SEROUS ENDOMETRIAL ADENOCARCINOMA |
---|---|---|---|
ALL | 395 | 21 | 112 |
DEL PEAK 12(5Q12.1) MUTATED | 35 | 4 | 70 |
DEL PEAK 12(5Q12.1) WILD-TYPE | 360 | 17 | 42 |
P value = 0.0747 (Fisher's exact test), Q value = 0.14
nPatients | AMERICAN INDIAN OR ALASKA NATIVE | ASIAN | BLACK OR AFRICAN AMERICAN | NATIVE HAWAIIAN OR OTHER PACIFIC ISLANDER | WHITE |
---|---|---|---|---|---|
ALL | 4 | 20 | 101 | 9 | 366 |
DEL PEAK 12(5Q12.1) MUTATED | 0 | 3 | 29 | 3 | 64 |
DEL PEAK 12(5Q12.1) WILD-TYPE | 4 | 17 | 72 | 6 | 302 |
P value = 0.00651 (Wilcoxon-test), Q value = 0.017
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 526 | 64.0 (11.2) |
DEL PEAK 13(6Q26) MUTATED | 45 | 68.7 (11.1) |
DEL PEAK 13(6Q26) WILD-TYPE | 481 | 63.6 (11.1) |
P value = 1e-05 (Fisher's exact test), Q value = 5.9e-05
nPatients | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA | MIXED SEROUS AND ENDOMETRIOID | SEROUS ENDOMETRIAL ADENOCARCINOMA |
---|---|---|---|
ALL | 395 | 21 | 112 |
DEL PEAK 13(6Q26) MUTATED | 13 | 3 | 29 |
DEL PEAK 13(6Q26) WILD-TYPE | 382 | 18 | 83 |
P value = 0.00112 (logrank test), Q value = 0.0039
nPatients | nDeath | Duration Range (Median), Month | |
---|---|---|---|
ALL | 526 | 69 | 0.1 - 191.8 (23.3) |
DEL PEAK 14(7P22.3) MUTATED | 69 | 17 | 0.6 - 110.1 (23.2) |
DEL PEAK 14(7P22.3) WILD-TYPE | 457 | 52 | 0.1 - 191.8 (23.4) |
P value = 6.52e-05 (Wilcoxon-test), Q value = 0.00034
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 526 | 64.0 (11.2) |
DEL PEAK 14(7P22.3) MUTATED | 69 | 68.8 (10.1) |
DEL PEAK 14(7P22.3) WILD-TYPE | 457 | 63.3 (11.2) |
P value = 1e-05 (Fisher's exact test), Q value = 5.9e-05
nPatients | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA | MIXED SEROUS AND ENDOMETRIOID | SEROUS ENDOMETRIAL ADENOCARCINOMA |
---|---|---|---|
ALL | 395 | 21 | 112 |
DEL PEAK 14(7P22.3) MUTATED | 21 | 5 | 44 |
DEL PEAK 14(7P22.3) WILD-TYPE | 374 | 16 | 68 |
P value = 0.119 (Fisher's exact test), Q value = 0.2
nPatients | AMERICAN INDIAN OR ALASKA NATIVE | ASIAN | BLACK OR AFRICAN AMERICAN | NATIVE HAWAIIAN OR OTHER PACIFIC ISLANDER | WHITE |
---|---|---|---|---|---|
ALL | 4 | 20 | 101 | 9 | 366 |
DEL PEAK 14(7P22.3) MUTATED | 0 | 2 | 21 | 1 | 40 |
DEL PEAK 14(7P22.3) WILD-TYPE | 4 | 18 | 80 | 8 | 326 |
P value = 5.17e-05 (Wilcoxon-test), Q value = 0.00027
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 526 | 64.0 (11.2) |
DEL PEAK 15(7Q11.22) MUTATED | 39 | 70.7 (9.8) |
DEL PEAK 15(7Q11.22) WILD-TYPE | 487 | 63.5 (11.2) |
P value = 1e-05 (Fisher's exact test), Q value = 5.9e-05
nPatients | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA | MIXED SEROUS AND ENDOMETRIOID | SEROUS ENDOMETRIAL ADENOCARCINOMA |
---|---|---|---|
ALL | 395 | 21 | 112 |
DEL PEAK 15(7Q11.22) MUTATED | 13 | 2 | 24 |
DEL PEAK 15(7Q11.22) WILD-TYPE | 382 | 19 | 88 |
P value = 0.0267 (logrank test), Q value = 0.057
nPatients | nDeath | Duration Range (Median), Month | |
---|---|---|---|
ALL | 526 | 69 | 0.1 - 191.8 (23.3) |
DEL PEAK 16(7Q31.1) MUTATED | 53 | 12 | 0.1 - 110.1 (22.1) |
DEL PEAK 16(7Q31.1) WILD-TYPE | 473 | 57 | 0.1 - 191.8 (23.5) |
P value = 5.65e-05 (Wilcoxon-test), Q value = 3e-04
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 526 | 64.0 (11.2) |
DEL PEAK 16(7Q31.1) MUTATED | 53 | 69.5 (7.8) |
DEL PEAK 16(7Q31.1) WILD-TYPE | 473 | 63.4 (11.4) |
P value = 1e-05 (Fisher's exact test), Q value = 5.9e-05
nPatients | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA | MIXED SEROUS AND ENDOMETRIOID | SEROUS ENDOMETRIAL ADENOCARCINOMA |
---|---|---|---|
ALL | 395 | 21 | 112 |
DEL PEAK 16(7Q31.1) MUTATED | 10 | 3 | 40 |
DEL PEAK 16(7Q31.1) WILD-TYPE | 385 | 18 | 72 |
P value = 0.114 (Fisher's exact test), Q value = 0.19
nPatients | AMERICAN INDIAN OR ALASKA NATIVE | ASIAN | BLACK OR AFRICAN AMERICAN | NATIVE HAWAIIAN OR OTHER PACIFIC ISLANDER | WHITE |
---|---|---|---|---|---|
ALL | 4 | 20 | 101 | 9 | 366 |
DEL PEAK 16(7Q31.1) MUTATED | 0 | 0 | 16 | 1 | 31 |
DEL PEAK 16(7Q31.1) WILD-TYPE | 4 | 20 | 85 | 8 | 335 |
P value = 0.00848 (logrank test), Q value = 0.021
nPatients | nDeath | Duration Range (Median), Month | |
---|---|---|---|
ALL | 526 | 69 | 0.1 - 191.8 (23.3) |
DEL PEAK 17(7Q36.1) MUTATED | 62 | 15 | 1.2 - 125.4 (22.2) |
DEL PEAK 17(7Q36.1) WILD-TYPE | 464 | 54 | 0.1 - 191.8 (23.5) |
P value = 3.24e-07 (Wilcoxon-test), Q value = 1.3e-05
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 526 | 64.0 (11.2) |
DEL PEAK 17(7Q36.1) MUTATED | 62 | 70.6 (8.5) |
DEL PEAK 17(7Q36.1) WILD-TYPE | 464 | 63.1 (11.3) |
P value = 1e-05 (Fisher's exact test), Q value = 5.9e-05
nPatients | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA | MIXED SEROUS AND ENDOMETRIOID | SEROUS ENDOMETRIAL ADENOCARCINOMA |
---|---|---|---|
ALL | 395 | 21 | 112 |
DEL PEAK 17(7Q36.1) MUTATED | 12 | 4 | 46 |
DEL PEAK 17(7Q36.1) WILD-TYPE | 383 | 17 | 66 |
P value = 0.000772 (logrank test), Q value = 0.0028
nPatients | nDeath | Duration Range (Median), Month | |
---|---|---|---|
ALL | 526 | 69 | 0.1 - 191.8 (23.3) |
DEL PEAK 18(8P23.2) MUTATED | 113 | 26 | 0.3 - 191.8 (22.3) |
DEL PEAK 18(8P23.2) WILD-TYPE | 413 | 43 | 0.1 - 185.8 (23.5) |
P value = 2.17e-05 (Wilcoxon-test), Q value = 0.00012
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 526 | 64.0 (11.2) |
DEL PEAK 18(8P23.2) MUTATED | 113 | 67.6 (9.2) |
DEL PEAK 18(8P23.2) WILD-TYPE | 413 | 63.0 (11.5) |
P value = 1e-05 (Fisher's exact test), Q value = 5.9e-05
nPatients | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA | MIXED SEROUS AND ENDOMETRIOID | SEROUS ENDOMETRIAL ADENOCARCINOMA |
---|---|---|---|
ALL | 395 | 21 | 112 |
DEL PEAK 18(8P23.2) MUTATED | 34 | 5 | 76 |
DEL PEAK 18(8P23.2) WILD-TYPE | 361 | 16 | 36 |
P value = 0.122 (Fisher's exact test), Q value = 0.2
nPatients | NO | YES |
---|---|---|
ALL | 141 | 387 |
DEL PEAK 18(8P23.2) MUTATED | 24 | 91 |
DEL PEAK 18(8P23.2) WILD-TYPE | 117 | 296 |
P value = 0.0585 (Fisher's exact test), Q value = 0.11
nPatients | R0 | R1 | R2 | RX |
---|---|---|---|---|
ALL | 363 | 23 | 17 | 35 |
DEL PEAK 18(8P23.2) MUTATED | 69 | 5 | 7 | 11 |
DEL PEAK 18(8P23.2) WILD-TYPE | 294 | 18 | 10 | 24 |
P value = 0.00564 (Fisher's exact test), Q value = 0.015
nPatients | AMERICAN INDIAN OR ALASKA NATIVE | ASIAN | BLACK OR AFRICAN AMERICAN | NATIVE HAWAIIAN OR OTHER PACIFIC ISLANDER | WHITE |
---|---|---|---|---|---|
ALL | 4 | 20 | 101 | 9 | 366 |
DEL PEAK 18(8P23.2) MUTATED | 1 | 2 | 35 | 2 | 67 |
DEL PEAK 18(8P23.2) WILD-TYPE | 3 | 18 | 66 | 7 | 299 |
P value = 0.00679 (logrank test), Q value = 0.017
nPatients | nDeath | Duration Range (Median), Month | |
---|---|---|---|
ALL | 526 | 69 | 0.1 - 191.8 (23.3) |
DEL PEAK 19(8P21.2) MUTATED | 112 | 24 | 0.3 - 191.8 (23.5) |
DEL PEAK 19(8P21.2) WILD-TYPE | 414 | 45 | 0.1 - 185.8 (23.3) |
P value = 2.6e-06 (Wilcoxon-test), Q value = 5.9e-05
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 526 | 64.0 (11.2) |
DEL PEAK 19(8P21.2) MUTATED | 112 | 68.1 (9.1) |
DEL PEAK 19(8P21.2) WILD-TYPE | 414 | 62.9 (11.5) |
P value = 1e-05 (Fisher's exact test), Q value = 5.9e-05
nPatients | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA | MIXED SEROUS AND ENDOMETRIOID | SEROUS ENDOMETRIAL ADENOCARCINOMA |
---|---|---|---|
ALL | 395 | 21 | 112 |
DEL PEAK 19(8P21.2) MUTATED | 26 | 6 | 81 |
DEL PEAK 19(8P21.2) WILD-TYPE | 369 | 15 | 31 |
P value = 0.151 (Fisher's exact test), Q value = 0.24
nPatients | NO | YES |
---|---|---|
ALL | 141 | 387 |
DEL PEAK 19(8P21.2) MUTATED | 24 | 89 |
DEL PEAK 19(8P21.2) WILD-TYPE | 117 | 298 |
P value = 0.146 (Fisher's exact test), Q value = 0.23
nPatients | R0 | R1 | R2 | RX |
---|---|---|---|---|
ALL | 363 | 23 | 17 | 35 |
DEL PEAK 19(8P21.2) MUTATED | 70 | 5 | 7 | 9 |
DEL PEAK 19(8P21.2) WILD-TYPE | 293 | 18 | 10 | 26 |
P value = 0.00731 (Fisher's exact test), Q value = 0.019
nPatients | AMERICAN INDIAN OR ALASKA NATIVE | ASIAN | BLACK OR AFRICAN AMERICAN | NATIVE HAWAIIAN OR OTHER PACIFIC ISLANDER | WHITE |
---|---|---|---|---|---|
ALL | 4 | 20 | 101 | 9 | 366 |
DEL PEAK 19(8P21.2) MUTATED | 1 | 2 | 34 | 2 | 65 |
DEL PEAK 19(8P21.2) WILD-TYPE | 3 | 18 | 67 | 7 | 301 |
P value = 0.0163 (logrank test), Q value = 0.037
nPatients | nDeath | Duration Range (Median), Month | |
---|---|---|---|
ALL | 526 | 69 | 0.1 - 191.8 (23.3) |
DEL PEAK 20(9P23) MUTATED | 76 | 17 | 0.3 - 149.6 (21.4) |
DEL PEAK 20(9P23) WILD-TYPE | 450 | 52 | 0.1 - 191.8 (23.5) |
P value = 0.00143 (Wilcoxon-test), Q value = 0.0047
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 526 | 64.0 (11.2) |
DEL PEAK 20(9P23) MUTATED | 76 | 67.7 (9.2) |
DEL PEAK 20(9P23) WILD-TYPE | 450 | 63.4 (11.4) |
P value = 1e-05 (Fisher's exact test), Q value = 5.9e-05
nPatients | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA | MIXED SEROUS AND ENDOMETRIOID | SEROUS ENDOMETRIAL ADENOCARCINOMA |
---|---|---|---|
ALL | 395 | 21 | 112 |
DEL PEAK 20(9P23) MUTATED | 28 | 4 | 44 |
DEL PEAK 20(9P23) WILD-TYPE | 367 | 17 | 68 |
P value = 0.0491 (Fisher's exact test), Q value = 0.096
nPatients | NO | YES |
---|---|---|
ALL | 141 | 387 |
DEL PEAK 20(9P23) MUTATED | 13 | 63 |
DEL PEAK 20(9P23) WILD-TYPE | 128 | 324 |
P value = 0.13 (Fisher's exact test), Q value = 0.21
nPatients | AMERICAN INDIAN OR ALASKA NATIVE | ASIAN | BLACK OR AFRICAN AMERICAN | NATIVE HAWAIIAN OR OTHER PACIFIC ISLANDER | WHITE |
---|---|---|---|---|---|
ALL | 4 | 20 | 101 | 9 | 366 |
DEL PEAK 20(9P23) MUTATED | 1 | 2 | 21 | 2 | 45 |
DEL PEAK 20(9P23) WILD-TYPE | 3 | 18 | 80 | 7 | 321 |
P value = 1.41e-05 (logrank test), Q value = 8.1e-05
nPatients | nDeath | Duration Range (Median), Month | |
---|---|---|---|
ALL | 526 | 69 | 0.1 - 191.8 (23.3) |
DEL PEAK 21(9Q21.2) MUTATED | 126 | 31 | 0.1 - 125.4 (21.9) |
DEL PEAK 21(9Q21.2) WILD-TYPE | 400 | 38 | 0.1 - 191.8 (23.7) |
P value = 5.38e-10 (Wilcoxon-test), Q value = 9.4e-08
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 526 | 64.0 (11.2) |
DEL PEAK 21(9Q21.2) MUTATED | 125 | 69.2 (8.9) |
DEL PEAK 21(9Q21.2) WILD-TYPE | 401 | 62.4 (11.4) |
P value = 1e-05 (Fisher's exact test), Q value = 5.9e-05
nPatients | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA | MIXED SEROUS AND ENDOMETRIOID | SEROUS ENDOMETRIAL ADENOCARCINOMA |
---|---|---|---|
ALL | 395 | 21 | 112 |
DEL PEAK 21(9Q21.2) MUTATED | 49 | 10 | 67 |
DEL PEAK 21(9Q21.2) WILD-TYPE | 346 | 11 | 45 |
P value = 0.135 (Fisher's exact test), Q value = 0.22
nPatients | NO | YES |
---|---|---|
ALL | 141 | 387 |
DEL PEAK 21(9Q21.2) MUTATED | 27 | 99 |
DEL PEAK 21(9Q21.2) WILD-TYPE | 114 | 288 |
P value = 0.0288 (Fisher's exact test), Q value = 0.061
nPatients | AMERICAN INDIAN OR ALASKA NATIVE | ASIAN | BLACK OR AFRICAN AMERICAN | NATIVE HAWAIIAN OR OTHER PACIFIC ISLANDER | WHITE |
---|---|---|---|---|---|
ALL | 4 | 20 | 101 | 9 | 366 |
DEL PEAK 21(9Q21.2) MUTATED | 1 | 1 | 34 | 2 | 81 |
DEL PEAK 21(9Q21.2) WILD-TYPE | 3 | 19 | 67 | 7 | 285 |
P value = 0.000133 (logrank test), Q value = 0.00061
nPatients | nDeath | Duration Range (Median), Month | |
---|---|---|---|
ALL | 526 | 69 | 0.1 - 191.8 (23.3) |
DEL PEAK 22(9Q34.2) MUTATED | 127 | 30 | 0.2 - 125.4 (23.7) |
DEL PEAK 22(9Q34.2) WILD-TYPE | 399 | 39 | 0.1 - 191.8 (23.3) |
P value = 2.65e-08 (Wilcoxon-test), Q value = 1.4e-06
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 526 | 64.0 (11.2) |
DEL PEAK 22(9Q34.2) MUTATED | 127 | 68.6 (8.5) |
DEL PEAK 22(9Q34.2) WILD-TYPE | 399 | 62.5 (11.6) |
P value = 1e-05 (Fisher's exact test), Q value = 5.9e-05
nPatients | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA | MIXED SEROUS AND ENDOMETRIOID | SEROUS ENDOMETRIAL ADENOCARCINOMA |
---|---|---|---|
ALL | 395 | 21 | 112 |
DEL PEAK 22(9Q34.2) MUTATED | 52 | 10 | 66 |
DEL PEAK 22(9Q34.2) WILD-TYPE | 343 | 11 | 46 |
P value = 0.109 (Fisher's exact test), Q value = 0.19
nPatients | NO | YES |
---|---|---|
ALL | 141 | 387 |
DEL PEAK 22(9Q34.2) MUTATED | 27 | 101 |
DEL PEAK 22(9Q34.2) WILD-TYPE | 114 | 286 |
P value = 0.00423 (logrank test), Q value = 0.012
nPatients | nDeath | Duration Range (Median), Month | |
---|---|---|---|
ALL | 526 | 69 | 0.1 - 191.8 (23.3) |
DEL PEAK 23(10Q23.31) MUTATED | 74 | 16 | 0.3 - 125.4 (18.8) |
DEL PEAK 23(10Q23.31) WILD-TYPE | 452 | 53 | 0.1 - 191.8 (23.7) |
P value = 0.000879 (Wilcoxon-test), Q value = 0.0032
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 526 | 64.0 (11.2) |
DEL PEAK 23(10Q23.31) MUTATED | 74 | 67.7 (9.7) |
DEL PEAK 23(10Q23.31) WILD-TYPE | 452 | 63.4 (11.3) |
P value = 1e-05 (Fisher's exact test), Q value = 5.9e-05
nPatients | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA | MIXED SEROUS AND ENDOMETRIOID | SEROUS ENDOMETRIAL ADENOCARCINOMA |
---|---|---|---|
ALL | 395 | 21 | 112 |
DEL PEAK 23(10Q23.31) MUTATED | 31 | 5 | 39 |
DEL PEAK 23(10Q23.31) WILD-TYPE | 364 | 16 | 73 |
P value = 0.00452 (Fisher's exact test), Q value = 0.013
nPatients | NO | YES |
---|---|---|
ALL | 141 | 387 |
DEL PEAK 23(10Q23.31) MUTATED | 10 | 65 |
DEL PEAK 23(10Q23.31) WILD-TYPE | 131 | 322 |
P value = 0.0163 (logrank test), Q value = 0.037
nPatients | nDeath | Duration Range (Median), Month | |
---|---|---|---|
ALL | 526 | 69 | 0.1 - 191.8 (23.3) |
DEL PEAK 24(11P15.5) MUTATED | 101 | 20 | 0.1 - 149.6 (20.5) |
DEL PEAK 24(11P15.5) WILD-TYPE | 425 | 49 | 0.1 - 191.8 (23.7) |
P value = 1.22e-05 (Wilcoxon-test), Q value = 7e-05
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 526 | 64.0 (11.2) |
DEL PEAK 24(11P15.5) MUTATED | 101 | 68.2 (8.9) |
DEL PEAK 24(11P15.5) WILD-TYPE | 425 | 63.0 (11.5) |
P value = 1e-05 (Fisher's exact test), Q value = 5.9e-05
nPatients | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA | MIXED SEROUS AND ENDOMETRIOID | SEROUS ENDOMETRIAL ADENOCARCINOMA |
---|---|---|---|
ALL | 395 | 21 | 112 |
DEL PEAK 24(11P15.5) MUTATED | 36 | 5 | 61 |
DEL PEAK 24(11P15.5) WILD-TYPE | 359 | 16 | 51 |
P value = 0.00584 (Fisher's exact test), Q value = 0.015
nPatients | NO | YES |
---|---|---|
ALL | 141 | 387 |
DEL PEAK 24(11P15.5) MUTATED | 16 | 86 |
DEL PEAK 24(11P15.5) WILD-TYPE | 125 | 301 |
P value = 0.0897 (Fisher's exact test), Q value = 0.16
nPatients | R0 | R1 | R2 | RX |
---|---|---|---|---|
ALL | 363 | 23 | 17 | 35 |
DEL PEAK 24(11P15.5) MUTATED | 63 | 3 | 7 | 8 |
DEL PEAK 24(11P15.5) WILD-TYPE | 300 | 20 | 10 | 27 |
P value = 0.0548 (Fisher's exact test), Q value = 0.11
nPatients | AMERICAN INDIAN OR ALASKA NATIVE | ASIAN | BLACK OR AFRICAN AMERICAN | NATIVE HAWAIIAN OR OTHER PACIFIC ISLANDER | WHITE |
---|---|---|---|---|---|
ALL | 4 | 20 | 101 | 9 | 366 |
DEL PEAK 24(11P15.5) MUTATED | 1 | 3 | 30 | 1 | 62 |
DEL PEAK 24(11P15.5) WILD-TYPE | 3 | 17 | 71 | 8 | 304 |
P value = 0.0903 (logrank test), Q value = 0.16
nPatients | nDeath | Duration Range (Median), Month | |
---|---|---|---|
ALL | 526 | 69 | 0.1 - 191.8 (23.3) |
DEL PEAK 25(11Q14.1) MUTATED | 70 | 12 | 0.3 - 116.2 (19.6) |
DEL PEAK 25(11Q14.1) WILD-TYPE | 456 | 57 | 0.1 - 191.8 (23.8) |
P value = 0.000288 (Wilcoxon-test), Q value = 0.0012
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 526 | 64.0 (11.2) |
DEL PEAK 25(11Q14.1) MUTATED | 70 | 68.6 (8.8) |
DEL PEAK 25(11Q14.1) WILD-TYPE | 456 | 63.3 (11.4) |
P value = 1e-05 (Fisher's exact test), Q value = 5.9e-05
nPatients | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA | MIXED SEROUS AND ENDOMETRIOID | SEROUS ENDOMETRIAL ADENOCARCINOMA |
---|---|---|---|
ALL | 395 | 21 | 112 |
DEL PEAK 25(11Q14.1) MUTATED | 21 | 6 | 43 |
DEL PEAK 25(11Q14.1) WILD-TYPE | 374 | 15 | 69 |
P value = 0.0591 (Fisher's exact test), Q value = 0.11
nPatients | NO | YES |
---|---|---|
ALL | 141 | 387 |
DEL PEAK 25(11Q14.1) MUTATED | 12 | 58 |
DEL PEAK 25(11Q14.1) WILD-TYPE | 129 | 329 |
P value = 0.0717 (Fisher's exact test), Q value = 0.13
nPatients | AMERICAN INDIAN OR ALASKA NATIVE | ASIAN | BLACK OR AFRICAN AMERICAN | NATIVE HAWAIIAN OR OTHER PACIFIC ISLANDER | WHITE |
---|---|---|---|---|---|
ALL | 4 | 20 | 101 | 9 | 366 |
DEL PEAK 25(11Q14.1) MUTATED | 1 | 2 | 21 | 0 | 41 |
DEL PEAK 25(11Q14.1) WILD-TYPE | 3 | 18 | 80 | 9 | 325 |
P value = 0.0431 (Fisher's exact test), Q value = 0.086
nPatients | HISPANIC OR LATINO | NOT HISPANIC OR LATINO |
---|---|---|
ALL | 14 | 367 |
DEL PEAK 25(11Q14.1) MUTATED | 5 | 52 |
DEL PEAK 25(11Q14.1) WILD-TYPE | 9 | 315 |
P value = 0.00906 (logrank test), Q value = 0.022
nPatients | nDeath | Duration Range (Median), Month | |
---|---|---|---|
ALL | 526 | 69 | 0.1 - 191.8 (23.3) |
DEL PEAK 26(11Q25) MUTATED | 92 | 18 | 0.3 - 116.2 (19.1) |
DEL PEAK 26(11Q25) WILD-TYPE | 434 | 51 | 0.1 - 191.8 (23.9) |
P value = 0.000253 (Wilcoxon-test), Q value = 0.001
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 526 | 64.0 (11.2) |
DEL PEAK 26(11Q25) MUTATED | 92 | 67.6 (9.7) |
DEL PEAK 26(11Q25) WILD-TYPE | 434 | 63.3 (11.4) |
P value = 1e-05 (Fisher's exact test), Q value = 5.9e-05
nPatients | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA | MIXED SEROUS AND ENDOMETRIOID | SEROUS ENDOMETRIAL ADENOCARCINOMA |
---|---|---|---|
ALL | 395 | 21 | 112 |
DEL PEAK 26(11Q25) MUTATED | 32 | 6 | 54 |
DEL PEAK 26(11Q25) WILD-TYPE | 363 | 15 | 58 |
P value = 0.00266 (Fisher's exact test), Q value = 0.0081
nPatients | NO | YES |
---|---|---|
ALL | 141 | 387 |
DEL PEAK 26(11Q25) MUTATED | 13 | 79 |
DEL PEAK 26(11Q25) WILD-TYPE | 128 | 308 |
P value = 0.0842 (Fisher's exact test), Q value = 0.15
nPatients | AMERICAN INDIAN OR ALASKA NATIVE | ASIAN | BLACK OR AFRICAN AMERICAN | NATIVE HAWAIIAN OR OTHER PACIFIC ISLANDER | WHITE |
---|---|---|---|---|---|
ALL | 4 | 20 | 101 | 9 | 366 |
DEL PEAK 26(11Q25) MUTATED | 1 | 2 | 26 | 1 | 54 |
DEL PEAK 26(11Q25) WILD-TYPE | 3 | 18 | 75 | 8 | 312 |
P value = 0.000179 (logrank test), Q value = 8e-04
nPatients | nDeath | Duration Range (Median), Month | |
---|---|---|---|
ALL | 526 | 69 | 0.1 - 191.8 (23.3) |
DEL PEAK 27(12Q23.1) MUTATED | 53 | 15 | 0.6 - 110.1 (21.9) |
DEL PEAK 27(12Q23.1) WILD-TYPE | 473 | 54 | 0.1 - 191.8 (23.5) |
P value = 0.00236 (Wilcoxon-test), Q value = 0.0073
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 526 | 64.0 (11.2) |
DEL PEAK 27(12Q23.1) MUTATED | 53 | 68.2 (9.5) |
DEL PEAK 27(12Q23.1) WILD-TYPE | 473 | 63.5 (11.3) |
P value = 1e-05 (Fisher's exact test), Q value = 5.9e-05
nPatients | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA | MIXED SEROUS AND ENDOMETRIOID | SEROUS ENDOMETRIAL ADENOCARCINOMA |
---|---|---|---|
ALL | 395 | 21 | 112 |
DEL PEAK 27(12Q23.1) MUTATED | 12 | 3 | 38 |
DEL PEAK 27(12Q23.1) WILD-TYPE | 383 | 18 | 74 |
P value = 0.0491 (Fisher's exact test), Q value = 0.096
nPatients | NO | YES |
---|---|---|
ALL | 141 | 387 |
DEL PEAK 27(12Q23.1) MUTATED | 8 | 45 |
DEL PEAK 27(12Q23.1) WILD-TYPE | 133 | 342 |
P value = 0.041 (Fisher's exact test), Q value = 0.083
nPatients | R0 | R1 | R2 | RX |
---|---|---|---|---|
ALL | 363 | 23 | 17 | 35 |
DEL PEAK 27(12Q23.1) MUTATED | 33 | 1 | 4 | 7 |
DEL PEAK 27(12Q23.1) WILD-TYPE | 330 | 22 | 13 | 28 |
P value = 0.0413 (Fisher's exact test), Q value = 0.083
nPatients | AMERICAN INDIAN OR ALASKA NATIVE | ASIAN | BLACK OR AFRICAN AMERICAN | NATIVE HAWAIIAN OR OTHER PACIFIC ISLANDER | WHITE |
---|---|---|---|---|---|
ALL | 4 | 20 | 101 | 9 | 366 |
DEL PEAK 27(12Q23.1) MUTATED | 1 | 0 | 16 | 0 | 29 |
DEL PEAK 27(12Q23.1) WILD-TYPE | 3 | 20 | 85 | 9 | 337 |
P value = 0.00562 (logrank test), Q value = 0.015
nPatients | nDeath | Duration Range (Median), Month | |
---|---|---|---|
ALL | 526 | 69 | 0.1 - 191.8 (23.3) |
DEL PEAK 28(12Q24.33) MUTATED | 63 | 14 | 0.1 - 110.1 (20.8) |
DEL PEAK 28(12Q24.33) WILD-TYPE | 463 | 55 | 0.1 - 191.8 (23.6) |
P value = 2.22e-05 (Wilcoxon-test), Q value = 0.00012
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 526 | 64.0 (11.2) |
DEL PEAK 28(12Q24.33) MUTATED | 63 | 69.3 (8.7) |
DEL PEAK 28(12Q24.33) WILD-TYPE | 463 | 63.3 (11.3) |
P value = 1e-05 (Fisher's exact test), Q value = 5.9e-05
nPatients | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA | MIXED SEROUS AND ENDOMETRIOID | SEROUS ENDOMETRIAL ADENOCARCINOMA |
---|---|---|---|
ALL | 395 | 21 | 112 |
DEL PEAK 28(12Q24.33) MUTATED | 18 | 2 | 43 |
DEL PEAK 28(12Q24.33) WILD-TYPE | 377 | 19 | 69 |
P value = 0.0219 (Fisher's exact test), Q value = 0.048
nPatients | NO | YES |
---|---|---|
ALL | 141 | 387 |
DEL PEAK 28(12Q24.33) MUTATED | 9 | 54 |
DEL PEAK 28(12Q24.33) WILD-TYPE | 132 | 333 |
P value = 0.0267 (Fisher's exact test), Q value = 0.057
nPatients | R0 | R1 | R2 | RX |
---|---|---|---|---|
ALL | 363 | 23 | 17 | 35 |
DEL PEAK 28(12Q24.33) MUTATED | 39 | 2 | 5 | 8 |
DEL PEAK 28(12Q24.33) WILD-TYPE | 324 | 21 | 12 | 27 |
P value = 0.00311 (logrank test), Q value = 0.0093
nPatients | nDeath | Duration Range (Median), Month | |
---|---|---|---|
ALL | 526 | 69 | 0.1 - 191.8 (23.3) |
DEL PEAK 29(13Q11) MUTATED | 93 | 22 | 0.1 - 149.6 (20.5) |
DEL PEAK 29(13Q11) WILD-TYPE | 433 | 47 | 0.1 - 191.8 (23.7) |
P value = 0.00111 (Wilcoxon-test), Q value = 0.0039
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 526 | 64.0 (11.2) |
DEL PEAK 29(13Q11) MUTATED | 93 | 67.2 (9.7) |
DEL PEAK 29(13Q11) WILD-TYPE | 433 | 63.3 (11.4) |
P value = 1e-05 (Fisher's exact test), Q value = 5.9e-05
nPatients | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA | MIXED SEROUS AND ENDOMETRIOID | SEROUS ENDOMETRIAL ADENOCARCINOMA |
---|---|---|---|
ALL | 395 | 21 | 112 |
DEL PEAK 29(13Q11) MUTATED | 39 | 5 | 50 |
DEL PEAK 29(13Q11) WILD-TYPE | 356 | 16 | 62 |
P value = 0.0397 (Fisher's exact test), Q value = 0.081
nPatients | NO | YES |
---|---|---|
ALL | 141 | 387 |
DEL PEAK 29(13Q11) MUTATED | 17 | 77 |
DEL PEAK 29(13Q11) WILD-TYPE | 124 | 310 |
P value = 0.00126 (logrank test), Q value = 0.0042
nPatients | nDeath | Duration Range (Median), Month | |
---|---|---|---|
ALL | 526 | 69 | 0.1 - 191.8 (23.3) |
DEL PEAK 30(13Q14.2) MUTATED | 102 | 22 | 0.1 - 149.6 (20.3) |
DEL PEAK 30(13Q14.2) WILD-TYPE | 424 | 47 | 0.1 - 191.8 (23.9) |
P value = 0.00137 (Wilcoxon-test), Q value = 0.0045
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 526 | 64.0 (11.2) |
DEL PEAK 30(13Q14.2) MUTATED | 102 | 67.1 (9.5) |
DEL PEAK 30(13Q14.2) WILD-TYPE | 424 | 63.3 (11.5) |
P value = 1e-05 (Fisher's exact test), Q value = 5.9e-05
nPatients | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA | MIXED SEROUS AND ENDOMETRIOID | SEROUS ENDOMETRIAL ADENOCARCINOMA |
---|---|---|---|
ALL | 395 | 21 | 112 |
DEL PEAK 30(13Q14.2) MUTATED | 51 | 6 | 46 |
DEL PEAK 30(13Q14.2) WILD-TYPE | 344 | 15 | 66 |
P value = 0.009 (Fisher's exact test), Q value = 0.022
nPatients | NO | YES |
---|---|---|
ALL | 141 | 387 |
DEL PEAK 30(13Q14.2) MUTATED | 17 | 86 |
DEL PEAK 30(13Q14.2) WILD-TYPE | 124 | 301 |
P value = 0.154 (Fisher's exact test), Q value = 0.24
nPatients | AMERICAN INDIAN OR ALASKA NATIVE | ASIAN | BLACK OR AFRICAN AMERICAN | NATIVE HAWAIIAN OR OTHER PACIFIC ISLANDER | WHITE |
---|---|---|---|---|---|
ALL | 4 | 20 | 101 | 9 | 366 |
DEL PEAK 30(13Q14.2) MUTATED | 0 | 2 | 28 | 2 | 66 |
DEL PEAK 30(13Q14.2) WILD-TYPE | 4 | 18 | 73 | 7 | 300 |
P value = 0.00804 (logrank test), Q value = 0.02
nPatients | nDeath | Duration Range (Median), Month | |
---|---|---|---|
ALL | 526 | 69 | 0.1 - 191.8 (23.3) |
DEL PEAK 31(14Q13.1) MUTATED | 71 | 14 | 0.1 - 125.4 (17.9) |
DEL PEAK 31(14Q13.1) WILD-TYPE | 455 | 55 | 0.1 - 191.8 (23.9) |
P value = 0.00402 (Wilcoxon-test), Q value = 0.012
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 526 | 64.0 (11.2) |
DEL PEAK 31(14Q13.1) MUTATED | 71 | 67.2 (9.9) |
DEL PEAK 31(14Q13.1) WILD-TYPE | 455 | 63.5 (11.3) |
P value = 1e-05 (Fisher's exact test), Q value = 5.9e-05
nPatients | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA | MIXED SEROUS AND ENDOMETRIOID | SEROUS ENDOMETRIAL ADENOCARCINOMA |
---|---|---|---|
ALL | 395 | 21 | 112 |
DEL PEAK 31(14Q13.1) MUTATED | 25 | 5 | 41 |
DEL PEAK 31(14Q13.1) WILD-TYPE | 370 | 16 | 71 |
P value = 0.00394 (Fisher's exact test), Q value = 0.011
nPatients | AMERICAN INDIAN OR ALASKA NATIVE | ASIAN | BLACK OR AFRICAN AMERICAN | NATIVE HAWAIIAN OR OTHER PACIFIC ISLANDER | WHITE |
---|---|---|---|---|---|
ALL | 4 | 20 | 101 | 9 | 366 |
DEL PEAK 31(14Q13.1) MUTATED | 1 | 1 | 25 | 1 | 38 |
DEL PEAK 31(14Q13.1) WILD-TYPE | 3 | 19 | 76 | 8 | 328 |
P value = 7.04e-05 (logrank test), Q value = 0.00036
nPatients | nDeath | Duration Range (Median), Month | |
---|---|---|---|
ALL | 526 | 69 | 0.1 - 191.8 (23.3) |
DEL PEAK 32(15Q15.1) MUTATED | 135 | 30 | 0.1 - 116.2 (20.8) |
DEL PEAK 32(15Q15.1) WILD-TYPE | 391 | 39 | 0.1 - 191.8 (23.9) |
P value = 2.37e-08 (Wilcoxon-test), Q value = 1.4e-06
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 526 | 64.0 (11.2) |
DEL PEAK 32(15Q15.1) MUTATED | 136 | 68.4 (9.6) |
DEL PEAK 32(15Q15.1) WILD-TYPE | 390 | 62.5 (11.4) |
P value = 1e-05 (Fisher's exact test), Q value = 5.9e-05
nPatients | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA | MIXED SEROUS AND ENDOMETRIOID | SEROUS ENDOMETRIAL ADENOCARCINOMA |
---|---|---|---|
ALL | 395 | 21 | 112 |
DEL PEAK 32(15Q15.1) MUTATED | 52 | 9 | 75 |
DEL PEAK 32(15Q15.1) WILD-TYPE | 343 | 12 | 37 |
P value = 0.0131 (Fisher's exact test), Q value = 0.031
nPatients | NO | YES |
---|---|---|
ALL | 141 | 387 |
DEL PEAK 32(15Q15.1) MUTATED | 25 | 111 |
DEL PEAK 32(15Q15.1) WILD-TYPE | 116 | 276 |
P value = 0.0396 (Fisher's exact test), Q value = 0.081
nPatients | R0 | R1 | R2 | RX |
---|---|---|---|---|
ALL | 363 | 23 | 17 | 35 |
DEL PEAK 32(15Q15.1) MUTATED | 83 | 7 | 8 | 13 |
DEL PEAK 32(15Q15.1) WILD-TYPE | 280 | 16 | 9 | 22 |
P value = 0.0549 (Fisher's exact test), Q value = 0.11
nPatients | AMERICAN INDIAN OR ALASKA NATIVE | ASIAN | BLACK OR AFRICAN AMERICAN | NATIVE HAWAIIAN OR OTHER PACIFIC ISLANDER | WHITE |
---|---|---|---|---|---|
ALL | 4 | 20 | 101 | 9 | 366 |
DEL PEAK 32(15Q15.1) MUTATED | 1 | 2 | 35 | 3 | 84 |
DEL PEAK 32(15Q15.1) WILD-TYPE | 3 | 18 | 66 | 6 | 282 |
P value = 0.0119 (logrank test), Q value = 0.029
nPatients | nDeath | Duration Range (Median), Month | |
---|---|---|---|
ALL | 526 | 69 | 0.1 - 191.8 (23.3) |
DEL PEAK 33(15Q23) MUTATED | 113 | 21 | 0.2 - 125.4 (19.4) |
DEL PEAK 33(15Q23) WILD-TYPE | 413 | 48 | 0.1 - 191.8 (24.6) |
P value = 8.57e-06 (Wilcoxon-test), Q value = 5.9e-05
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 526 | 64.0 (11.2) |
DEL PEAK 33(15Q23) MUTATED | 113 | 67.8 (9.4) |
DEL PEAK 33(15Q23) WILD-TYPE | 413 | 63.0 (11.5) |
P value = 1e-05 (Fisher's exact test), Q value = 5.9e-05
nPatients | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA | MIXED SEROUS AND ENDOMETRIOID | SEROUS ENDOMETRIAL ADENOCARCINOMA |
---|---|---|---|
ALL | 395 | 21 | 112 |
DEL PEAK 33(15Q23) MUTATED | 38 | 7 | 68 |
DEL PEAK 33(15Q23) WILD-TYPE | 357 | 14 | 44 |
P value = 0.0551 (Fisher's exact test), Q value = 0.11
nPatients | NO | YES |
---|---|---|
ALL | 141 | 387 |
DEL PEAK 33(15Q23) MUTATED | 22 | 91 |
DEL PEAK 33(15Q23) WILD-TYPE | 119 | 296 |
P value = 0.0338 (Fisher's exact test), Q value = 0.069
nPatients | AMERICAN INDIAN OR ALASKA NATIVE | ASIAN | BLACK OR AFRICAN AMERICAN | NATIVE HAWAIIAN OR OTHER PACIFIC ISLANDER | WHITE |
---|---|---|---|---|---|
ALL | 4 | 20 | 101 | 9 | 366 |
DEL PEAK 33(15Q23) MUTATED | 0 | 2 | 32 | 1 | 68 |
DEL PEAK 33(15Q23) WILD-TYPE | 4 | 18 | 69 | 8 | 298 |
P value = 0.00536 (logrank test), Q value = 0.014
nPatients | nDeath | Duration Range (Median), Month | |
---|---|---|---|
ALL | 526 | 69 | 0.1 - 191.8 (23.3) |
DEL PEAK 34(16P13.3) MUTATED | 89 | 19 | 0.1 - 125.4 (21.9) |
DEL PEAK 34(16P13.3) WILD-TYPE | 437 | 50 | 0.1 - 191.8 (23.5) |
P value = 2.2e-06 (Wilcoxon-test), Q value = 5.9e-05
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 526 | 64.0 (11.2) |
DEL PEAK 34(16P13.3) MUTATED | 90 | 68.9 (8.6) |
DEL PEAK 34(16P13.3) WILD-TYPE | 436 | 63.0 (11.4) |
P value = 1e-05 (Fisher's exact test), Q value = 5.9e-05
nPatients | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA | MIXED SEROUS AND ENDOMETRIOID | SEROUS ENDOMETRIAL ADENOCARCINOMA |
---|---|---|---|
ALL | 395 | 21 | 112 |
DEL PEAK 34(16P13.3) MUTATED | 26 | 5 | 59 |
DEL PEAK 34(16P13.3) WILD-TYPE | 369 | 16 | 53 |
P value = 0.0682 (Fisher's exact test), Q value = 0.13
nPatients | NO | YES |
---|---|---|
ALL | 141 | 387 |
DEL PEAK 34(16P13.3) MUTATED | 17 | 73 |
DEL PEAK 34(16P13.3) WILD-TYPE | 124 | 314 |
P value = 0.105 (Fisher's exact test), Q value = 0.18
nPatients | R0 | R1 | R2 | RX |
---|---|---|---|---|
ALL | 363 | 23 | 17 | 35 |
DEL PEAK 34(16P13.3) MUTATED | 53 | 6 | 5 | 8 |
DEL PEAK 34(16P13.3) WILD-TYPE | 310 | 17 | 12 | 27 |
P value = 0.0297 (Fisher's exact test), Q value = 0.062
nPatients | AMERICAN INDIAN OR ALASKA NATIVE | ASIAN | BLACK OR AFRICAN AMERICAN | NATIVE HAWAIIAN OR OTHER PACIFIC ISLANDER | WHITE |
---|---|---|---|---|---|
ALL | 4 | 20 | 101 | 9 | 366 |
DEL PEAK 34(16P13.3) MUTATED | 0 | 2 | 28 | 1 | 53 |
DEL PEAK 34(16P13.3) WILD-TYPE | 4 | 18 | 73 | 8 | 313 |
P value = 0.00957 (logrank test), Q value = 0.024
nPatients | nDeath | Duration Range (Median), Month | |
---|---|---|---|
ALL | 526 | 69 | 0.1 - 191.8 (23.3) |
DEL PEAK 35(16Q21) MUTATED | 149 | 27 | 0.1 - 113.4 (22.0) |
DEL PEAK 35(16Q21) WILD-TYPE | 377 | 42 | 0.1 - 191.8 (23.6) |
P value = 1.31e-08 (Wilcoxon-test), Q value = 1e-06
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 526 | 64.0 (11.2) |
DEL PEAK 35(16Q21) MUTATED | 150 | 68.1 (9.1) |
DEL PEAK 35(16Q21) WILD-TYPE | 376 | 62.4 (11.6) |
P value = 1e-05 (Fisher's exact test), Q value = 5.9e-05
nPatients | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA | MIXED SEROUS AND ENDOMETRIOID | SEROUS ENDOMETRIAL ADENOCARCINOMA |
---|---|---|---|
ALL | 395 | 21 | 112 |
DEL PEAK 35(16Q21) MUTATED | 63 | 8 | 79 |
DEL PEAK 35(16Q21) WILD-TYPE | 332 | 13 | 33 |
P value = 0.082 (Fisher's exact test), Q value = 0.15
nPatients | NO | YES |
---|---|---|
ALL | 141 | 387 |
DEL PEAK 35(16Q21) MUTATED | 32 | 118 |
DEL PEAK 35(16Q21) WILD-TYPE | 109 | 269 |
P value = 0.0232 (Fisher's exact test), Q value = 0.051
nPatients | AMERICAN INDIAN OR ALASKA NATIVE | ASIAN | BLACK OR AFRICAN AMERICAN | NATIVE HAWAIIAN OR OTHER PACIFIC ISLANDER | WHITE |
---|---|---|---|---|---|
ALL | 4 | 20 | 101 | 9 | 366 |
DEL PEAK 35(16Q21) MUTATED | 1 | 2 | 40 | 2 | 95 |
DEL PEAK 35(16Q21) WILD-TYPE | 3 | 18 | 61 | 7 | 271 |
P value = 0.0289 (logrank test), Q value = 0.061
nPatients | nDeath | Duration Range (Median), Month | |
---|---|---|---|
ALL | 526 | 69 | 0.1 - 191.8 (23.3) |
DEL PEAK 36(16Q22.3) MUTATED | 153 | 26 | 0.1 - 113.4 (20.8) |
DEL PEAK 36(16Q22.3) WILD-TYPE | 373 | 43 | 0.1 - 191.8 (23.9) |
P value = 5.81e-09 (Wilcoxon-test), Q value = 6.8e-07
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 526 | 64.0 (11.2) |
DEL PEAK 36(16Q22.3) MUTATED | 154 | 68.0 (8.9) |
DEL PEAK 36(16Q22.3) WILD-TYPE | 372 | 62.3 (11.6) |
P value = 1e-05 (Fisher's exact test), Q value = 5.9e-05
nPatients | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA | MIXED SEROUS AND ENDOMETRIOID | SEROUS ENDOMETRIAL ADENOCARCINOMA |
---|---|---|---|
ALL | 395 | 21 | 112 |
DEL PEAK 36(16Q22.3) MUTATED | 67 | 8 | 79 |
DEL PEAK 36(16Q22.3) WILD-TYPE | 328 | 13 | 33 |
P value = 0.0323 (Fisher's exact test), Q value = 0.066
nPatients | AMERICAN INDIAN OR ALASKA NATIVE | ASIAN | BLACK OR AFRICAN AMERICAN | NATIVE HAWAIIAN OR OTHER PACIFIC ISLANDER | WHITE |
---|---|---|---|---|---|
ALL | 4 | 20 | 101 | 9 | 366 |
DEL PEAK 36(16Q22.3) MUTATED | 1 | 2 | 40 | 2 | 98 |
DEL PEAK 36(16Q22.3) WILD-TYPE | 3 | 18 | 61 | 7 | 268 |
P value = 0.00282 (logrank test), Q value = 0.0085
nPatients | nDeath | Duration Range (Median), Month | |
---|---|---|---|
ALL | 526 | 69 | 0.1 - 191.8 (23.3) |
DEL PEAK 37(16Q23.1) MUTATED | 161 | 30 | 0.1 - 113.4 (21.2) |
DEL PEAK 37(16Q23.1) WILD-TYPE | 365 | 39 | 0.1 - 191.8 (23.9) |
P value = 8.79e-09 (Wilcoxon-test), Q value = 8.8e-07
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 526 | 64.0 (11.2) |
DEL PEAK 37(16Q23.1) MUTATED | 162 | 67.8 (9.3) |
DEL PEAK 37(16Q23.1) WILD-TYPE | 364 | 62.3 (11.6) |
P value = 1e-05 (Fisher's exact test), Q value = 5.9e-05
nPatients | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA | MIXED SEROUS AND ENDOMETRIOID | SEROUS ENDOMETRIAL ADENOCARCINOMA |
---|---|---|---|
ALL | 395 | 21 | 112 |
DEL PEAK 37(16Q23.1) MUTATED | 69 | 7 | 86 |
DEL PEAK 37(16Q23.1) WILD-TYPE | 326 | 14 | 26 |
P value = 0.0173 (Fisher's exact test), Q value = 0.039
nPatients | R0 | R1 | R2 | RX |
---|---|---|---|---|
ALL | 363 | 23 | 17 | 35 |
DEL PEAK 37(16Q23.1) MUTATED | 102 | 8 | 11 | 12 |
DEL PEAK 37(16Q23.1) WILD-TYPE | 261 | 15 | 6 | 23 |
P value = 0.00318 (Fisher's exact test), Q value = 0.0094
nPatients | AMERICAN INDIAN OR ALASKA NATIVE | ASIAN | BLACK OR AFRICAN AMERICAN | NATIVE HAWAIIAN OR OTHER PACIFIC ISLANDER | WHITE |
---|---|---|---|---|---|
ALL | 4 | 20 | 101 | 9 | 366 |
DEL PEAK 37(16Q23.1) MUTATED | 1 | 3 | 46 | 2 | 99 |
DEL PEAK 37(16Q23.1) WILD-TYPE | 3 | 17 | 55 | 7 | 267 |
P value = 0.000112 (logrank test), Q value = 0.00052
nPatients | nDeath | Duration Range (Median), Month | |
---|---|---|---|
ALL | 526 | 69 | 0.1 - 191.8 (23.3) |
DEL PEAK 38(17P13.3) MUTATED | 118 | 27 | 0.1 - 125.4 (20.6) |
DEL PEAK 38(17P13.3) WILD-TYPE | 408 | 42 | 0.1 - 191.8 (23.9) |
P value = 0.000232 (Wilcoxon-test), Q value = 0.00097
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 526 | 64.0 (11.2) |
DEL PEAK 38(17P13.3) MUTATED | 118 | 67.0 (9.0) |
DEL PEAK 38(17P13.3) WILD-TYPE | 408 | 63.1 (11.6) |
P value = 1e-05 (Fisher's exact test), Q value = 5.9e-05
nPatients | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA | MIXED SEROUS AND ENDOMETRIOID | SEROUS ENDOMETRIAL ADENOCARCINOMA |
---|---|---|---|
ALL | 395 | 21 | 112 |
DEL PEAK 38(17P13.3) MUTATED | 46 | 9 | 64 |
DEL PEAK 38(17P13.3) WILD-TYPE | 349 | 12 | 48 |
P value = 0.0451 (Fisher's exact test), Q value = 0.089
nPatients | NO | YES |
---|---|---|
ALL | 141 | 387 |
DEL PEAK 38(17P13.3) MUTATED | 23 | 96 |
DEL PEAK 38(17P13.3) WILD-TYPE | 118 | 291 |
P value = 0.146 (Fisher's exact test), Q value = 0.23
nPatients | R0 | R1 | R2 | RX |
---|---|---|---|---|
ALL | 363 | 23 | 17 | 35 |
DEL PEAK 38(17P13.3) MUTATED | 72 | 7 | 4 | 12 |
DEL PEAK 38(17P13.3) WILD-TYPE | 291 | 16 | 13 | 23 |
P value = 0.00155 (Fisher's exact test), Q value = 0.0051
nPatients | AMERICAN INDIAN OR ALASKA NATIVE | ASIAN | BLACK OR AFRICAN AMERICAN | NATIVE HAWAIIAN OR OTHER PACIFIC ISLANDER | WHITE |
---|---|---|---|---|---|
ALL | 4 | 20 | 101 | 9 | 366 |
DEL PEAK 38(17P13.3) MUTATED | 0 | 2 | 37 | 3 | 69 |
DEL PEAK 38(17P13.3) WILD-TYPE | 4 | 18 | 64 | 6 | 297 |
P value = 0.000381 (logrank test), Q value = 0.0015
nPatients | nDeath | Duration Range (Median), Month | |
---|---|---|---|
ALL | 526 | 69 | 0.1 - 191.8 (23.3) |
DEL PEAK 39(17P11.2) MUTATED | 123 | 27 | 0.1 - 125.4 (20.5) |
DEL PEAK 39(17P11.2) WILD-TYPE | 403 | 42 | 0.1 - 191.8 (23.9) |
P value = 4.49e-06 (Wilcoxon-test), Q value = 5.9e-05
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 526 | 64.0 (11.2) |
DEL PEAK 39(17P11.2) MUTATED | 123 | 67.7 (9.3) |
DEL PEAK 39(17P11.2) WILD-TYPE | 403 | 62.9 (11.5) |
P value = 1e-05 (Fisher's exact test), Q value = 5.9e-05
nPatients | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA | MIXED SEROUS AND ENDOMETRIOID | SEROUS ENDOMETRIAL ADENOCARCINOMA |
---|---|---|---|
ALL | 395 | 21 | 112 |
DEL PEAK 39(17P11.2) MUTATED | 45 | 8 | 71 |
DEL PEAK 39(17P11.2) WILD-TYPE | 350 | 13 | 41 |
P value = 0.105 (Fisher's exact test), Q value = 0.18
nPatients | NO | YES |
---|---|---|
ALL | 141 | 387 |
DEL PEAK 39(17P11.2) MUTATED | 26 | 98 |
DEL PEAK 39(17P11.2) WILD-TYPE | 115 | 289 |
P value = 0.0125 (Fisher's exact test), Q value = 0.03
nPatients | AMERICAN INDIAN OR ALASKA NATIVE | ASIAN | BLACK OR AFRICAN AMERICAN | NATIVE HAWAIIAN OR OTHER PACIFIC ISLANDER | WHITE |
---|---|---|---|---|---|
ALL | 4 | 20 | 101 | 9 | 366 |
DEL PEAK 39(17P11.2) MUTATED | 0 | 2 | 36 | 1 | 77 |
DEL PEAK 39(17P11.2) WILD-TYPE | 4 | 18 | 65 | 8 | 289 |
P value = 0.0291 (logrank test), Q value = 0.061
nPatients | nDeath | Duration Range (Median), Month | |
---|---|---|---|
ALL | 526 | 69 | 0.1 - 191.8 (23.3) |
DEL PEAK 40(17Q11.2) MUTATED | 100 | 20 | 0.2 - 125.4 (22.3) |
DEL PEAK 40(17Q11.2) WILD-TYPE | 426 | 49 | 0.1 - 191.8 (23.4) |
P value = 8.58e-07 (Wilcoxon-test), Q value = 2.7e-05
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 526 | 64.0 (11.2) |
DEL PEAK 40(17Q11.2) MUTATED | 101 | 68.3 (9.4) |
DEL PEAK 40(17Q11.2) WILD-TYPE | 425 | 63.0 (11.4) |
P value = 1e-05 (Fisher's exact test), Q value = 5.9e-05
nPatients | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA | MIXED SEROUS AND ENDOMETRIOID | SEROUS ENDOMETRIAL ADENOCARCINOMA |
---|---|---|---|
ALL | 395 | 21 | 112 |
DEL PEAK 40(17Q11.2) MUTATED | 43 | 5 | 53 |
DEL PEAK 40(17Q11.2) WILD-TYPE | 352 | 16 | 59 |
P value = 0.000198 (logrank test), Q value = 0.00086
nPatients | nDeath | Duration Range (Median), Month | |
---|---|---|---|
ALL | 526 | 69 | 0.1 - 191.8 (23.3) |
DEL PEAK 41(17Q21.31) MUTATED | 108 | 26 | 0.2 - 125.4 (22.3) |
DEL PEAK 41(17Q21.31) WILD-TYPE | 418 | 43 | 0.1 - 191.8 (23.4) |
P value = 1.18e-05 (Wilcoxon-test), Q value = 6.9e-05
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 526 | 64.0 (11.2) |
DEL PEAK 41(17Q21.31) MUTATED | 108 | 67.9 (9.7) |
DEL PEAK 41(17Q21.31) WILD-TYPE | 418 | 63.0 (11.4) |
P value = 1e-05 (Fisher's exact test), Q value = 5.9e-05
nPatients | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA | MIXED SEROUS AND ENDOMETRIOID | SEROUS ENDOMETRIAL ADENOCARCINOMA |
---|---|---|---|
ALL | 395 | 21 | 112 |
DEL PEAK 41(17Q21.31) MUTATED | 44 | 5 | 60 |
DEL PEAK 41(17Q21.31) WILD-TYPE | 351 | 16 | 52 |
P value = 0.0522 (Fisher's exact test), Q value = 0.1
nPatients | NO | YES |
---|---|---|
ALL | 141 | 387 |
DEL PEAK 41(17Q21.31) MUTATED | 21 | 88 |
DEL PEAK 41(17Q21.31) WILD-TYPE | 120 | 299 |
P value = 0.0707 (Fisher's exact test), Q value = 0.13
nPatients | R0 | R1 | R2 | RX |
---|---|---|---|---|
ALL | 363 | 23 | 17 | 35 |
DEL PEAK 41(17Q21.31) MUTATED | 66 | 6 | 6 | 11 |
DEL PEAK 41(17Q21.31) WILD-TYPE | 297 | 17 | 11 | 24 |
P value = 0.0481 (Fisher's exact test), Q value = 0.094
nPatients | HISPANIC OR LATINO | NOT HISPANIC OR LATINO |
---|---|---|
ALL | 14 | 367 |
DEL PEAK 41(17Q21.31) MUTATED | 6 | 73 |
DEL PEAK 41(17Q21.31) WILD-TYPE | 8 | 294 |
P value = 3e-04 (Wilcoxon-test), Q value = 0.0012
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 526 | 64.0 (11.2) |
DEL PEAK 42(18Q21.2) MUTATED | 89 | 67.6 (9.8) |
DEL PEAK 42(18Q21.2) WILD-TYPE | 437 | 63.3 (11.4) |
P value = 1e-05 (Fisher's exact test), Q value = 5.9e-05
nPatients | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA | MIXED SEROUS AND ENDOMETRIOID | SEROUS ENDOMETRIAL ADENOCARCINOMA |
---|---|---|---|
ALL | 395 | 21 | 112 |
DEL PEAK 42(18Q21.2) MUTATED | 37 | 6 | 46 |
DEL PEAK 42(18Q21.2) WILD-TYPE | 358 | 15 | 66 |
P value = 0.00383 (Fisher's exact test), Q value = 0.011
nPatients | NO | YES |
---|---|---|
ALL | 141 | 387 |
DEL PEAK 42(18Q21.2) MUTATED | 13 | 76 |
DEL PEAK 42(18Q21.2) WILD-TYPE | 128 | 311 |
P value = 0.129 (Fisher's exact test), Q value = 0.21
nPatients | R0 | R1 | R2 | RX |
---|---|---|---|---|
ALL | 363 | 23 | 17 | 35 |
DEL PEAK 42(18Q21.2) MUTATED | 51 | 5 | 5 | 8 |
DEL PEAK 42(18Q21.2) WILD-TYPE | 312 | 18 | 12 | 27 |
P value = 0.0696 (Fisher's exact test), Q value = 0.13
nPatients | AMERICAN INDIAN OR ALASKA NATIVE | ASIAN | BLACK OR AFRICAN AMERICAN | NATIVE HAWAIIAN OR OTHER PACIFIC ISLANDER | WHITE |
---|---|---|---|---|---|
ALL | 4 | 20 | 101 | 9 | 366 |
DEL PEAK 42(18Q21.2) MUTATED | 0 | 2 | 25 | 3 | 54 |
DEL PEAK 42(18Q21.2) WILD-TYPE | 4 | 18 | 76 | 6 | 312 |
P value = 0.0051 (logrank test), Q value = 0.014
nPatients | nDeath | Duration Range (Median), Month | |
---|---|---|---|
ALL | 526 | 69 | 0.1 - 191.8 (23.3) |
DEL PEAK 43(18Q23) MUTATED | 94 | 19 | 0.1 - 116.2 (20.0) |
DEL PEAK 43(18Q23) WILD-TYPE | 432 | 50 | 0.1 - 191.8 (23.9) |
P value = 0.000443 (Wilcoxon-test), Q value = 0.0017
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 526 | 64.0 (11.2) |
DEL PEAK 43(18Q23) MUTATED | 94 | 67.5 (10.2) |
DEL PEAK 43(18Q23) WILD-TYPE | 432 | 63.2 (11.3) |
P value = 1e-05 (Fisher's exact test), Q value = 5.9e-05
nPatients | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA | MIXED SEROUS AND ENDOMETRIOID | SEROUS ENDOMETRIAL ADENOCARCINOMA |
---|---|---|---|
ALL | 395 | 21 | 112 |
DEL PEAK 43(18Q23) MUTATED | 37 | 6 | 52 |
DEL PEAK 43(18Q23) WILD-TYPE | 358 | 15 | 60 |
P value = 0.000482 (Fisher's exact test), Q value = 0.0018
nPatients | NO | YES |
---|---|---|
ALL | 141 | 387 |
DEL PEAK 43(18Q23) MUTATED | 12 | 83 |
DEL PEAK 43(18Q23) WILD-TYPE | 129 | 304 |
P value = 0.0122 (Fisher's exact test), Q value = 0.029
nPatients | R0 | R1 | R2 | RX |
---|---|---|---|---|
ALL | 363 | 23 | 17 | 35 |
DEL PEAK 43(18Q23) MUTATED | 56 | 5 | 8 | 7 |
DEL PEAK 43(18Q23) WILD-TYPE | 307 | 18 | 9 | 28 |
P value = 0.0608 (Fisher's exact test), Q value = 0.11
nPatients | AMERICAN INDIAN OR ALASKA NATIVE | ASIAN | BLACK OR AFRICAN AMERICAN | NATIVE HAWAIIAN OR OTHER PACIFIC ISLANDER | WHITE |
---|---|---|---|---|---|
ALL | 4 | 20 | 101 | 9 | 366 |
DEL PEAK 43(18Q23) MUTATED | 1 | 2 | 26 | 3 | 57 |
DEL PEAK 43(18Q23) WILD-TYPE | 3 | 18 | 75 | 6 | 309 |
P value = 0.149 (Fisher's exact test), Q value = 0.24
nPatients | HISPANIC OR LATINO | NOT HISPANIC OR LATINO |
---|---|---|
ALL | 14 | 367 |
DEL PEAK 43(18Q23) MUTATED | 5 | 65 |
DEL PEAK 43(18Q23) WILD-TYPE | 9 | 302 |
P value = 7.09e-06 (logrank test), Q value = 5.9e-05
nPatients | nDeath | Duration Range (Median), Month | |
---|---|---|---|
ALL | 526 | 69 | 0.1 - 191.8 (23.3) |
DEL PEAK 44(19P13.3) MUTATED | 150 | 35 | 0.1 - 125.4 (21.9) |
DEL PEAK 44(19P13.3) WILD-TYPE | 376 | 34 | 0.1 - 191.8 (23.8) |
P value = 1.35e-10 (Wilcoxon-test), Q value = 4.7e-08
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 526 | 64.0 (11.2) |
DEL PEAK 44(19P13.3) MUTATED | 150 | 68.6 (8.6) |
DEL PEAK 44(19P13.3) WILD-TYPE | 376 | 62.2 (11.6) |
P value = 1e-05 (Fisher's exact test), Q value = 5.9e-05
nPatients | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA | MIXED SEROUS AND ENDOMETRIOID | SEROUS ENDOMETRIAL ADENOCARCINOMA |
---|---|---|---|
ALL | 395 | 21 | 112 |
DEL PEAK 44(19P13.3) MUTATED | 45 | 8 | 98 |
DEL PEAK 44(19P13.3) WILD-TYPE | 350 | 13 | 14 |
P value = 0.0815 (Fisher's exact test), Q value = 0.15
nPatients | NO | YES |
---|---|---|
ALL | 141 | 387 |
DEL PEAK 44(19P13.3) MUTATED | 32 | 119 |
DEL PEAK 44(19P13.3) WILD-TYPE | 109 | 268 |
P value = 0.00614 (Fisher's exact test), Q value = 0.016
nPatients | R0 | R1 | R2 | RX |
---|---|---|---|---|
ALL | 363 | 23 | 17 | 35 |
DEL PEAK 44(19P13.3) MUTATED | 90 | 9 | 9 | 15 |
DEL PEAK 44(19P13.3) WILD-TYPE | 273 | 14 | 8 | 20 |
P value = 0.00027 (Fisher's exact test), Q value = 0.0011
nPatients | AMERICAN INDIAN OR ALASKA NATIVE | ASIAN | BLACK OR AFRICAN AMERICAN | NATIVE HAWAIIAN OR OTHER PACIFIC ISLANDER | WHITE |
---|---|---|---|---|---|
ALL | 4 | 20 | 101 | 9 | 366 |
DEL PEAK 44(19P13.3) MUTATED | 1 | 2 | 46 | 3 | 90 |
DEL PEAK 44(19P13.3) WILD-TYPE | 3 | 18 | 55 | 6 | 276 |
P value = 0.0869 (logrank test), Q value = 0.16
nPatients | nDeath | Duration Range (Median), Month | |
---|---|---|---|
ALL | 526 | 69 | 0.1 - 191.8 (23.3) |
DEL PEAK 45(19P12) MUTATED | 57 | 12 | 0.2 - 116.2 (24.0) |
DEL PEAK 45(19P12) WILD-TYPE | 469 | 57 | 0.1 - 191.8 (23.3) |
P value = 0.0143 (Wilcoxon-test), Q value = 0.033
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 526 | 64.0 (11.2) |
DEL PEAK 45(19P12) MUTATED | 56 | 67.2 (9.7) |
DEL PEAK 45(19P12) WILD-TYPE | 470 | 63.6 (11.3) |
P value = 1e-05 (Fisher's exact test), Q value = 5.9e-05
nPatients | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA | MIXED SEROUS AND ENDOMETRIOID | SEROUS ENDOMETRIAL ADENOCARCINOMA |
---|---|---|---|
ALL | 395 | 21 | 112 |
DEL PEAK 45(19P12) MUTATED | 20 | 5 | 32 |
DEL PEAK 45(19P12) WILD-TYPE | 375 | 16 | 80 |
P value = 0.0256 (Fisher's exact test), Q value = 0.055
nPatients | NO | YES |
---|---|---|
ALL | 141 | 387 |
DEL PEAK 45(19P12) MUTATED | 8 | 49 |
DEL PEAK 45(19P12) WILD-TYPE | 133 | 338 |
P value = 0.126 (Fisher's exact test), Q value = 0.21
nPatients | AMERICAN INDIAN OR ALASKA NATIVE | ASIAN | BLACK OR AFRICAN AMERICAN | NATIVE HAWAIIAN OR OTHER PACIFIC ISLANDER | WHITE |
---|---|---|---|---|---|
ALL | 4 | 20 | 101 | 9 | 366 |
DEL PEAK 45(19P12) MUTATED | 1 | 1 | 17 | 1 | 34 |
DEL PEAK 45(19P12) WILD-TYPE | 3 | 19 | 84 | 8 | 332 |
P value = 0.00191 (logrank test), Q value = 0.0061
nPatients | nDeath | Duration Range (Median), Month | |
---|---|---|---|
ALL | 526 | 69 | 0.1 - 191.8 (23.3) |
DEL PEAK 46(19Q13.43) MUTATED | 64 | 16 | 0.1 - 125.4 (21.9) |
DEL PEAK 46(19Q13.43) WILD-TYPE | 462 | 53 | 0.1 - 191.8 (23.4) |
P value = 0.000307 (Wilcoxon-test), Q value = 0.0012
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 526 | 64.0 (11.2) |
DEL PEAK 46(19Q13.43) MUTATED | 64 | 68.3 (9.7) |
DEL PEAK 46(19Q13.43) WILD-TYPE | 462 | 63.4 (11.3) |
P value = 1e-05 (Fisher's exact test), Q value = 5.9e-05
nPatients | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA | MIXED SEROUS AND ENDOMETRIOID | SEROUS ENDOMETRIAL ADENOCARCINOMA |
---|---|---|---|
ALL | 395 | 21 | 112 |
DEL PEAK 46(19Q13.43) MUTATED | 19 | 4 | 42 |
DEL PEAK 46(19Q13.43) WILD-TYPE | 376 | 17 | 70 |
P value = 0.0255 (Fisher's exact test), Q value = 0.055
nPatients | R0 | R1 | R2 | RX |
---|---|---|---|---|
ALL | 363 | 23 | 17 | 35 |
DEL PEAK 46(19Q13.43) MUTATED | 36 | 6 | 3 | 7 |
DEL PEAK 46(19Q13.43) WILD-TYPE | 327 | 17 | 14 | 28 |
P value = 8.85e-05 (logrank test), Q value = 0.00043
nPatients | nDeath | Duration Range (Median), Month | |
---|---|---|---|
ALL | 526 | 69 | 0.1 - 191.8 (23.3) |
DEL PEAK 47(20P12.1) MUTATED | 35 | 13 | 0.3 - 149.6 (21.9) |
DEL PEAK 47(20P12.1) WILD-TYPE | 491 | 56 | 0.1 - 191.8 (23.4) |
P value = 0.14 (Wilcoxon-test), Q value = 0.23
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 526 | 64.0 (11.2) |
DEL PEAK 47(20P12.1) MUTATED | 34 | 66.9 (10.4) |
DEL PEAK 47(20P12.1) WILD-TYPE | 492 | 63.8 (11.3) |
P value = 2e-04 (Fisher's exact test), Q value = 0.00086
nPatients | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA | MIXED SEROUS AND ENDOMETRIOID | SEROUS ENDOMETRIAL ADENOCARCINOMA |
---|---|---|---|
ALL | 395 | 21 | 112 |
DEL PEAK 47(20P12.1) MUTATED | 16 | 2 | 17 |
DEL PEAK 47(20P12.1) WILD-TYPE | 379 | 19 | 95 |
P value = 0.106 (Fisher's exact test), Q value = 0.18
nPatients | R0 | R1 | R2 | RX |
---|---|---|---|---|
ALL | 363 | 23 | 17 | 35 |
DEL PEAK 47(20P12.1) MUTATED | 20 | 1 | 2 | 5 |
DEL PEAK 47(20P12.1) WILD-TYPE | 343 | 22 | 15 | 30 |
P value = 0.000218 (logrank test), Q value = 0.00092
nPatients | nDeath | Duration Range (Median), Month | |
---|---|---|---|
ALL | 526 | 69 | 0.1 - 191.8 (23.3) |
DEL PEAK 48(22Q13.32) MUTATED | 135 | 28 | 0.1 - 116.2 (20.0) |
DEL PEAK 48(22Q13.32) WILD-TYPE | 391 | 41 | 0.1 - 191.8 (24.3) |
P value = 1.05e-07 (Wilcoxon-test), Q value = 4.6e-06
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 526 | 64.0 (11.2) |
DEL PEAK 48(22Q13.32) MUTATED | 135 | 68.4 (9.5) |
DEL PEAK 48(22Q13.32) WILD-TYPE | 391 | 62.5 (11.4) |
P value = 1e-05 (Fisher's exact test), Q value = 5.9e-05
nPatients | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA | MIXED SEROUS AND ENDOMETRIOID | SEROUS ENDOMETRIAL ADENOCARCINOMA |
---|---|---|---|
ALL | 395 | 21 | 112 |
DEL PEAK 48(22Q13.32) MUTATED | 54 | 10 | 72 |
DEL PEAK 48(22Q13.32) WILD-TYPE | 341 | 11 | 40 |
P value = 0.0242 (Fisher's exact test), Q value = 0.053
nPatients | NO | YES |
---|---|---|
ALL | 141 | 387 |
DEL PEAK 48(22Q13.32) MUTATED | 26 | 110 |
DEL PEAK 48(22Q13.32) WILD-TYPE | 115 | 277 |
P value = 0.0157 (Fisher's exact test), Q value = 0.036
nPatients | AMERICAN INDIAN OR ALASKA NATIVE | ASIAN | BLACK OR AFRICAN AMERICAN | NATIVE HAWAIIAN OR OTHER PACIFIC ISLANDER | WHITE |
---|---|---|---|---|---|
ALL | 4 | 20 | 101 | 9 | 366 |
DEL PEAK 48(22Q13.32) MUTATED | 1 | 1 | 37 | 2 | 89 |
DEL PEAK 48(22Q13.32) WILD-TYPE | 3 | 19 | 64 | 7 | 277 |
P value = 1.97e-05 (logrank test), Q value = 0.00011
nPatients | nDeath | Duration Range (Median), Month | |
---|---|---|---|
ALL | 526 | 69 | 0.1 - 191.8 (23.3) |
DEL PEAK 49(XP21.1) MUTATED | 83 | 23 | 0.3 - 113.4 (20.1) |
DEL PEAK 49(XP21.1) WILD-TYPE | 443 | 46 | 0.1 - 191.8 (23.5) |
P value = 0.000139 (Wilcoxon-test), Q value = 0.00064
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 526 | 64.0 (11.2) |
DEL PEAK 49(XP21.1) MUTATED | 83 | 68.1 (9.3) |
DEL PEAK 49(XP21.1) WILD-TYPE | 443 | 63.2 (11.4) |
P value = 1e-05 (Fisher's exact test), Q value = 5.9e-05
nPatients | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA | MIXED SEROUS AND ENDOMETRIOID | SEROUS ENDOMETRIAL ADENOCARCINOMA |
---|---|---|---|
ALL | 395 | 21 | 112 |
DEL PEAK 49(XP21.1) MUTATED | 31 | 3 | 50 |
DEL PEAK 49(XP21.1) WILD-TYPE | 364 | 18 | 62 |
P value = 0.125 (Fisher's exact test), Q value = 0.21
nPatients | R0 | R1 | R2 | RX |
---|---|---|---|---|
ALL | 363 | 23 | 17 | 35 |
DEL PEAK 49(XP21.1) MUTATED | 53 | 2 | 6 | 6 |
DEL PEAK 49(XP21.1) WILD-TYPE | 310 | 21 | 11 | 29 |
P value = 0.00411 (Fisher's exact test), Q value = 0.012
nPatients | AMERICAN INDIAN OR ALASKA NATIVE | ASIAN | BLACK OR AFRICAN AMERICAN | NATIVE HAWAIIAN OR OTHER PACIFIC ISLANDER | WHITE |
---|---|---|---|---|---|
ALL | 4 | 20 | 101 | 9 | 366 |
DEL PEAK 49(XP21.1) MUTATED | 1 | 1 | 28 | 1 | 47 |
DEL PEAK 49(XP21.1) WILD-TYPE | 3 | 19 | 73 | 8 | 319 |
-
Copy number data file = all_lesions.txt from GISTIC pipeline
-
Processed Copy number data file = /xchip/cga/gdac-prod/tcga-gdac/jobResults/GDAC_Correlate_Genomic_Events_Preprocess/UCEC-TP/15106279/transformed.cor.cli.txt
-
Clinical data file = /xchip/cga/gdac-prod/tcga-gdac/jobResults/Append_Data/UCEC-TP/15094079/UCEC-TP.merged_data.txt
-
Number of patients = 528
-
Number of significantly focal cnvs = 100
-
Number of selected clinical features = 7
-
Exclude genes that fewer than K tumors have mutations, K = 3
For survival clinical features, the Kaplan-Meier survival curves of tumors with and without gene mutations were plotted and the statistical significance P values were estimated by logrank test (Bland and Altman 2004) using the 'survdiff' function in R
For binary or multi-class clinical features (nominal or ordinal), two-tailed Fisher's exact tests (Fisher 1922) were used to estimate the P values using the 'fisher.test' function in R
For multiple hypothesis correction, Q value is the False Discovery Rate (FDR) analogue of the P value (Benjamini and Hochberg 1995), defined as the minimum FDR at which the test may be called significant. We used the 'Benjamini and Hochberg' method of 'p.adjust' function in R to convert P values into Q values.
In addition to the links below, the full results of the analysis summarized in this report can also be downloaded programmatically using firehose_get, or interactively from either the Broad GDAC website or TCGA Data Coordination Center Portal.